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Abstract 
 
Background: There is a high prevalence of unhealthy alcohol use and problem 
drug use among patients presenting to general hospital settings. However, 
many unhealthy alcohol users and problem drug users in these settings are not 
even aware, or do not acknowledge that they have such problems. Their 
presentation to hospital for the treatment of other conditions offers an 
opportunity to engage with them. However, there is uncertainty over how best to 
identify, assess and intervene with this population. 
 
Aim: To investigate how unhealthy alcohol users or problem drug users can be 
effectively identified, assessed and intervened with when they present to 
general hospital settings for the treatment of other conditions. 
 
Methods: This thesis is based on six published papers that used systematic 
review, meta-regression and Delphi methods.  
 
Main findings: To date, research on interventions for unhealthy alcohol use in 
general hospital settings has focused on brief interventions (BIs). Multiple 
session BIs are likely to be beneficial for unhealthy alcohol use in these 
settings. Where targeted screening and intervention is the strategy of choice, a 
focus on gastroenterology and emergency medicine is a promising way to target 
resources for unhealthy alcohol use. There is lack of evidence on how to 
effectively identify and intervene with problem drug users. The available 
evidence favours the ASSIST as the problem drug use screening instrument of 
choice. There is also lack of evidence to inform which comprehensive 
substance misuse assessment package to use in these settings. 
 
Conclusions: There is still need for robustly designed research on how to 
effectively identify, assess and intervene with unhealthy alcohol users and 
problem drug users within general hospital settings. It is to be hoped that the 
body of work presented in this thesis will, effectively, contribute to the 
development stage for other primary research in the future. 
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1. Introduction 
 
Unhealthy alcohol use and problem drug use have a major impact on population 
health, health service costs and society (United Nations Office on Drugs and 
Crime (UNODC), 2012; World Health Organization (WHO), 2011). Many 
unhealthy alcohol users or problem drug users do not actively seek help for 
these problems (Madras et al., 2009; WHO, 2011). They may however present 
to healthcare settings including hospitals with other illnesses or conditions that 
might or might not be related to unhealthy alcohol use or problem drug use 
(Madras et al., 2009; Crome, Bloor and Thom, 2006; Watson, 2000). Hospitals 
are therefore an opportune setting to identify patients with these problems and 
provide interventions. There is however uncertainty over how best to do this, 
including which interventions should be delivered.   
 
This thesis is based on six papers (Table 1) that examine a number of key 
interrelated themes concerning the identification and provision of interventions 
for unhealthy alcohol use and problem drug use among adult patients 
presenting at general hospital settings. The full texts of the papers are provided 
as Appendix 1. This integrative chapter clarifies how these papers form a 
coherent body of work and make an original contribution to knowledge and 
understanding. 
 
Before proceeding further, it is important to consider the definitions used for this 
thesis. Unhealthy alcohol use is defined as any level of drinking that causes 
problems or puts the drinker at risk of developing problems (Saitz et al., 2007). 
Problem drug use is defined as regular illicit drug use with or without drug use 
disorders or dependence (UNODC, 2014). Illicit drug use is defined as the use 
of drugs which are under international control (and which may or may not have 
licit medical purposes) but which are produced, trafficked and consumed illicitly 
(UNODC, n.d.). The six papers presented for this thesis utilised a variety of 
terms to refer to substance use. However, following reflection, unhealthy alcohol 
use and problem drug use have been adapted for this integrative chapter as 
terms that best capture the types of substance use on which these papers 
focus. 
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Table 1: List of Papers included as part of the thesis 
 
Paper 
number 
Citation 
Paper 1 Mdege, N.D. and Lang, J., on behalf of the ARIAS Research Group. 
(2011). Screening instruments for detecting illicit drug use/abuse that 
could be useful in general hospital wards: a systematic review. 
Addictive Behaviors, 36(12), 1111–1119. 
Paper 2 Sweetman, J., Raistrick, D., Mdege, N.D. and Crosby, H. (2013). A 
systematic review of substance misuse assessment packages. Drug 
and Alcohol Review, 32(4), 347-355. 
Paper 3 Mdege, N.D., Fayter, D., Watson, J.M., Stirk, L., Sowden, A. and 
Godfrey, C. (2013). Interventions for reducing alcohol consumption 
among general hospital inpatient heavy alcohol users: a systematic 
review. Drug and Alcohol Dependence, 131(1-2), 1-22. 
Paper 4 Watson, J.M., Fayter, D., Mdege, N., Stirk, L., Sowden, A.J. and 
Godfrey, C. (2013). Interventions for alcohol and drug problems in 
outpatient settings: a systematic review. Drug and Alcohol Review, 
32(4), 356-367. 
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(primary care vs. hospital setting) among studies of the effectiveness 
of brief interventions among heavy alcohol users: a systematic 
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Paper 6 Mdege, N.D., Raistrick, D. and Johnson, G. (2014). Medical 
specialists’ views on the impact of reducing alcohol consumption on 
prognosis of, and risk of, hospital admission due to specific medical 
conditions: results from a Delphi survey. Journal of Evaluation in 
Clinical Practice, 20(1), 100-110. 
 
The work presented here was carried out as part of a larger programme of 
research entitled Addiction Research in Acute Settings (ARiAS). ARiAS aimed 
to investigate methods for improving the physical and mental health of 
unhealthy alcohol users and problem drug users identified within general 
hospital settings in Leeds, United Kingdom (UK). The general hospital settings 
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of interest were inpatient medical units, hospital outpatients/ ambulatory care 
(where medical care is provided on an outpatient basis, including diagnosis, 
observation, consultation, treatment, intervention, and rehabilitation services), 
and accident and emergency departments (including trauma centres) based at 
hospitals not specializing in the treatment of psychiatric disorders or addiction. 
 
This introduction section comprises a number of subsections: 
 The background section summarizes: 
o the extent of the problems associated with alcohol and illicit drug 
use at general population level, and  
o unhealthy alcohol use and problem drug use in general hospital 
settings including prevalence; presentation of unhealthy alcohol 
users and problem drug users; the role and impact of healthcare 
workers; an introduction to screening, assessment and 
interventions which demonstrate how the papers form a coherent 
body of work; and implementation challenges 
 A description of the ARiAS programme 
 The aim 
 Objectives, and 
 A description of the thesis structure. 
 
1.1 Background 
 
1.1.1 The extent of the problem 
 
1.1.1.1 Alcohol 
 
Alcohol is the world’s third largest risk factor for premature deaths, disease and 
disability (WHO, 2010). In 2012, 5.1% of the burden of disease as measured in 
disability adjusted life years, and almost 6% of all deaths worldwide were 
attributed to alcohol (WHO, 2014). In the UK over the past decade alcohol has 
increasingly been recognised as one of the highest priority public health issues 
(Davies, 2014; Department of Health, 2013). In England in 2010, 26% of adult 
men and 17% of adult women reported drinking above the recommended units 
- 16 - 
 
in a typical week (21-28 for men; 14-21 for women) (Health and Social Care 
Information Centre (HSCIC), 2012; Office for National Statistics, 2012). 
 
Unhealthy alcohol use is associated with a wide range of both acute and 
chronic physical health, mental health and social problems (WHO, 2004; WHO, 
2014). The main causal impact on these problems is exerted by overall volume 
of alcohol consumed and patterns of drinking (Rehm et al., 2010). The 
relationship between these two main dimensions and the health and social 
harms is through three main intermediate mechanisms: direct biological effects 
of alcohol on organs and tissues, intoxication and dependence (Rehm et al., 
2003; Rehm et al., 2010). In addition, the quality of alcohol consumed may also 
impact on health, for example through methanol or lead poisoning (Rehm et al., 
2010). The main pathways and relationships are shown in Figure 1. 
 
Jones and Bellis (2014) list 52 alcohol attributable conditions: 20 of these are 
wholly attributable to alcohol consumption (i.e. alcohol is 100% contributory e.g. 
alcoholic liver disease), and 32 are partially attributable to alcohol (i.e. only a 
proportion of cases are attributable to alcohol consumption e.g. oesophageal 
cancer). For the UK in 2012/2013, there were over a million hospital admissions 
with a primary or secondary diagnosis related to alcohol (HSCIC, 2014a). In 
2012, 6,490 deaths in the UK were related to alcohol (HSCIC, 2014a). 
Unhealthy alcohol use costs the UK’s National Health Service (NHS) 
approximately £3.5 billion per year, 78% of which is incurred for hospital-based 
care; and society as a whole approximately £21 billion annually (Department of 
Health, 2013). 
 
Alcohol consumption can also affect the social behaviour of individuals, or their 
interaction with partners and other family members (Klingemann and Gmel, 
2001).The social harms due to alcohol include workplace-related problems, 
family and domestic problems, public disorder and interpersonal violence 
(Klingemann and Gmel, 2001; Odlaug et al., 2015). The social consequences 
can also affect individuals other than the unhealthy alcohol user. For example 
family members can be affected by the unhealthy alcohol user’s failure to fulfil 
social role obligations, or incidences of violence (WHO, 2004). These events 
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have an impact on society as a whole, for example through reduced economic 
productivity, or increased use of resources for criminal justice, healthcare 
systems and other social institutions (Gmel and Rehm, 2003).  
 
 
Figure 1: Model of alcohol consumption, mediating variables, and short-
term and long-term consequences. 
Adapted from Rehm et al., 2003: Rehm et al., 2010; WHO, 2004. 
 
 
 
Alcohol consumption 
Patterns Volume Quality 
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1.1.1.2 Drugs 
 
Between 16 million and 39 million adults worldwide are problem drug users 
(UNODC, 2014). As with alcohol consumption, problem drug use is also 
associated with a wide range of physical health, mental health and social 
problems (Degenhardt and Hall, 2012). Around 0.2 million drug related deaths 
were reported in 2012 (UNODC, 2014). In the UK estimates suggest there are 
about 380,000 problem drug users, a rate of 9.3 per 1,000 population (Davies et 
al., 2011). In England problem drug use was responsible for 1,957 deaths in 
2013, an increase of 321 from 2012 (HSCIC, 2014b). It was also responsible for 
7,107 hospital admissions with a primary diagnosis of drug-related mental 
health and behavioural disorders in 2013/14, a 8.5% increase from 2012/13; 
and 13,917 admissions with a primary diagnosis of illicit drug poisoning in 
2013/14, a 76,7% increase since 2003/04 (HSCIC, 2014b). 
  
The risk of morbidity and premature mortality from problem drug use is 
dependent on a number of factors including type of drugs used, patterns of use 
(number of different drugs used, frequency and route of administration), volume 
or dose and quality (Degenhardt and Hall, 2012). Similar to alcohol, the adverse 
effects of problem drug use are through three main intermediate mechanisms: 
direct toxic biochemical effects of drugs on organs and tissues, intoxication and 
dependence (Degenhardt and Hall, 2012). The risks include acute diseases or 
conditions such as overdose and accidental injury and chronic diseases or 
conditions such as cardiovascular diseases, blood borne viruses (e.g. HIV, 
hepatitis B and hepatitis C) and mental health disorders (Degenhardt and Hall, 
2012; UNODC, 2014). 
 
Problem drug use also has a negative impact on economic and social 
development (UNODC, 2014).  It results in adverse social effects on drug users, 
such as stigma and discrimination; as well as adverse effects that drug users’ 
behaviours have on public amenity (e.g. drug dealing and discarded injection 
equipment) and public safety (e.g. violence between drug dealers and property 
crime to finance illicit drug use). It also contributes to instability and insecurity 
(UNODC, 2014).  Chronic social problems may also include family problems 
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and unemployment. Problem drug use is also associated with significant 
economic and social costs, including costs to the health service, criminal justice 
and other social services (Gordon et al., 2006).  
 
1.1.2 Unhealthy alcohol use and problem drug use in general hospital 
settings 
 
1.1.2.1 Prevalence 
 
Evidence indicates a high prevalence of unhealthy alcohol use and problem 
drug use among patients presenting in general hospital settings (Crome, Bloor 
and Thom, 2006). Roche, Freeman and Skinner’s (2005) review found average 
prevalence rates of self-report positive alcohol screen of 16.5% among hospital 
inpatients and 15.6% in emergency departments. In England, Pirmohamed et al 
(2000) reported that alcohol related problems accounted for 12% of accident 
and emergency attendances, and 6.2% of all hospital admissions. In Scotland, 
self-report alcohol positive screen prevalence of 18.6% (Cameron, Morris and 
Forrest, 2006) and 25% (Watson, 2000), and a prevalence of alcohol related 
illness of 25% (Hislop and Heading, 2004) have been reported among general 
hospital inpatients. A recent study by Johnson and colleagues (2014) reported a 
prevalence of 34.7% for unhealthy alcohol use in outpatient clinics at a large 
public hospital in Australia. 
 
In England, Binks and colleagues (2005) reported prevalence of illicit drug use 
among patients attending an accident and emergency department of 16% for 
previous month use, and 10% for use within the previous 24 hours. In another 
study, 7% of adult patients presenting with chest pain at accident and 
emergency departments tested positive for cocaine use (Maric et al., 2010). 
Binks and colleague (2005) also reported that about 7% of all patients 
attendances were directly or indirectly related to illicit drug use, with 50% of 
these attendances requiring hospital admission.  
 
The high prevalence of unhealthy alcohol use and problem drug use in general 
hospital settings means it may be beneficial to incorporate proactive 
- 20 - 
 
identification and interventions for these problems as routine practice within 
hospital settings (Roche, Freeman and Skinner, 2005). 
 
1.1.2.2 Presentation of unhealthy alcohol users and problem drug users 
 
As outlined earlier, many unhealthy alcohol users and problem drug users who 
present to general hospital settings are likely to be seeking treatment for other 
acute and/or chronic health problems (see Figure 1 for examples), and not 
specifically for substance use (Madras et al., 2009; Saitz et al., 2010; WHO, 
2011). These individuals who are not seeking treatment for their substance use 
problems fall into different categories. Some individuals present with types of 
conditions that are only partially attributable to alcohol or the use of other 
substances (an example of such conditions is given in section 1.1.1.1), and are 
either not aware that they are unhealthy alcohol users or problem drug users, or 
do not acknowledge their drinking or drug use as problematic (Madras et al., 
2009; WHO, 2011). In addition, there are individuals who present with 
conditions where abstinence is the hallmark of successful treatment, for 
example conditions that are wholly attributable to alcohol such as alcoholic liver 
disease (Frazier et al., 2011). They might however, not acknowledge their 
unhealthy alcohol use or problem drug use, or might not be willing to engage 
with interventions for these problems. These individuals may be identified by 
opportunistic screening in general hospital settings (Moyer et al., 2002). 
However, they may well be defensive about their behaviour and unwilling to 
receive any intervention (Moyer et al., 2002). How then can these patients be 
approached and engaged with, when they do not necessarily know or consider 
their alcohol consumption or illicit drug use to be problematic? This issue was 
the main driver of the ARiAS research programme (described in more detail in 
section 1.2). 
 
Healthcare settings also encounter unhealthy alcohol users and problem drug 
users who are aware of, and acknowledge their substance use problems, and 
are willing to engage with interventions for these problems. Some individuals 
may already be receiving treatment or have received treatment in the past for 
these problems (Watson et al., 2015). Sometimes, patients will suffer from 
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severe, acute substance use-related withdrawal symptoms whilst in hospital, 
necessitating symptom-triggered therapy (Mayo-Smith, 1997). These different 
presentations to general hospital settings will have implications on what 
intervention approaches could be applied. This is discussed further in section 
5.1.  
 
There are also potential differences in patients that are encountered in the 
different general hospital settings. For example, the majority of attendances to 
outpatient settings and emergency departments are ambulatory attendances 
for: actual or suspected acute or chronic conditions which are sufficiently 
serious to require acute unscheduled care; planned return visits as a result of 
previous hospital presentations; or for clerical, nursing or medical processes to 
be undertaken (Australian Institute of Health and Welfare, 2013). These visits 
might or might not result in admission into hospital where a bed is allocated. 
Emergency departments may also encounter patients in transit: for example 
patients waiting for transport to another facility, or those who are admitted as 
inpatients through the emergency department (Australian Institute of Health and 
Welfare, 2013). On the other hand, most presentations to hospital inpatient 
settings are of patients with chronic or acute conditions that are sufficiently 
serious to require admission for further observation, tests and examinations or 
treatment as a hospital inpatient. Patients could be coming from other sections 
of the hospital, or another hospital or healthcare facility with admission pre-
arranged by the referring medical officer/ healthcare professional and a bed 
allocated. There could also be patients in transit to other sections of the hospital 
or to another hospital or healthcare facility. These differences in presentation 
could have implications on the identification and intervention strategies that can 
be adopted, or the way that the appropriateness of these interventions is 
perceived for each setting (i.e. inpatient, accident and emergency, or outpatient 
setting). For example, there may be differences, by setting, on whether patients 
are generally considered well enough, or the average contact time with patients 
is considered sufficiently long, to allow the exploration of unhealthy alcohol use 
and problem drug use (Groves et al., 2010). However, the differences in 
presentations by setting are not as ‘clear cut’ as presented above. They will 
differ for example by country or from hospital to hospital. 
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1.1.2.3 The role and impact of healthcare workers 
 
There is a wide range of service models for unhealthy alcohol use and problem 
drug use in general hospital settings: from multi-disciplinary general hospital-
based alcohol care teams, to in-reach alcohol care teams which involve 
addiction specialist service personnel coming into the hospital on a regular 
basis (Baker et al., 2014; NSW Ministry of Health, 2015; Public Health England, 
2014).  
 
Services that can be offered will depend on the service model adopted, and 
include: identification and brief interventions, comprehensive assessment, care 
planning, other interventions including medically assisted alcohol withdrawal 
management, and safe discharge and referral to community services (Baker et 
al., 2014; Public Health England 2014; NSW Ministry of Health, 2015; Makdissi 
and Stewart, 2013). Likewise, the role of the different general hospital 
healthcare personnel depends on the chosen service model. However, it has 
been widely recommended that, as a minimum, healthcare professionals 
working within these settings, such as nurses, physicians and social workers, 
be able to provide screening and brief advice for unhealthy alcohol use and 
problem drug use (Heather, 2010; National Institute for Health and Clinical 
Excellence (NICE), 2008; NICE, 2011; NSW Ministry of Health, 2015; WHO, 
2010). Although the impact of such services is still unclear, it is anticipated that 
they can result in improvements such as: improving quality and efficiency of 
care; reducing admissions, re-admissions and length of hospital stay for 
patients with substance use-related problems; contributing to reduction in 
substance use-related accident and emergency department attendances; and 
reducing substance use-related mortality (NSW Ministry of Health, 2015; Public 
Health England, 2014). 
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1.1.2.4 Screening, assessment and intervention 
 
This section gives a brief overview of the processes of identification, 
assessment and intervention which form the integrated structure of this thesis. 
More detailed discussions are provided in sections 3 (screening), 4 
(assessment) and 5 (interventions). 
 
As briefly highlighted in sections 1.1.1.1 and 1.1.1.2, there are different levels 
and patterns of unhealthy alcohol use and problem drug use, and these are 
associated with different levels of risk and problems. The most commonly used 
categories are hazardous use, harmful use and dependence (Babor and 
Higgins-Biddle, 2001; Raistrick, Heather and Godfrey, 2006). Hazardous use is 
defined as a level and pattern of use that puts the user at risk of harmful 
consequences (which may be physical health, mental health or social 
consequences) (Babor and Higgins-Biddle, 2001; Edwards, Arif and Hodgson, 
1981; WHO, 1994). Harmful use is where the level and pattern of use is already 
causing damage to physical or mental health (Edwards, Arif and Hodgson, 
1981; WHO, 1993). Dependence is where the level and pattern of use has 
resulted in a dependence syndrome which is a cluster of cognitive, behavioural 
and physiological symptoms (Babor and Higgins-Biddle, 2001; WHO, 1993). 
This distinction among the different categories of unhealthy alcohol use or 
problem drug use, and the associated risk and problems, is important because 
it enables the matching of health needs of different types of users with the most 
appropriate intervention and intervention pathway (Institute of Medicine, 1990; 
McCambridge and Rollnick, 2014; NICE, 2010a; Raistrick, Heather and 
Godfrey, 2006). However, as Raistrick, Heather and Godfrey (2006, p19-20) 
point out, these categories are based on convenient cut-off points along the 
continuum of consumption and associated problems. 
 
Identification of unhealthy alcohol users or problem drug users generally 
involves a screening process to identify those with, or at risk of developing, 
problems (NICE, 2010b). Identification is followed by making patients with a 
positive screen aware, and increasing their understanding, of the risks and 
problems associated with their alcohol or drug use. 
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It is recommended that, after being identified, non-dependent unhealthy alcohol 
users or problem drug users receive less intensive interventions such as brief 
interventions (BIs) aimed at motivating them to change or consider changing 
their alcohol or drug use behaviour (NICE, 2008; NICE, 2011; WHO, 2010). For 
the very heavy or dependent alcohol or problem drug users, the process might 
involve referral for detailed assessment and treatment in specialist treatment 
agencies (Babor et al., 2001; NICE, 2008; NICE, 2011).  
 
From the description above, the key stages from identification to intervention for 
unhealthy alcohol use or problem drug use are screening, assessment and 
intervention (Connors and Volk, 2003; Raistrick, Heather and Godfrey, 2006). 
The interrelationship between these three stages can be summarized as in 
Figure 2 below. The research carried out for this thesis was similarly divided 
into three work streams: screening, assessment and intervention. Each of the 
six papers addresses a research question related to at least one of these work 
streams; thus forming a coherent body of work. 
 
Although Figure 2 depicts a linear interrelationship, this is not always the case 
in practice (Connors and Volk, 2003; Raistrick, Heather and Godfrey, 2006). For 
example, for dependent alcohol or problem drug users, screening could be 
followed by a less intensive intervention such as a BI and then referral for 
detailed assessment and specialist treatment (NICE, 2008; NICE, 2011). There 
are other intermediary stages not represented here such as formulating a 
clinical diagnosis and treatment planning (Rasmussen, 2000; Teesson et al., 
2012).  
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Figure 2: Interrelationships between stages of screening, assessment and 
intervention   
 
Although pro-active identification and provision of interventions for unhealthy 
alcohol users and problem drug users who come into contact with health 
services has been recommended (NICE, 2008; NICE, 2011), implementation 
has not been realised in many healthcare settings because of a number of 
barriers. Some of these implementation challenges are discussed below. 
 
1.1.2.5 Implementation challenges 
 
Barriers to implementation include factors related to healthcare professionals, 
organization of care, as well as factors related to patients. 
 
 Healthcare professionals 
 
Overall, healthcare professionals working in general hospital settings regard 
screening and provision of interventions for unhealthy alcohol use or problem 
drug use within these settings worthwhile (Anderson et al., 2001; Brooker et al., 
1999; Groves et al., 2010; Huntley, Patton and Touquet, 2004; Pauly, 2008). 
However, time constrains are often cited as a barrier (Anderson et al., 2001; 
Brooker et al., 1999; Groves et al., 2010; Huntley, Patton and Touquet, 2004; 
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Pauly, 2008). In addition, patients may not be in one department long enough to 
build rapport and allow the exploration of problems (Anderson et al., 2001; 
Groves et al., 2010). Some healthcare professionals question the compatibility 
of screening and interventions with the acute care paradigm and their role 
(Broyles et al., 2012). Raistrick, Tober and Unsworth (2015) reported low levels 
of therapeutic commitment from healthcare professionals, which has a negative 
impact on engagement with treatment and outcomes (Cartwright, Hyams and 
Spratley, 1996). Other barriers include healthcare professionals’ negative views 
and attitudes towards unhealthy alcohol users and problem drug users; limited 
interdisciplinary collaboration and communication around alcohol-related care 
(Broyles et al., 2012); and lack of training, motivation, skills, as well as 
confidence to deal with these problems (Anderson et al., 2001; Brooker et al., 
1999; Groves et al., 2010; McKeown, Matheson and Bond, 2003; McLaughlin, 
Mckenna and Leslie, 2000; Pauly, 2008). Some healthcare professionals 
consider questions about these problems as offensive and intrusive to patients 
(Brooker et al., 1999), and will not approach individuals they perceive as less 
likely to have such problems because of their age, gender or religion (Groves et 
al., 2010). The poor physical and mental state of patients at the time of 
presentation has also been reported as a barrier (Anderson et al., 2001; Groves 
et al., 2010).  
 
 Organization of care 
 
Implementation barriers include limited awareness by healthcare staff of 
substance misuse professionals or services on offer in the hospital (Groves et 
al., 2010), or other external sources of help (Anderson et al., 2001; McLaughlin, 
Mckenna and Leslie, 2000). Other barrier are: inadequate provision of services, 
including support services such as out of hours, long term and community 
support (Anderson et al., 2001; McLaughlin, Mckenna and Leslie, 2000), and 
inadequate alcohol assessment protocols and poor integration with the 
electronic medical record (Broyles et al., 2012). Lack of privacy when 
discussing unhealthy alcohol use or problem drug use can also render the 
screening and intervention process less acceptable to patients (Groves et al., 
2010).  
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 Patients 
 
Sometimes patients are not willing to engage with screening and interventions 
for unhealthy alcohol use or problem drug use because of the stigma they feel 
to be associated with it (Groves et al., 2010). They may also perceive their 
drinking or drug use as not risky or problematic (Madras et al., 2009; WHO, 
2011). Those who do find screening and interventions useful and acceptable 
often prefer for them to be conducted in a private room (Groves et al., 2010). 
This can be very difficult to achieve in busy hospital settings. Some very heavy 
drinkers and problem drug users view generalist healthcare professionals as 
inadequately equipped to deal with substance misuse, with a preference for 
specialist addiction workers (Groves et al., 2010).   
 
1.2 The ARiAS programme 
 
The ARiAS programme was funded for just over 5 years from 2008 to 2013 by 
the National Institute of Health Research (NIHR) under the Collaborations for 
Leadership in Applied Health Research and Care (CLAHRC) initiative. ARiAS 
aimed to investigate methods for improving the physical and mental health of 
unhealthy alcohol users and problem drug users identified within general 
hospital settings in Leeds, UK. 
 
The ARiAS programme was divided into two phases: 
 Phase 1 combined local data with the international evidence base in 
order to: understand the patterns of alcohol and drug related hospital 
admissions and patterns of care in Leeds; identify effective interventions 
for unhealthy alcohol users and problem drug users identified within 
general hospital settings; determine key gaps in knowledge; and inform 
the design and implementation of Phase 2. 
 Phase 2 was built on Phase 1 findings and consisted of a pilot 
randomised controlled trial (RCT) of the clinical and cost-effectiveness of 
interventions for general hospital inpatient problem drinkers. 
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More details on the ARiAS programme are available at 
http://www.york.ac.uk/healthsciences/research/mental-health/projects/arias/. 
 
The work presented in this thesis was conducted between 2009 and 2012 as 
part of Phase 1. The specific aim and objectives are detailed below. 
 
1.3 Aim 
 
To investigate how unhealthy alcohol users or problem drug users can be 
effectively identified, assessed and intervened with when they present to 
general hospital settings for the treatment of other conditions. 
 
The aim has two main dimensions: the type of substance use (unhealthy 
alcohol use and problem drug use), and the three key stages of screening, 
assessment and intervention. 
 
1.4 Objectives 
 
1. To identify and examine existing evidence on the psychometric 
properties of illicit drug use screening instruments that could be useful in 
general hospital settings. 
2. To identify and examine existing evidence on the psychometric 
properties of substance misuse assessment packages. 
3. To identify and examine existing evidence on the effectiveness of 
interventions for unhealthy alcohol use or problem drug use for 
individuals identified in general hospital settings. 
4. To explore intervention characteristics, methodological issues and 
contextual factors that could impact on the effectiveness of interventions 
for unhealthy alcohol use in general hospital settings, in order to facilitate 
the development of more effective interventions.  
5. To explore acceptable and feasible strategies for identifying and 
intervening with unhealthy alcohol users, and engaging them in 
treatment. 
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6. To identify critical evidence gaps on identification, assessment and 
intervention that will guide the development of a pilot RCT for phase 2 of 
the ARiAS programme, as well as future research programmes. 
 
Each of the objectives maps onto the two dimensions outlined above (type of 
substance use and the three key stages) as presented in Table 2. 
 
Table 2: Mapping of objectives onto the aim with regards to type of 
substance use and the three key stages 
 
 Unhealthy alcohol use Problem drug use 
Screening 
 
5, 6 1, 6 
Assessment 
 
2, 5, 6 2, 6 
Intervention 
 
3, 4, 5, 6 3, 6 
The numbers within the cells represent the corresponding objectives as listed in 1.4.  
 
Each paper addresses at least one of the objectives as indicated in Table 3 
below. 
 
Table 3: Mapping of papers onto objectives 
 
Objective Paper(s)* 
Objective 1 Paper 1 
Objective 2 Paper 2 
Objective 3 Papers 3, 4 
Objective 4 Papers 3, 5 
Objective 5 Paper 6 
Objective 6 Papers 1 to 6 
*Paper numbers are as indicated in Table 1 
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1.5 Thesis structure 
 
This thesis is divided into six further separate sections. The next section, 
section 2, briefly summarizing the methods used. This is followed by three 
sections that reflect the three key stages, with a section on screening (section 
3), assessment (section 4) and intervention (section 5). Section 6 focuses on 
implementation of screening, assessment and interventions. Section 7 contains 
the final remarks and recommendations. 
 
As mentioned before, section 2 below summarises the methods utilized. 
 
 
 
- 31 - 
 
2. Summary of methods 
 
The following methods were used: systematic review (Mdege et al., 2013; 
Mdege and Lang, 2011; Sweetman et al., 2013; Watson et al., 2013a), meta-
regression (Mdege and Watson, 2013) and the Delphi method (Mdege, 
Raistrick and Johnson, 2014). These methods were used because they readily 
addressed the research objectives, and the time constraints due to funding 
timelines called for pragmatic scientific techniques that are quicker and more 
efficient than new empirical studies (Linstone and Turoff, 1975; Mulrow, 1994). 
The methods are only briefly described here as more detailed descriptions are 
provided within the relevant papers.  
 
2.1 Systematic review and meta-regression methods 
 
Systematic review methodology was utilised to: collate all empirical evidence 
that meets pre-specified eligibility criteria, summarize the evidence in order to 
answer specific research questions, and explain differences among studies on 
the same question (Crowther and Cook, 2007; Higgins and Green, 2008). Meta-
regression was utilised to investigate whether particular covariates or potential 
effect modifiers explain any of the difference in the consistency of findings on 
intervention effects between studies conducted in different healthcare settings 
(Higgins and Green, 2008; Thompson and Higgins, 2002). The systematic 
reviews and meta-regression used explicit, systematic methods aimed at 
minimizing random and systematic bias to the assembly, critical appraisal, and 
synthesis of studies (Centre for Reviews and Dissemination, 2009; Crowther 
and Cook, 2007; Higgins and Green, 2008). This allows for more reliable 
findings from which conclusions can be drawn and decisions made (Centre for 
Reviews and Dissemination, 2009; Higgins and Green, 2008). 
 
Systematic reviews and meta-regressions depend heavily on the availability and 
consistency of data across studies (Bartolucci and Hillegass, 2010). 
Unfortunately, for the systematic reviews and meta-regression conducted as 
part of this thesis, study reporting was poor. Study authors can be contacted for 
the unreported or poorly reported data (Centre for Reviews and Dissemination, 
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2009; Higgins and Green, 2008). However, this is only possible if time and other 
resources permit (Centre for Reviews and Dissemination, 2009). In addition, 
authors may not respond to data enquiries, particularly if the study is old. 
Sometimes outcomes are assessed and measured in many different ways 
across studies making pooling of results very difficult (McQueen et al., 2011; 
Pycroft, 2010), as was the case for the systematic reviews and meta-regression 
conducted as part of this thesis (Mdege and Lang, 2011; Mdege and Watson, 
2013; Mdege et al., 2013; Sweetman et al., 2013; Watson et al., 2013a).  
 
Another challenge encountered was that poor quality primary studies made it 
difficult to derive any robust conclusions from the findings of the systematic 
reviews or meta-regression (Mdege and Watson, 2013; Mdege et al., 2013; 
Watson et al., 2013a). In some cases, a few small studies were identified 
(Watson et al., 2013a).  Any meta-analysis or meta-regression with very few 
small studies would very likely produce biased estimates due to the high 
possibility of publication bias (Crowther and Cook, 2007b). 
 
The retrospective nature of systematic reviews and meta-regressions also 
present a problem, particularly for research fields where there is rapid 
advancement of ideas and methods. In such cases, findings of a systematic 
review could become obsolete very quickly. In addition, meta-regressions are 
entirely observational in nature because individuals within the studies are not 
randomized to go into one trial or another (Higgins and Green, 2008; Thompson 
and Higgins, 2002). Hence they suffer the limitations of any observational 
investigation, including possible bias through confounding by other study-level 
characteristics (Higgins and Green, 2008). However, if the meta-regression 
findings replicate findings from another study conducted in a different way, then 
this adds confidence to the findings (Higgins and Green, 2008). 
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2.2 The Delphi method 
 
The Delphi method was utilised as a formal, systematic and structured 
communication technique for consensus development, priority setting and 
collective decision making (Keeney, Hasson and Mckenna, 2011; Linstone and 
Turoff, 1975). It relied on a panel of experts as a readily available source of 
knowledge and information, and served as an economical way of gathering 
knowledge and information on a topic where evidence does not exist yet, within 
the time frame it was required (Murphy et al., 1998; Raine et al., 2004; Glasier 
et al., 2003; NICE (UK) National Collaborating Centre for Acute Care (UK), 
2003). The main premise was the assumption that group opinions are more 
valid and reliable than individual opinions (Keeney, Hasson and Mckenna, 
2011). Although there has not been much research to confirm this assumption, 
the existing limited evidence suggests that comparable, and sometimes even 
different, expert panels can produce similar results; which supports the idea that 
making group rather than individual decisions could increase the validity and 
reliability of those decisions (Duffield, 1993; Walker, 1994). Hence the Delphi 
method was appropriate for the study reported in Paper 6 which explored the 
presence or absence of consensus. 
 
Although it is widely acknowledged that experts can provide invaluable 
information, there are concerns about the lack of account, guidance or 
standards with regards to how or why experts are identified and selected 
(Keeney, Hasson and Mckenna, 2011; Linstone and Turoff, 1975). The Delphi 
survey conducted as part of the thesis utilised attributes of an expert that have 
been suggested in literature: their knowledge (e.g. a professional qualification), 
experience (e.g. length of time of actual practice in that field) and policy 
influence (Baker et al., 2006). However, critics have argued that neither 
knowledge on a particular subject nor practice experience necessarily qualify 
one as an expert (Keeney, Hasson and Mckenna, 2011; Baker et al., 2006). 
Others have argued that panels may not even need experts (Sackman, 1975), 
with research indicating similar results between panel groups with different 
levels of expertise (Walker, 1994). Another issue raised is the need for 
respondents who are relatively impartial so as to obtain information that reflects 
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current knowledge and perception (Goodman, 1987). However, because of the 
experts’ interest in and involvement with the issue under investigation, it is 
difficult to see how impartiality could be achieved. 
 
Typically, Delphi survey questions are generated by survey participants 
(Keeney, Hasson and McKenna, 2011; Murphy et al., 1998). However, for the 
Delphi survey reported here the questions were generated through literature 
scoping and consultation with a small group of stakeholders who were not part 
of the survey itself. This could have had a negative impact on the reliability and 
generalizability of the findings. The stakeholders involved included clinicians 
(two psychiatrists and an emergency medicine specialist), a psychologist, 
commissioning managers for alcohol services and a team of researchers. The 
other specialty areas of focus, namely cardiology, gastroenterology and 
oncology were not represented in this process. However, the framing of the 
questions was only highlighted as problematic by one oncologist. 
  
After summarising the methods, section 3 will now discuss screening for 
unhealthy alcohol use and problem drug use, including a systematic review that 
was carried out as part of this thesis. 
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3. Screening 
 
This section discusses screening which involves the use of procedures to 
identify individuals with alcohol or illicit drug use related problems or 
consequences, or those who are at risk for such problems (Connors and Volk, 
2003; WHO ASSIST Working Group, 2002). 
 
3.1 Screening for unhealthy alcohol use 
 
Screening for unhealthy alcohol use can be done through biological markers of 
alcohol consumption, clinical indicators using physical examination, or the use 
of screening questionnaires/ instruments (hereafter referred to as screening 
instruments) (Raistrick, Heather and Godfrey, 2006). 
 
Biological markers such as blood or breath alcohol concentration, mean 
corpuscular volume (MCV) and serum gamma-glutamyltransferase (GGT) can 
provide an objective indication of recent alcohol consumption (Leigh and 
Skinner, 1988; Rosman and Lieber, 1990). Biological markers are however 
largely recommended as adjuncts to screening instruments, and the reasons for 
this include the following: 1) some biological markers such as GGT are not 
specific to alcohol, which can lead to false positives (Raistrick, Heather and 
Godfrey, 2006); 2) some markers such as MCV have very low sensitivity for 
detecting heavy drinking (Helander, 2001); 3) laboratory testing is more 
expensive compared to other methods of screening (Raistrick, Heather and 
Godfrey, 2006); 4) usefulness can be limited by the short half-life after cessation 
of drinking, for example for blood alcohol concentration (Wolff and Marshall, 
2006); and 5) they add little information that cannot be gained more cheaply 
and efficiently by self-report (Raistrick, Heather and Godfrey, 2006). 
 
Some healthcare professionals prefer clinical history taking and physical 
examination as means of detecting harmful drinking (Raistrick, Heather and 
Godfrey, 2006). This involves looking for any physical disorders and signs (such 
as hypertension, gastrointestinal disorders, dilated facial capillaries or frequent 
accidents) (Saunders and Conigrave, 1990), as well as psychiatric and social 
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indicators (such as depression and anxiety) (Yang and Skinner, 2004) that are 
suggestive of harmful drinking. One drawback is that hazardous drinkers who 
do not have obvious signs of alcohol problems will be missed (Raistrick, 
Heather and Godfrey, 2006). 
 
The use of standardized alcohol consumption screening instruments that are 
simple, brief, and easy to administer and interpret is the most highly 
recommended way of identifying unhealthy alcohol users in general hospital 
settings (NICE, 2011; Raistrick, Heather and Godfrey, 2006; WHO, 2010). 
Screening instruments are as valid and reliable (Babor et al., 2000; de 
Meneses-Gaya et al., 2009), and provide as much information as biological 
markers in a faster and much cheaper way (Raistrick, Heather and Godfrey, 
2006). They also make it possible for generalists (i.e. healthcare professionals 
that are not alcohol or addiction specialists) or paraprofessionals to carry out 
the screening (Rasmussen, 2000). A substantial amount research and 
recommendations on which screening instruments for unhealthy alcohol use to 
use in general hospital settings exist (Connors and Volk, 2003; NICE, 2011). 
For example, the Alcohol Use Disorder Identification Test (AUDIT) is now widely 
recommended and used within research and practice worldwide (Babor et al., 
2001; de Meneses-Gaya et al., 2009; NICE, 2011; Raistrick, Heather and 
Godfrey, 2006; Reinert and Allen, 2007). AUDIT has generated a very large 
amount of research spanning over a period of at least two decades, and has 
demonstrated very good psychometric properties in emergency departments, 
general hospital inpatient and outpatient settings in a range of populations and 
cultural groups (Babor et al., 2001; de Meneses-Gaya et al., 2009; Reinert and 
Allen, 2007). 
 
3.2 Screening for problem drug use 
 
Two approaches can be used to screen for problem drug use: biochemical tests 
such as urinalysis, hair testing and saliva testing; and standardized screening 
instruments such as the Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST) (Lanier and Ko, 2008; WHO ASSIST Working Group, 
2002). One main advantage of using some standardized screening instruments 
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over biochemical tests is that, unlike the latter they distinguish between 
occasional users, non-dependent problematic use and dependence which is 
important for treatment planning (Hoffmann et al., 2003; Lanier and Ko, 2008; 
WHO ASSIST Working Group, 2002). Some standardized screening 
instruments can also distinguish between active and inactive problems which is 
useful in linking substance misuse to current health status (Brown et al., 2001; 
Humeniuk et al., 2008). As with alcohol, screening instruments are also much 
cheaper than biochemical tests. 
 
The need for and potential utility of problem drug use screening instruments in 
general hospital settings is widely acknowledged (Brown et al., 2001; Madras et 
al., 2009; National Treatment Agency, 2007). However, reviews of evidence, 
guidance or recommendations on which screening instruments to use are 
scarce (Madras et al., 2009; WHO, 2008). Practice may therefore vary widely.  
Thus, Paper 1 focused on problem drug use in order to address this evidence 
gap. 
 
3.2.1 Paper 1 
 
Mdege, N.D., and Lang, J., on behalf of the ARIAS Research Group. (2011). 
Screening instruments for detecting illicit drug use/abuse that could be useful 
in general hospital wards: a systematic review. Addictive Behaviors, 36(12), 
1111–1119. 
 
Paper 1 aimed to identify and describe screening instruments that can be used 
to detect problem drug use in general hospital wards and review evidence for 
reliability, validity, feasibility and acceptability. A summary of the main results is 
presented in Box 1. 
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Box 1: Summary of main findings from Paper 1 
1. Thirteen instruments were identified that are potentially useful for screening 
adult patients not known to have an illicit drug use problem in general 
hospital wards: 
ASSIST: Alcohol, Smoking, and Substance Involvement Screening Test 
CAGE-AID: Cut Down, Annoyed, Guilty, Eye-opener- Adapted to Include 
Drugs 
DAST: Drug Abuse Screening Test 
DHQ/ PDHQ: Drug History Questionnaire or Psychoactive Drug History 
Questionnaire 
DUDIT: Drug Use Disorders Identification Test 
DUS: Drug Use Screening 
NMASSIST: NIDA- Modified Alcohol, Smoking, and Substance Involvement 
Screening Test 
SMAST-AID: Short Michigan Alcoholism Screening Test Adapted to 
Include Drugs  
SIP- AD: Short Inventory of Problems- Alcohol and Drugs 
SDS: Severity of Dependence Scale 
SSI-SA: Simple Screening Instrument for Substance Abuse  
TICS: Two Item Conjoint Screen for Alcohol and other Drug Problems 
UNCOPE: Use, Neglect, Cut down, Objection, Preoccupied, Emotional 
discomfort. 
 
2. From the available evidence:  
 Construct and concurrent validity was high for ASSIST, CAGE-AID 
and SIP-AD 15.  
 ASSIST, CAGE-AID, DAST (28, 20 and 10), SIP-AD (10 and 15), 
TICS and UNCOPE had good to excellent internal consistency.  
 The DAST-28 and DAST-10 also showed optimal test–retest 
reliability, whilst that for ASSIST suggests the need for improvement.  
 The sensitivity and specificity scores for the DAST-28, DAST-10, 
TICS and UNCOPE were optimal (~80%). Those for ASSIST, 
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Box 1: Summary of main findings from Paper 1 
CAGE-AID, DAST-20 and SMAST generally indicate the need for 
improvement.  
 The ASSIST and TICS were reported to be highly accepted by 
participants. 
3. Usefulness of these instruments in general hospital wards may however be 
limited due to the following: 
 Most of these instruments have not been extensively evaluated in adult 
patients not known to have an illicit drug use problem, especially in 
general hospital wards. The ASSIST is currently the only instrument 
with some evidence of extensive evaluation, in different countries, 
populations and settings including general hospital wards.  
 A number of these instruments focus on dependence (CAGE-AID, 
DAST, SDS, SMART-AID) and some do not distinguish between non-
dependent problematic use and dependence (TICS and UNCOPE).  
This could be problematic if the interventions or treatment pathways for 
patients depend on the level of drug use. 
 Some of the instruments (CAGE-AID, DAST, SMAST-AID and SSI-SA) 
do not distinguish between active and inactive problems. They only ask 
about life time illicit drug use experience. 
 The structure or format of some of the instruments could affect 
acceptability and feasibility of use. For example, the ASSIST in its 
current format appears bulky and this could deter its use. 
 
4. There is insufficient comparative evidence on the psychometric properties, 
as well as acceptability and feasibility of use, to enable choice between the 
available screening instruments. 
 
3.2.1.1 What does this study contribute to the body of knowledge? 
 
This study makes an original contribution to literature in a number of ways. First, 
this was the first review to generate a list of instruments that could be used with 
this particular population. Second, it brought together existing evidence on the 
performance of these screening instruments. Thus, it is a very useful resource 
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for clinicians or researchers searching for such instruments. Third, it highlights a 
fundamental gap in the evidence base. By raising the profile of the issue, the 
chances of other researchers addressing this gap are increased. Fourth, it 
identifies some important screening instrument characteristics that appear to 
have been overlooked by the design of currently existing instruments (e.g. 
distinguishing between active and inactive problems and different levels of illicit 
drug use, and how the structure or format of the instrument could affect 
acceptability). This is useful information for researchers and research 
commissioners interested in developing and evaluating such instruments. Paper 
1 has been cited in at least 13 peer reviewed journal articles (Ali et al., 2013; 
Boothroyd et al., 2013; Chuang et al., 2013; Evren et al., 2013; Evren et al, 
2014a; Evren et al., 2014b; Evren et al., 2014c; Matuszka et al., 2014; McNeely 
et al., 2014; McPherson and Benson, 2013; Nydegger et al., 2014; Raistrick, 
2013; Tantirangsee, Assanangkornchai and Marsden, 2014) and one Masters 
thesis (Eastman, 2013). Examples of the ways the findings have been utilized 
will be given in sections 3.3 and 3.4. 
 
3.3 Implications of research findings to policy and practice 
 
The utility of the identified screening instruments in general hospital wards may 
be limited by the lack of evidence on their performance in these settings (Harris, 
2013; Raistrick, 2013). In reality however, many clinicians conduct some form of 
screening for problem drug use when necessary (Boothroyd et al., 2013). 
Without guidance, inappropriate screening tools or strategies could be used.  
 
In order to inform policy and practice, a research brief targeted at policy makers, 
service providers and healthcare professionals was produced from Paper 1. 
Although in Paper 1 no recommendation was made on the best instrument to 
use in general hospital setting due to the paucity of evidence, this research brief 
recommended that, based on the currently available evidence, the ASSIST 
should be considered as the instrument of choice for a number of reasons. First, 
it is the only instrument that has been evaluated extensively in different 
populations and settings including general hospital wards, and has generally 
consistently exhibited good psychometric properties. Second, it has some 
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evidence of good acceptability by patients. Third, it exhibits a number of vital 
properties that are lacking in many of the other instruments that are: 
distinguishing between active and inactive problems, and distinguishing 
between different levels of illicit drug use. However, the use of the ASSIST has 
to be accompanied by further validation, including comparisons with other 
alternatives. 
 
As highlighted earlier, after a positive screen healthcare professionals have to 
make patients aware of the risks and harms associated with problem drug use, 
and increase their understanding of these harms. This also applies for 
unhealthy alcohol use. There are many diseases/ conditions where either 
alcohol or drug use is a component cause: that is, alcohol or drug use is one 
among a number of components, which, when all are present, a sufficient cause 
for the condition is formed (WHO, 2008; WHO, 2014; Jones and Bellis, 2014). 
In practice this means that a clinician might know that the use of alcohol, or illicit 
drug use, at a certain level and pattern may result in the development of a 
particular condition. However, at individual level they will not know which 
individuals will develop the condition and which ones will not (Hollnagel, 1999). 
This raises a number of fundamental challenges for healthcare professionals. 
For example, how many of those who screen positive for unhealthy alcohol use 
or problem drug use would actually benefit from interventions aimed at their 
substance use? Understanding this is important as research has revealed 
concerns among health practitioners that screening might not benefit sufficient 
numbers of people to warrant the extra workload required (NICE 2010b).   
 
In addition, how do you explain to the patient that their ill health may be due to 
drug use or alcohol, or that they are at risk of getting ill, in a way that actually 
convinces them to change their behaviour or seek help? Risk is based on 
population level data and not on individualised knowledge (Hollnagel, 1999). In 
addition, different levels and patterns of alcohol consumption are associated 
with different risks and risk levels. There is a wide range of drugs that can be 
used illicitly, as well as a variety of administration routes; both of which have an 
implication on the associated risks and risk levels. This means risk messages 
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have to be adapted depending on the patient’s alcohol or illicit drug use 
circumstances, which can be challenging for healthcare professionals.   
 
Very few healthcare professionals have any training in risk communication 
(Paling, 2003). There is also very limited understanding of how best to 
communicate risk in general, and whether risk information can alter individual 
risk perception and actually lead to change in health behaviour (Edwards et al., 
2000).  Fagerlin, Zikmund-Fisher and Ubel (2011) present 10 risk 
communication strategies that have shown strong, or at least preliminary, 
evidence for improving patient understanding and decision making on 
healthcare. The strategies range from the use of plain language, presenting 
absolute risks using frequencies (rather than presenting relative risks), through 
to using a risk format that clarifies how an intervention changes risks from pre-
existing baseline levels. These strategies offer a starting point for exploring 
ways of communicating risk information that can result in behaviour change in 
the context of unhealthy alcohol use and problem drug use, and for training 
healthcare professionals in risk communication.  
 
3.4 Implications for future research 
 
There is a need for validation of problem drug use screening instruments in 
general hospital populations. This should include comparative evidence on the 
psychometric properties, as well as acceptability and feasibility of use, to enable 
choice between the available measures. In light of findings from Paper 1, 
Raistrick (2013) suggests the need for fewer instruments and more testing of 
the best ones. The list of potential screening instruments produced in this study 
is a useful reference from which instruments can be selected for evaluation and 
use. Some researchers have already used this list in this way (Boothroyd et al., 
2013; Evren et al., 2013; Evren et al., 2014b; Evren et al., 2014c; Tantirangsee, 
Assanangkornchai and Marsden, 2014; Evren et al, 2014a). However, although 
a number of articles that have cited Paper 1 investigate the psychometric 
properties of problem drug use screening instruments, only one includes a 
general hospital population (Ali et al., 2013).  
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Research also needs to explore the perspectives of service users, clinicians, 
any other staff groups who are expected to administer the instrument and other 
relevant stakeholders. The views of these stakeholders can impact on the 
performance, acceptability, actual uptake and use of instruments in clinical 
practice. For example, it would be vital to understand different perceptions on 
how important different domains or questions are, how well they are 
understood, and how acceptable they are (Raistrick, 2013). It is also useful to 
know how user-friendly a screening instrument is in terms of structure and 
format. 
 
The other issue to consider is the development of less bulky tools. Since the 
publication of Paper 1, a group of researchers have developed a new short 
screening instrument derived from the ASSIST, called ASSIST-Lite (Ali et al., 
2013). They cited the observation from Paper 1 that the bulkiness of the 
ASSIST could deter its use as one of their reasons for developing this new short 
form that has been optimised for general medical settings. The original ASSIST 
has 8 questions, seven of which ask about ten different types of psychoactive 
substances. The eighth question asks about injection drug use. By comparison, 
the ASSIST-Lite asks about six types of psychoactive substances, and the 
researchers managed to remove between three and four questions from the 
ASSIST for each of the six types of substances, while preserving the ability to 
measure substance use disorder severity (Ali et al., 2013). The ASSIST-Lite 
demonstrated good psychometric properties in this study, using data from 2,082 
participants drawn from nine countries, 70% of which were recruited from 
general medical settings. However, this figure was not disaggregated by the 
type of general medical setting. More studies in diverse settings, including 
general hospital settings, and cultures are needed for this new instrument, as 
well as other promising screening instruments. 
 
In order to inform the policy and practice developments suggested in the 
previous section, future research also needs to explore better ways of 
communicating risk in order to increase engagement with and the success of 
interventions. This will inform training of healthcare professionals on risk 
communication.  
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4. Assessment 
 
When an individual screens positive for unhealthy alcohol use or problem drug 
use they may, where necessary, be referred for comprehensive assessment as 
indicated in section 1.1.2.2. This assessment is briefly discussed below. 
 
4.1 Assessment for unhealthy alcohol use and problem drug use 
 
Assessment is designed to explore fully the nature and extent of a person’s 
problems with alcohol or illicit drugs, and to gain an understanding of exactly 
how they might be helped (Raistrick, Heather and Godfrey, 2006). It involves 
closely examining a number of health and well-being domains. The important 
ones include substance use and dependence, psychological well-being, and 
social well-being (Edwards, Arif and Hodgson, 1981). Assessment can also 
include physical examination and other necessary specialized testing 
(Rasmussen, 2000). The product is a treatment/care plan (Raistrick, Heather 
and Godfrey, 2006). 
 
Assessment needs may vary according to a number of factors such as the 
setting. A wide range of assessment tools for alcohol and illicit drug use 
problems exist. However, standardising assessment and outcome reporting to a 
certain degree facilitates the comparison of services locally, nationally and 
internationally (Raistrick, Heather and Godfrey, 2006). Paper 2 examines the 
utility of existing comprehensive assessment packages for alcohol and illicit 
drug use problems that can be used in any healthcare setting. 
 
4.1.1 Paper 2 
 
Sweetman, J., Raistrick, D., Mdege, N.D., and Crosby, H. (2013). A 
systematic review of substance misuse assessment packages. Drug and 
Alcohol Review, 32(4), 347-355.  
 
- 45 - 
 
Paper 2 aimed to identify and describe comprehensive assessment packages 
that can be used for alcohol and illicit drug use problems in any setting and 
review evidence for validity. The main findings are summarised in Box 2 below. 
 
Box 2: Summary of main findings from Paper 2 
1. Six comprehensive assessment packages met the inclusion criteria: 
ASI: Addiction Severity Index 
CUAD: Chemical Use, Abuse and Dependence Scale 
Form 90: Form 90 
MAP: Maudsley Addiction Profile 
MATE: Measurements in the Addictions for Triage and Evaluation 
SAOM: Substance Abuse Outcomes Module 
 
2. There has not been enough relevant evaluation of the psychometric and 
user acceptability properties of most of these packages. Only the ASI has 
been extensively evaluated and translated. 
 
3. There is insufficient evidence to support the use of comprehensive 
assessment packages. 
 
4. The validation studies are generally of poor quality judging from the study 
reports, and study reporting is also poor. 
 
4.1.1.1 What does this study contribute to the body of knowledge? 
 
This review is the first to bring together information on comprehensive 
assessment packages that can be used in any setting and existing evidence on 
their performance. The review also highlights research gaps in the validation of 
the performance of these packages. This makes it a useful resource for 
clinicians or researchers with an interest in this area. The paper has been cited 
by one peer reviewed journal article (Fairhurst et al., 2014).  
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4.2 Implications of research findings to policy and practice 
 
It is difficult to recommend any one comprehensive assessment packages due 
to the limited evidence and its poor quality. Based on the currently available 
evidence, the opinion of the authors of Paper 2 was that the best candidates for 
routine clinical use were the MAP, CUAD and the ASI. However, these 
packages work well for some services but not for others. There have been 
attempts in the past to make the ASI mandatory in the USA (Fairhurst et al., 
2014). Although it is probably the most widely used assessment package in 
clinical and research settings in the USA, many services failed to comply 
(Cacciola et al., 2011; Mäkelä, 2004). Some of the problems encountered 
included that the ASI failed to cater for the wide variation in the needs of 
individuals with substance use disorders (Mäkelä, 2004). In addition, its use 
requires intensive training and continuous monitoring, which is both expensive 
and unrealistic (Mäkelä, 2004). An alternative for clinicians would be to have a 
set of single construct scales with good psychometric properties based on 
demographic characteristics of service users (Mäkelä, 2004).  The implication of 
this is that different services will assess patients’ healthcare needs in different 
ways. The lack of standardization can potentially present problems, particularly 
in healthcare systems where performance and payment for healthcare providers 
is determined by patients seen or treated, taking into account the complexity of 
the patient’s healthcare needs, such as the Payment by Results scheme for 
alcohol and drugs in the UK (Department of Health Payment by Results Team, 
2011; Thurgood et al., 2014).  
 
4.3 Implications for future research 
 
There is need for more validation of existing comprehensive assessment 
packages. It is probably better to have a small number of instruments that are 
continuously improved and validated in the light of new evidence. Each new 
application of a package has to be validated, as well as each translation, taking 
into account differences in substance use cultures (Cacciola et al., 2011; 
Mäkelä, 2004). There is also need to improve the quality of research, as well as 
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guidance on how best to measure, evaluate and report the different 
psychometric properties. 
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5. Intervention 
 
This section discusses the available interventions for unhealthy alcohol use and 
problem drug use. The three papers (3, 4 and 5) focusing on interventions are 
very closely linked in terms of implications of findings to policy, practice and 
research. For this reason, the discussion of these issues is combined across 
the papers.  
 
5.1 Interventions for unhealthy alcohol use and problem drug use 
 
Interventions for unhealthy alcohol use or problem drug use include 
pharmacological and non-pharmacological approaches (NICE, 2008; National 
Treatment Agency, 2007; Raistrick, Heather and Godfrey, 2006). An example of 
a pharmacological approach is clinically managed detoxification which involves 
prescribing medication to minimise withdrawal symptoms, with the aim of rapidly 
achieving an alcohol or drug free state (Mayo-Smith, 1997; Raistrick, Heather 
and Godfrey, 2006). Pharmacological interventions are generally administered 
by specialist and competent healthcare professionals (NICE, 2011; Raistrick, 
Heather and Godfrey, 2006).  
 
Non-pharmacological interventions mostly consist of psychotherapy, that is, 
verbal interaction between the patient and the therapist aimed at changing the 
behaviour and feelings of the patient (NICE, 2008; National Treatment Agency, 
2007; Raistrick, Heather and Godfrey, 2006). These are used in a number of 
ways including: to prevent the progression of hazardous use to harmful use or 
dependence; to motivate behavioural change; and to maximize the likelihood of 
successful pharmacological treatment (Carroll and Schottenfeld, 1997). These 
interventions vary widely, for example in terms of mode of delivery (e.g. face-to-
face, via the internet or telephone), personnel delivering the intervention (e.g. 
specialists in alcohol or addiction interventions, or generalists who are not 
alcohol or addiction specialists), format (e.g. individual/ group format) and 
intensity (e.g. duration of intervention) (Heather, 1995). The more intensive non-
pharmacological interventions or treatments, typically consisting of eight or 
more sessions, are mostly directed at alcohol or drug dependent patients and 
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are generally delivered by specialists (Babor, 1994; Raistrick, Heather and 
Godfrey, 2006).  
 
‘Moderate’ interventions, sometimes referred to as brief treatments and usually 
delivered over five to seven sessions, have been recommended for substance 
use treatment seeking moderately dependent drinkers in generalist or specialist 
settings (Babor, 1994; Raistrick, Heather and Godfrey, 2006). These 
interventions have also been suggested for those who are not seeking 
treatment for their substance use, but may be presenting with a condition where 
abstinence, as compared to a reduction in substance use, is critical for 
successful treatment (Frazier et al., 2011). Such interventions might include 
referral for further treatment in specialist services (Frazier et al., 2011; Makdissi 
and Stewart, 2013). 
 
The less intensive interventions can be delivered by non-specialist healthcare 
professionals such as hospital physicians, nurses and social workers (Raistrick, 
Heather and Godfrey, 2006; Secretary of State for the Home Department, 
2012). An example is brief interventions (BIs) which involve one to four sessions 
of engagement with a patient, and the provision of information/ advice designed 
to reduce risky alcohol or illicit drug consumption and related problems, or 
provide referral to additional care (Kaner et al., 2007; McQueen et al., 2011; 
Saitz et al., 2010). These non-specialist interventions are mainly directed at 
non-dependent hazardous and harmful drinkers (Babor and Higgins-Biddle, 
2001; Raistrick, Heather and Godfrey, 2006; WHO, 1993); typically those who 
are not seeking treatment for unhealthy alcohol use, have less severe problems 
and whose intervention goal is reduced or non-problematic drinking as opposed 
to abstinence (Moyer et al., 2002). BIs have also been suggested for occasional 
and non-dependent problem drug users (Saitz et al., 2010). These interventions 
have attracted a great deal of attention in recent years because of their potential 
to be used opportunistically (i.e. they can be used for patients presenting to the 
health service for reasons other than their alcohol or drug use but who are then 
identified as unhealthy alcohol users or problem drug users) (Raistrick, Heather 
and Godfrey, 2006; Saitz et al., 2010). They can also be delivered by non-
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specialist health professionals which means they can have a wide reach (Saitz 
et al., 2010; Secretary of State for the Home Department, 2012). 
 
However, there is still uncertainty over whether these opportunistic 
interventions, or indeed a number of other interventions, can result in significant 
long-term reduction in alcohol consumption or illicit drug use among non-help 
seeking patients identified in general hospital settings (McQueen et al., 2011; 
Raistrick, Heather and Godfrey, 2006; Saitz, 2014). It is important to note that, 
despite the distinction depicted above between intensive treatment, brief 
treatment and brief interventions, it is not that ‘clear cut’ in practice. For 
example, what is considered a brief intervention by some researchers or 
clinicians might be considered brief treatment by others (Jönson et al., 1995). 
 
Paper 3 and 4 were aimed at addressing the uncertainty over the effectiveness 
of interventions through systematically reviewing the currently available 
evidence. Although the systematic review focus was on both unhealthy alcohol 
use and problem drug use, Paper 3 focused on unhealthy alcohol use only 
because there were no eligible studies evaluating problem drug use 
interventions. The initial report submitted for publication consideration included 
problem drug use, and highlighted the research gap in this area. However, this 
inclusion was criticised by the peer reviewers who argued the report should 
concentrate on alcohol consumption where there is already a body of evidence. 
 
5.1.1 Paper 3 
 
Mdege, N.D., Fayter, D., Watson, J.M., Stirk, L., Sowden, A., and Godfrey, C. 
(2013). Interventions for reducing alcohol consumption among general 
hospital inpatient heavy alcohol users: a systematic review. Drug and Alcohol 
Dependence, 131(1-2), 1-22. 
 
Paper 3 aimed to determine, from the available evidence, the effectiveness of 
interventions in reducing alcohol consumption among general hospital inpatient 
heavy alcohol users. Box 3 below summarises the main findings from Paper 3. 
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Box 3: Summary of main findings from Paper 3 
1. Brief interventions of more than one session are likely to be more effective 
than usual care/ no intervention on reducing alcohol consumption, 
especially for non-dependent patients. 
 
2. There was no clear intervention benefit from single session brief 
interventions and self-help literature (e.g. booklets, leaflets) on alcohol 
consumption outcomes, with indications of benefit from some studies but 
not others. 
 
3. There were intervention benefits from single session brief interventions on 
motivation/ readiness to change. 
 
4. Research on the evaluation of interventions for unhealthy alcohol use in 
general hospital wards have mostly been on brief interventions, especially 
single session brief interventions. 
 
5. Many studies found significant improvements in all study groups for some 
outcomes including alcohol consumption. 
 
6. All the interventions were non-pharmacological and alcohol focused. 
 
7. There is great variability in the measures used to assess alcohol 
consumption across studies. 
 
5.1.1.1 What does this study contribute to the body of knowledge? 
 
This review recognizes the range of ways by which people’s behaviour 
changes, from self-help through to more intensive intervention, as well as the 
diverse range of possible interventions that are available for unhealthy alcohol 
use (Pycroft, 2010). Hence, unlike previous reviews that focused on one type of 
intervention such as BIs (Emmen et al., 2004; McQueen et al., 2011), this 
review was not restricted by intervention type. In so doing, it highlighted that, 
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despite a diverse range of possible interventions, research with this population 
has mostly concentrated on alcohol focused BIs, especially single session BIs. 
 
The review also explores the impact of different intervention characteristics 
such as format, modality or design on outcomes. In so doing it found that single 
session BIs have not demonstrated a clear benefit on alcohol consumption 
outcomes, despite more than two decades of research investment. On the other 
hand, BIs of two sessions or more, which have received much less research 
attention, seem to be more promising. This has important implications for 
research, policy and practice in this field. The paper has been cited by at least 
10 peer reviews journal articles (Bergen et al., 2014; Chiappetta et al., 2014; 
Droste, Miller and Baker, 2014; Gordon et al., 2013; Govier and Rees, 2013; 
Heather, 2014a; Mdege and Chindove, 2014; Riper et al., 2014; Roerecke and 
Rehm, 2014; Shiles et al., 2013). It has mostly been cited for showing no clear 
benefit from single session BIs (Bergen et al., 2014; Chiappetta et al., 2014; 
Droste, Miller and Baker, 2014; Gordon et al., 2013; Heather, 2014a; Riper et 
al., 2014). Two articles restated the need for multiple session BIs (Roerecke 
and Rehm, 2014; Shiles et al., 2013). 
 
5.1.2 Paper 4 
 
Watson, J.M., Fayter, D., Mdege, N., Stirk, L., Sowden, A.J., and Godfrey, C. 
(2013). Interventions for alcohol and drug problems in outpatient settings: a 
systematic review. Drug and Alcohol Review, 32(4), 356-367. 
 
Paper 4 was a review of available evidence on the effectiveness of interventions 
for alcohol and drug problems in general hospital outpatient settings. The main 
results are summarised in Box 4. 
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Box 4: Summary of main findings from Paper 4 
1. Evidence for interventions to tackle either unhealthy alcohol use or problem 
drug use, or both problems at the same time, for patients identified in 
general hospital outpatient settings is scarce. 
 
2. The few studies conducted in most general hospital outpatient departments 
have not found positive effects of brief interventions on reducing alcohol 
consumption and other outcomes, except in oral-maxillofacial clinics.  
 
3. Interventions based on motivational techniques may be effective among 
unhealthy alcohol users identified in oral-maxillofacial clinics. This is 
however based on two studies. 
 
4. Most studies were of poor quality judging from study reports, and the 
quality of study reporting was also poor. 
 
5.1.2.1 What does this study contribute to the body of knowledge? 
 
This is the first review to solely focus on interventions for unhealthy alcohol use 
and problem drug use in general hospital outpatient settings. This review also 
included any type of intervention for reasons already mentioned. The review 
informed a study on electronic alcohol screening and BI in hospital outpatient 
settings by highlighting the lack of evaluation of such interventions (Johnson, 
Kypri and Attia, 2013). Its conclusions were found consistent with findings from 
a recent RCT by Crawford and colleagues (2015) that found no BI impact on 
unhealthy alcohol use among people attending outpatient sexual health clinics. 
Other researchers have also restated the lack of research in this area (Fletcher, 
Nutton and Brend, 2014), and mixed findings from the few studies that exist 
(Riper et al., 2014).  
 
The hospital outpatient clinics explored by paper 4 (as described in the 
introduction section 1) encompassed a wide range of patients: from those 
attending oral and maxillofacial, internal medicine, and HIV clinics, through to 
homeless and women’s clinics. BIs for unhealthy alcohol use based on 
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motivational techniques seem promising in oral-maxillofacial clinics, whilst in 
general BIs have not worked well in other outpatient settings. This could 
suggest the need for tailoring interventions for each of the different outpatient 
settings. The results of the two ongoing trials identified in paper 4 are yet to be 
published (McCaul and Chander, n.d.; Rowe, n.d.).  
 
The findings from Paper 3 and 4 resulted in another piece of work which aimed 
to explore how the effectiveness of BIs for reducing alcohol consumption in 
patients identified in general hospital settings could be improved. This is 
discussed below. 
 
5.2 How can the effectiveness of brief interventions in general hospital 
settings be enhanced? 
 
Systematic reviews in primary care settings have concluded that BIs are 
effective in reducing alcohol use in unhealthy alcohol users (Bertholet et al., 
2005; Kaner et al., 2007; Moyer et al., 2002), whilst most in general hospital 
settings have reported inconclusive findings (Emmen et al., 2004; McQueen et 
al., 2011; Field et al., 2010). This difference in findings and conclusions could 
be due to a number of factors such as potential differences in the patient 
population, the actual interventions delivered, how the interventions are 
delivered and the environment within which interventions are delivered.  There 
is a potential here for future BI studies conducted in general hospital settings to 
learn from what has been done in primary care. 
 
Paper 5 takes up this opportunity and explores if there are any differences on 
intervention characteristics, study design or patient characteristics, between BI 
studies conducted in primary care and those conducted in general hospital 
settings that could explain the variance in the consistency of findings. 
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5.2.1 Paper 5 
 
Mdege, N.D., and Watson, J. (2013). Predictors of study setting (primary care 
vs. hospital setting) among studies of the effectiveness of brief interventions 
among heavy alcohol users: a systematic review. Drug and Alcohol Review, 
32(4), 368-380. 
 
Paper 5 aimed to compare studies by their setting in order to identify differences 
between studies on BIs for heavy alcohol use conducted in primary care 
settings and those in general hospital settings. The main findings are 
summarised in Box 5. 
 
Box 5: Summary of main findings from Paper 5 
1. Studies comprising fewer intervention sessions were more likely to have 
been conducted in hospital settings than primary care settings. 
 
2. Studies that did not exclude very heavy/ dependent drinkers were more 
likely to have been conducted in hospital settings than primary care 
settings. 
 
3. Studies with a higher proportion of male participants were more likely to 
have been conducted in hospital settings than primary care settings. 
 
5.2.1.1 What does this study contribute to the body of knowledge? 
 
This study suggests the need to evaluate multiple session BIs, which is 
consistent with the findings from Paper 3. It also contributes to current debate 
on whether BIs are effective in reducing alcohol consumption among very 
heavy/ dependent drinkers. Whilst there is currently not enough evidence to 
either support or refute the effectiveness of BIs for this population, the results 
here suggest that the inclusion or exclusion of this population could be one of 
the reasons for differences in consistency of results between primary care and 
hospital settings.  
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Paper 5 has been cited by two articles, one on the need to assess intervention 
fidelity in trials where this is applicable (Chariot et al., 2014); and the other on 
the importance of addiction services in general healthcare settings (Shea, 
2013). 
 
5.3 Implications of research findings to policy and practice 
 
The results from Papers 3 and 5 suggest that BIs for alcohol problems provided 
for individuals identified in general hospital settings should consist of at least 
two sessions. One session could be enough for improving motivation or 
readiness to change, but not to significantly reduce alcohol consumption. A 
recent review in primary care has also reported that brief multi-contact 
interventions (each contact up to 15 min) can achieve greater effect sizes 
compared with very brief (up to 5 min) and brief (>5 min, up to 15 min) single-
contact interventions for unhealthy alcohol use (Jonas et al., 2012). This is 
consistent with findings in other areas such as smoking cessation where it has 
been demonstrated that interventions of low intensity do not significantly 
increase smoking cessation rates among hospitalised patients (Rigotti et al., 
2012). Effective interventions are those where counselling interventions begin 
during hospitalisation and patient contact continues for at least one month after 
discharge (Rigotti et al., 2012). This could also be true for unhealthy alcohol 
users or problem drug users in general hospitals.  
 
The feasibility of multiple session interventions in hospital settings is however 
questionable. A recent qualitative study conducted in England found very low 
levels of commitment to the delivery of substance misuse interventions among 
hospital setting healthcare professionals (Raistrick, Tober and Unsworth, 2015). 
The researchers suggested it is best if these interventions are delivered by 
trained addiction specialists, rather than trying to ‘piggy back’ them onto the 
services of other clinical specialties. In the UK it has been recommended that 
hospitals include alcohol liaison nurses or alcohol health workers (AHWs) 
whose roles are dedicated to tackling individuals with alcohol-related problems 
(HM Government, 2012; Royal College of Physicians, 2001). A recent survey of 
48 NHS hospitals in England which I co-authored found that AHWs 
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predominantly target alcohol dependant adults, with those who are non-
dependent being under prioritised (Baker et al., 2014). This means the 
opportunity to prevent non-dependent unhealthy alcohol users from progressing 
to more serious alcohol related problems and dependence is missed. There is 
need therefore to improve the AHW model, and to explore other models with 
active roles for interdisciplinary generalists and alcohol or addiction specialists 
(Broyles et al., 2012), in order to carter for all categories of unhealthy alcohol 
users. 
 
It is very difficult to derive any recommendations for practice from Paper 4 due 
to the limited number of studies and weaknesses in study design. However, 
there could be unexplored potential to deliver multiple session interventions in 
hospital outpatient settings, particularly where patients are likely to have 
multiple appointments. Healthcare professionals might also find it easier to talk 
to outpatients about their alcohol consumption or illicit drug use as they are 
more likely to be in better physical and mental health states than those 
presenting to hospital inpatient settings or accident and emergency 
departments (Anderson et al., 2001; Groves et al., 2010). 
 
5.4 Implications for future research 
 
There is need for more research on the clinical and cost-effectiveness of 
multiple session BIs for unhealthy alcohol use in general hospital settings, and 
perhaps other interventions that are not BIs. Compared to primary care settings 
where it is possible to take advantage of future appointments for continued 
engagement with patients, in general hospital settings single session BIs could 
be more attractive to evaluate than multiple contact interventions because they 
seem more feasible. However, it is clear that these very short-term single 
session interventions might not result in lasting improvement on unhealthy 
alcohol use or problem drug use behaviour (Humphreys and Tucker, 2002; 
Pycroft, 2010). Building rapport and therapeutic alliance, which is important for 
the effectiveness of such interventions (Groves et al., 2010; Raistrick, Tober 
and Unsworth, 2015), could be difficult to achieve during a single session 
intervention. In addition, the patient’s state of health when they present to 
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general hospital settings might make them less attentive or receptive to 
interventions for unhealthy alcohol use or problem drug use. It could therefore 
be that the current BI model consisting of a single session between an acutely ill 
patient and a healthcare provider with whom the patient might be meeting for 
the first time, with no distinction between non-dependent and dependent 
drinkers, might not be the most effective model for general hospital settings. 
Research should also include patients’ and clinicians’ perspectives on how and 
where multiple session interventions (or their difference components) should be 
delivered. 
 
The differences observed in Paper 5 between BI studies conducted in primary 
care versus those in secondary care settings could also be explained by the 
limitations of meta-regression already mentioned in section 2.1. For example, 
since the methodology is observational in nature, there is the possibility that the 
results were biased through confounding by other study-level characteristics. 
The poor primary study quality which was observed also makes it difficult to 
derive any robust conclusions from the findings. However, the fact that the 
findings from paper 5 support findings from paper 3 particularly on the need for 
multiple session interventions, and those reported by other studies on the 
effectiveness of BIs among dependent unhealthy alcohol users (Moyer et al., 
2002; Saitz, 2010), adds confidence to the findings (Higgins and Green, 2008). 
  
There is also need for studies designed to explore which drinkers (i.e. 
hazardous, harmful and dependent drinkers) benefit from which interventions 
(Institute of Medicine, 1990; McCambridge and Rollnick, 2014; Raistrick, 
Heather and Godfrey, 2006). Most references to and recommendations for BIs 
suggest that they are expected to work for non-dependent hazardous and 
harmful drinkers, and not for dependent drinkers (Moyer et al., 2002; NICE, 
2011; Raistrick, Heather and Godfrey, 2006; Saitz, 2010). However, many BI 
studies conducted in general hospital settings enrol a wide variety of 
participants in terms of severity of drinking and alcohol problems; from 
hazardous, through to harmful and dependent drinkers. For example, one study 
evaluating a single session BI had very high proportions of dependent drinkers 
(Saitz et al., 2007). Although the effectiveness of BIs for alcohol dependent 
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patients remains unknown (Saitz, 2010), observations in primary care suggest a 
reduction in intervention effect size if dependent drinkers are included (Moyer et 
al., 2002), and absence of BI effectiveness among dependent drinkers (Saitz, 
2010). This might be the same for general hospital settings, although the 
uncertainty over the issue will continue until studies are designed to explore 
which drinkers benefit from which interventions. 
 
Another research gap is on the evaluation of interventions that do not only focus 
on drinking behaviour, but also address directly any actual problems individuals 
might be experiencing because of their drinking (McCambridge and Rollnick, 
2014). Undoubtedly, the volume of alcohol consumed is an important 
determinant of alcohol related harm (Norstrom and Ramstedt, 2005; WHO, 
2014). Hence most policies and interventions are aimed at reducing total 
consumption of alcohol at individual level as well as in society. However, this 
has had a negative impact on the attention given to the problems associated 
with unhealthy alcohol use both on policy and intervention design, as well as on 
outcome measurement. 
 
It has been suggested that BIs that focus on drinking less might be useful for 
hazardous drinkers for early intervention and secondary prevention (Heather, 
2014b), whilst those employing motivational interviewing and addressing 
alcohol related harm in addition to drinking can be targeted at harmful and 
dependent drinkers (Heather, 2014b; McCambridge and Rollnick, 2014). 
However, findings from a WHO Collaborative study suggest the opposite, 
particularly for male patients: that is, simple advice works best for those who 
recognise their alcohol problem after having experienced a recent alcohol-
related problem; whilst more extended counselling is needed for those who are 
ambivalent about their unhealthy alcohol use, which could include hazardous 
drinkers (Babor and Grant, 1992). Although this debate has mostly been in 
primary care, these issues are also relevant to general hospital settings. Only 
through adequately designed research can we address these issues.  
 
There is a clear need to invest in more research on the effectiveness and cost-
effectiveness of interventions for alcohol and illicit drug use problems in general 
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hospital outpatient settings. There is possibly untapped potential for delivering 
multiple session interventions in this setting as has already been mentioned. 
 
Systematic reviews in this area have been criticised for not evaluating outcomes 
in relation to intervention content (McCambridge and Rollnick, 2014). However, 
we found that most studies did not describe the interventions in sufficient detail 
to allow for this exploration (Mdege et al., 2013; Mdege and Watson, 2013). 
Guidance on how to report non-pharmacological intervention details exist 
(Boutron et al., 2008). It might be worthwhile to investigate if the quality of 
reporting has improved since the publication of the guidance. In the case of no 
improvement it would also be useful to understand why that is and explore ways 
of facilitating improvement. As highlighted in section 2.1, another challenge 
encountered in this work was the variability of the methodological quality of 
studies, patient groups, the duration and content of interventions, control 
conditions, how outcomes were defined and measured, and time points for 
outcome measurements. This heterogeneous nature of this literature made 
quantitative pooling of trial outcomes impossible, and it was difficult to assess 
the overall effects of interventions across studies. These challenges have also 
been observed elsewhere (Kaner, Brown and Jackson, 2011).  A number of 
strengths of the systematic reviews conducted as part of this thesis have 
already been highlighted in sections 2.1, 5.1.1.1 and 5.1.2.1. An additional 
strength is the fact that all the reviews systematically applied extensive search 
strategies to key databases covering health and social care research, and 
included scanning the reference lists of eligible studies.  
 
Implementation of screening, assessment and interventions for individuals with 
alcohol and illicit drug use problems is challenging. Section 5 below will focus 
how some of the challenges can be addressed. 
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6. Implementation of interventions in general hospital settings 
 
Results from the research studies conducted as part of this thesis present a 
number of potential policy and practice level implications. However, there are a 
number of significant implementation challenges that are encountered in 
general hospital settings (section 1.1.2.3). The section below will discuss how 
the impact of some of these barriers such as time constraints can be reduced 
through prioritising and targeting high risk patient groups and settings.   
 
6.1 Addressing implementation challenges 
 
Time constraints are the most commonly cited barrier to screening, assessment 
and intervention for unhealthy alcohol use and problem drug use (Beich, 
Thorsen and Rollnick, 2003; Patton et al., 2004; Sullivan et al., 2011). General 
shortage of resources such as financial and human resources is also a major 
barrier. Strategies such as self-administered screening, having dedicated 
addiction teams, or shifting the screening task from clinicians to other lower 
level workers can potentially improve screening and intervention rates 
(Raistrick, Tober and Unsworth, 2015). Targeted screening (i.e. screening 
specific high-risk patient groups) has also been suggested as a solution, not 
only for efficiency, but also for ensuring credibility of screening and any further 
intervention to both patients and clinicians (Beich, Gannick and Malterud, 2002; 
Hutchings et al., 2006; Prime Minister's Strategy Unit, 2004). For unhealthy 
alcohol use, a patient’s presenting condition could provide a means of targeting 
those with a high likelihood of alcohol related problems who will potentially have 
the largest expected health gain from interventions aimed at reducing alcohol 
consumption (Patton et al., 2004). However, evidence on how to target patients 
in this way is limited, hence practice may vary widely. This is the subject of 
Paper 6 which focuses on the following medical specialties: gastroenterology, 
emergency medicine, cardiology and oncology. 
 
Paper 6 utilized the Delphi method to explore whether there was consensus on 
the expected health gains by presenting condition among medical specialists. 
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6.1.1 Paper 6 
 
Mdege, N.D., Raistrick, D., and Johnson G. (2014). Medical specialists’ views 
on the impact of reducing alcohol consumption on prognosis of, and risk of, 
hospital admission due to specific medical conditions: results from a Delphi 
survey. Journal of Evaluation in Clinical Practice, 20(1), 100-110. 
 
The sixth paper was aimed at investigating how to target patients for screening 
and interventions for unhealthy alcohol use based on their presenting medical 
condition. Box 6 summarizes the main findings. 
 
Box 6: Summary of main findings from Paper 6 
1. There was strong support from experts that reducing alcohol consumption 
could result in improvement in prognosis for gastroenterology and 
emergency medicine patients. 
 
2. There were high levels of uncertainty over the prognostic benefits of 
reducing alcohol consumption for oncology and cardiology patients, except 
for alcoholic cardiomyopathy where there was unanimous consensus for 
high benefit. 
 
3. The benefits of reducing alcohol consumption on hospital admissions due 
to the different conditions were not clear for all specialties. 
 
4. The severity of a disease or condition was viewed as an important 
consideration. There was also strong support for the availability of aftercare 
and social support services within the community. 
 
6.2 Study’s contribution to the body of knowledge, and implication for 
policy, practice and future research 
 
This study provides useful information for clinicians on which priority specialty 
areas to target for opportunistic screening and interventions for alcohol 
problems in hospital settings, where a targeting strategy has been adopted. A 
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focus on gastroenterology and emergency medicine patients may be an 
acceptable approach. 
 
The study also highlights a number of unasked, unanswered and unemphasised 
questions for future research. For example, does perception reflect reality in 
terms of expected health gains from interventions aimed at reducing alcohol 
consumption for the different diseases or conditions? Is targeted screening by 
disease or condition more effective, cost-effective and acceptable than 
universal screening? 
 
After discussing the six papers and the implications of their findings on policy, 
practice and future research, section seven contains the final remarks and 
conclusions. 
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7. Final remarks and recommendations 
 
This integrative chapter has summarised the aims, objectives, methodology, 
results and conclusions from contributing papers. It has clarified how they form 
a coherent body of work and make a significant and original contribution to 
knowledge and understanding. The integrative chapter also specified the 
candidate's contribution to each of the papers. 
 
The portfolio of work presented here aimed to address a number of evidence 
gaps regarding screening, assessment and interventions for unhealthy alcohol 
users and problem drug users in general hospital settings. First, there were no 
systematic reviews of evidence to guide the choice of problem drug use 
screening instruments or comprehensive substance use assessment packages 
to use. Second, there was lack of clarity on which interventions are 
effectiveness, or are most likely to be effective, for unhealthy alcohol use and 
problem drug use for general hospital patients. In addition, for unhealthy alcohol 
use there is lack of evidence on how to prioritise and target high risk patient 
groups and settings by presenting condition when resources are scarce. 
Overall, the portfolio of work has highlighted that the currently available body of 
evidence does not provide clear answers on how unhealthy alcohol users and 
problem drug users can be effectively intervened with in general hospital 
settings. However, there are still a number of policy, practice and research 
recommendations that can be drawn from this work. These are summarised 
below. 
 
7.1 Policy and practice recommendations 
 
Although there is lack of evidence demonstrating the validity of screening 
instruments for problem drug use, and the effectiveness of interventions for both 
unhealthy alcohol use and problem drug use within general hospital settings, 
identifying and addressing these issues in patients is still important (Boothroyd 
et al., 2013; Heather, 2014b; Saitz, 2014). When relevant to care, patients need 
to be asked about alcohol and/or drug use as such information could be critical 
to appropriate diagnosis and care.  
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Four main policy and practice recommendations can be drawn from the work 
presented here. First, currently available evidence favours the ASSIST as the 
screening instrument of choice. Second, instead of comprehensive assessment 
packages, clinicians can use a set of single construct scales with good 
psychometric properties based on the demographic characteristics of the 
service users. Third, BIs for unhealthy alcohol users in general hospital settings 
should consist of at least two sessions as such interventions are more likely to 
be effective than usual care or no intervention. Single session brief interventions 
might be attractive from the feasibility and implementation perspectives. 
However, they have not demonstrated any clear benefit when compared to 
usual care or no intervention on alcohol consumption outcomes. Fourth, the 
findings from Paper 6 suggest that a focus on gastroenterology and emergency 
medicine patients is a promising way to target resources for opportunistic 
screening and interventions for unhealthy alcohol use by presenting condition in 
hospital settings.  
 
Together these conclusions inform policy and practice on screening, 
assessment and interventions for unhealthy alcohol users and problem drug 
users in general hospital settings. 
 
7.2 Research recommendations  
 
The main areas where research studies are most needed in this field are 
highlighted below and in Box 7. 
 
There is need for randomised controlled trials (RCTs) evaluating the 
effectiveness of interventions for unhealthy alcohol use and problem drug use in 
hospital inpatient and outpatient settings. These trials need to investigate if 
multiple session brief interventions are effective, particularly for non-dependent 
hazardous and harmful alcohol users and drug users. It is encouraging to see 
that from the seven on-going hospital inpatient studies listed in Paper 3, at least 
three are multiple session interventions. Brief treatments also need to be 
evaluated for moderately dependent drinkers and drug users, including non-
treatment seekers with conditions where abstinence is critical for successful 
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treatment. In addition, there is need for research on interventions (either 
pharmacological or non-pharmacological) aimed at dependent patients since 
studies have shown large proportions of alcohol or illicit drug dependent 
patients in general hospital settings. Research should also incorporate process 
evaluation relating to the design and delivery of the interventions, mechanisms 
of action and the active ingredients of interventions (Gaume et al., 2014). An 
exploration of the key barriers and facilitators affecting the implementation of 
such interventions in general hospital settings is also needed. This could 
include using quantitative data from RCTs as well as qualitative data exploring 
the perspectives of patients, clinicians and other stakeholders. 
 
Box 7: Main research recommendations 
1. There is need for randomised controlled trials evaluating multiple session 
BIs and other interventions that are not BIs, for unhealthy alcohol users and 
problem drug users identified in general hospital settings. 
 
2. The evaluation of interventions in general hospital settings need to 
incorporate process evaluation, as well as the exploration of key barriers 
and facilitators affecting intervention implementation. 
 
3. There is need for the design and evaluation of the psychometric and 
diagnostic properties of screening instruments for problem drug use in 
general hospital settings. 
 
 
For problem drug use, there is optimism that screening and BIs could be 
effective since they have shown success for smoking cessation and unhealthy 
alcohol use (particularly in primary care) (Saitz, 2014). However, evidence 
generated from other behaviours might not be directly transferable to problem 
drug use. It has been suggested that the criminogenic nature of problem drug 
use (i.e. prohibited use, by law, of a substance) might have an impact on the 
transferability of intervention effectiveness evidence generated from tobacco or 
alcohol use. However, there is lack of evidence to support this notion. It will be 
interesting to contrast the intervention effectiveness evidence for problem novel 
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psychoactive substance (NPS) use as it develops, with the developments in 
problem drug use (as defined in this thesis) with regards to whether the legality/ 
illegality of a substance per se makes a difference. NPS use is the use of a new 
narcotic or psychotropic drug, in pure form or in preparation, that is not 
controlled by the United Nations drug conventions and not prohibited by law, but 
which may pose a public health threat comparable to that posed by substances 
listed in these conventions (European Monitoring Centre for Drugs and Drug 
Addiction, 2006). Problem drug use is often more socially proscribed when 
compared to tobacco use and unhealthy alcohol use (Saitz, 2014). Thus, there 
could be significant differences in the way that problem drug users engage with, 
interacts with and respond to interventions when compared to tobacco users or 
unhealthy drinkers. For example, qualitative studies have reported lack of trust 
between problem drug users and healthcare professionals (Chan, 2008; Merrill 
et al., 2002; Morgan, 2006). In some studies, healthcare professionals, as well 
as the drug users themselves, perceived problem drug users as blameworthy 
and unworthy of care (Chan, 2008; Crockett and Gifford, 2004; Pauly, 2008). 
These views could be different for non-dependent unhealthy alcohol use and 
tobacco use. Hence the need for research that is specific for problem drug use. 
 
Studies on the design and evaluation of the psychometric and diagnostic 
properties of screening instruments for problem drug use in general hospital 
settings are needed in this field. This could include the optimisation of the 
already existing instruments to suit general hospital settings by making them 
less bulky and ensuring they can distinguish between active and inactive 
problems as well as different levels of substance use. 
 
7.3 How the portfolio of work informed phase 2 of the ARiAS 
  
The work described within this thesis formed the phase 1 developmental work 
that informed the ADAPTA pilot RCT in phase 2 of the ARiAS programme 
(Watson et al., 2013b), as demonstrated in Figure 3. 
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Figure 3:  An illustration of how the presented body of work informed the 
ADAPTA pilot trial 
 
In conclusion, there is great potential for identifying, assessing and intervening 
with unhealthy alcohol users and problem drug users in general hospital 
settings. The health, social and economic dividends from effective interventions 
could be very great. However, fundamental challenges stand in the way of 
realising such outcomes. First, many of the unhealthy alcohol users and 
problem drug users might not even be aware, or acknowledge, that they have 
such problems. Second, too little is known about the most effective ways of 
identifying and intervening with patients in this setting. Lastly, there are 
Study implementation: Participants were recruited from wards that admitted 
patients with condition: a) that could be related to unhealthy alcohol use, 
and b) for which treating problem drinking is perceived to have the highest 
impact on prognosis (Informed by paper 6). 
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considerable barriers to engaging healthcare professionals and patients in this 
process. This thesis, and the body of work that it comprises, has contributed to 
this knowledge base, but there continue to be glaring gaps in our understanding 
that future research needs to address. 
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Appendix 1: Papers 1 to 6 
 
Screening instruments for detecting illicit drug use/abuse that could be useful in
general hospital wards: A systematic review
Noreen D. Mdege a,⁎,1, Jenny Lang b,1
a Department of Health Sciences, University of York, Heslington, York, YO10 5DD, United Kingdom
b Leeds Addiction Unit, 19 Springﬁeld Lane, Leeds, LS2 9NG, United Kingdom
a b s t r a c ta r t i c l e i n f o
Keywords:
Screening
Illicit drugs
Hospital
Validity
Reliability
Systematic review
Aim: To identify and describe screening instruments for detecting illicit drug use/abuse that are appropriate
for use in general hospital wards and review evidence for reliability, validity, feasibility and acceptability.
Methods: Instruments were identiﬁed from a number of screening instrument databases/libraries and Google
Scholar. They were independently assessed for eligibility by two reviewers. MEDLINE, EMBASE, PSYCINFO,
and Cochrane Library were searched for articles published up to February 2010. Two reviewers independently
assessed the identiﬁed articles for eligibility and extracted data from the eligible studies.
Results: 13 instruments, ASSIST, CAGE-AID, DAST, DHQ/PDHQ, DUDIT, DUS, NMASSIST, SIP-AD, SDS, SMAST-
AID, SSI-SA, TICS and UNCOPE were included in the review. They had 2 to 28 items and took less than 10 min
to administer and score. Evidence on validity, reliability, acceptability and feasibility of instruments in adult
patients not known to have a substance abuse problem was scarce. Of the 21 studies included in the review,
only one included participants from general hospital wards. Reported sensitivity, speciﬁcity and predictive
values varied widely both between studies of the same instrument and also between different instruments.
No study was identiﬁed comparing two or more of the included instruments.
Conclusion: The review identiﬁed and described 13 instruments that could be useful in general hospital wards.
There is however lack of evaluation of illicit drug use screening instruments in general hospital wards.
Currently clinicians or researchers searching for a simple, reliable, general screening instrument for current
drug use to guide practice or research in general hospital wards do not have enough comparative evidence to
choose between the available measures.
© 2011 Elsevier Ltd. All rights reserved.
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1. Introduction
Themisuse of illicit drugs has amajor impact on population health,
including accounting for the loss of 11.6 million Disability Adjusted
Life Years (DALYs) annually worldwide, which is 0.8% of the total
burden of disease (World Health Organization (WHO), 2002). In
England illicit drugs were responsible for 1738 deaths in 2008; 42,170
hospital admissions with a primary or secondary diagnosis of drug-
related mental health and behavioral disorders in 2008/9; and 11,090
admissionswith a primary diagnosis of drug poisoning in 2008/9 (NHS
Information Centre, 2009). The economic and societal costs of illicit
drug use are substantial. In England the use of Class A drugs (those
treated as the most harmful and so carry the harshest penalty e.g.
cocaine and heroin) was associated with economic and social costs of
around £15.4 billion in 2003/04 of which £488 million (3%) were
health service use costs (Gordon, Tinsley, Godfrey, & Parrott, 2006).
Empirical information on the effectiveness and cost-effectiveness of
methods for both identifying and treating substance misusers is scarce
(Bernstein et al., 2005; Madras et al., 2009;WHO, 2008). Although illicit
druguse is associatedwith increased risk of anumber of health problems
(Mertens, Lu, Parthasarathy, Moore, & Weisner, 2003; Swanson et al.,
2007), the majority of people with illicit drug use disorders do not seek
treatment as they are unaware they have a problem (Madras et al.,
2009). There is mounting evidence of a high prevalence of drug misuse
among inpatients in general hospital wards (Brown, Leanard, Saunders,
& Papasouliotis, 1997; Crome, Bloor, & Thom, 2006). Such wards
therefore provide opportunity to engage patients who are unaware they
have a problem or may not seek care. Whilst hospitalized, potential
interventions are less time-limited and patientsmay also link their illicit
drug use and hospitalization, thereby providing a “teachable moment”,
such as suggested for alcoholmisuse (Mitka, 1998; Saitz, Palfai, Cheng et
al., 2007). Hospitalized patients generally have more severe medical
conditions than those in primary care which allows health professionals
to argue more effectively for screening and intervention if the medical
conditions are related to illicit drug use (Emmen, Schippers, Bleijenberg,
& Wollersheim, 2004).
Identiﬁcation of illicit drug use problems is useful for: optimizing
treatment effectiveness for the diagnosed health problem; directing
behavioral interventions to inﬂuence future drug use; and reducing
health care costs (Crome et al., 2006; Mertens et al., 2003). This is
particularly important for patients presenting with medical condi-
tions where illicit drug use could be a contributing factor. Research
has suggested screening alone, without any further intervention,
signiﬁcantly inﬂuenced participants to reduce their substance use,
which could concomitantly reduce associated health problems and
other consequences (Copeland, Swift, Roffman, & Stephens, 2001;
WHO, 2008). According to Gossop, Marsden, and Stewart (1998,
2001) the total cost savings to society are greater than £3 for every
extra £1 spent on drug misuse treatment. Standardized illicit drug
screening instruments can be useful tools for identifying illicit drug
use problems and facilitating treatment (Hoffmann, Hunt, Rhodes, &
Riley, 2003; Lanier & Ko, 2008; WHO ASSIST Working Group, 2002).
However various factors may hinder health professionals from using
standardized screening instruments including: lack of time, inade-
quate training, low conﬁdence, and negative attitudes to both its
purpose and the ‘target group’ (Crome et al., 2006).
The aim of this review is to identify and describe screening
instruments for detecting illicit drug use/abuse that are appropriate
for use in general hospital wards, and review evidence for reliability,
validity, feasibility and acceptability. We used speciﬁed criteria to
identify the screening instruments (see Section 2.2.1). For the
identiﬁed instruments, we explored 1) their ability to distinguish
between different levels of substance abuse (i.e. active and inactive
problems, abstainers/non-problematic use, abuse and dependence; 2)
reliability and validity; 3) speciﬁcity, sensitivity and predictive values;
4) the extent to which the scale has been tested with different
population groups, cultural or geographical locations; 5) the per-
ceived relevance of the instrument for a particular group or setting;
and 6) the acceptability of the instrument to patients and those
administering it. These are among the essential features for ﬁnding
the best match between a screening instrument and the proposed
screening exercise (Crome et al., 2006). To the best of our knowledge,
no such review of illicit drug use screening instruments that could be
used in general hospital wards has been completed before.
2. Methods
2.1. Search strategy
A three stage search strategy was used. First, in February 2010 an
extensive search for illicit drug screening instruments was con-
ducted in the following: the Alcohol and Drug Abuse Institute Library
(http://lib.adai.washington.edu), a regularly updated database of
screening, assessment and outcome measurement instruments
for alcohol and drug abuse; National Institute of Drug Abuse,
USA (http://www.nida.nih.gov/NIDAHome.html); Addiction Re-
search Institute of the Centre for Social Work, The University of
Texas at Austin (http://www.utexas.edu/research/cswr/nida/
instrumentListing.html); Centre on Alcoholism, Substance Abuse
and Addictions (CASAA) (http://casaa.unm.edu/inst.html) and Goo-
gle Scholar. The identiﬁed instruments were selected for inclusion in
the review using the criteria in Section 2.2.1.
Secondly, for each selected instrument from the ﬁrst stage, literature
searches were conducted in Medline (1950—February Week 4, 2010),
PsycIFO (1806—February Week 4, 2010), Embase (1980–2010 Week
09), and Cochrane Library (Issue 4, 2010) for published evidence of each
instrument's performance. The instrument's full name and/or acronym
were used in combinationwith the followingphrases: substance-related
disorders; drug misuse/abuse/addiction/dependence; substance mis-
use/abuse/addiction/dependence; and opioid/amphetamine/cocaine/
marijuana/cannabis/benzodiazepines in combination with misuse/
abuse/addiction or dependence. The search was conducted in February
2010 and limited to English language. No date limits were applied.
Thirdly, the identiﬁed studies from the second stage were cross-
checked to identify supplementary instruments and any research on
the identiﬁed instruments not already revealed in the ﬁrst and second
stages of the search.
5
6
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2.2. Selection criteria
2.2.1. Types of screening instruments
We included screening instruments to detect illicit drug use in adult
patients not known to have a substance abuse problem, that are short
enough for use in general hospital wards (10 min or less to administer
and score), and do not require speciﬁc training to administer, score and
interpret results. Although instruments which take less than 10 min
could be preferred in some settings, a cut off of 10 min was chosen
because instrument with the shortest time were often reported as
taking5 to 10 min to complete and score. Speciﬁc training requirements
would affect sustainability of routine screening because of the high
turnovers of staff which might be associated hospital settings.
Screening instruments for one or two speciﬁc drugs only and dual
diagnosis (illicit druguseandmentalhealthdisorders)wereexcluded.We
were interested in screening instruments that take into account the
diverse nature of illicit drugs that some patients could be using, therefore
those only screening for one or two speciﬁc drugs would not cover an
adequate range of illicit drugs to be useful in general hospital wards.
Although many people with drug problems also experience a range of
otherpsychiatric andpsychological problems, screening fordual diagnosis
is a lengthy process which might require clinicians with necessary
expertise (Barnaby, Drummond, McCloud, Burns, & Omu, 2003; Dawe &
Mattick, 1997), hence may not be feasible in general hospital wards.
2.2.2. Types of studies
We included studies evaluating any of the following: validity,
sensitivity and speciﬁcity, predictive values, reliability, acceptability,
feasibility. We excluded studies only including patients already
identiﬁed or diagnosed as having a substance abuse disorder, those
conducted in populations other than adults, and studies on one or two
speciﬁc drugs only.
2.3. Selection process for inclusion of instruments and studies
Two reviewers (NM and JL) independently assessed the in-
struments for inclusion using the pre-speciﬁed selection criteria.
Differences in opinion were resolved through consensus.
All titles and abstracts retrieved from the search process were
independently screened by NM and JL to identify all potentially
relevant studies. Full articles were then independently judged by NM
and JL according to the pre-speciﬁed criteria and classiﬁed as
included, excluded, or unclear. Differences in opinion were resolved
through consensus. Where a study was classiﬁed by both reviewers as
unclear, eligibility was determined through discussion.
2.4. Data extraction
NM and JL independently extracted data from the published
sources using a data extraction form. The extracted information
included study identiﬁers (lead author, publication year); general
instrument characteristics (number of items, time required, com-
pletion, format, availability); recall period, type of instrument,
distinguishing between active and inactive use, distinguishing
between abstainers/low risk users, hazardous/harmful and depen-
dent users; and validity, reliability, acceptability, feasibility, sensi-
tivity, speciﬁcity, and predictive values. The data extraction form
was piloted on 3 papers and adjusted accordingly. Differences in data
extraction were resolved through discussion.
3. Results
3.1. Screening instruments
Seven hundred and eight instruments were identiﬁed, of which: 543
instruments were for detailed assessment after a person has already
been identiﬁed as having a problem using a shorter screening method,
46 were for adolescents and 95 were for alcohol only or other addictive
behaviors. Of the remaining twenty four screening instruments three
were speciﬁc for one or two drugs only, ﬁve took more than 10 min to
complete and score, onewas for dual diagnosis, andone requires speciﬁc
training.We also excluded one instrument (Substance Use Inventory) as
wewere not able to obtain enough information to assess its eligibility for
the reviewdespite extensive efforts, including contacting thedevelopers
of the instrument. Although some studies have used the Substance Use
Inventory for research purposes, our search did not identify any studies
on its evaluation. Thus, thirteen screening instrumentswere selected for
this review:
ASSIST:Alcohol, Smoking, andSubstance Involvement Screening Test
CAGE-AID: Cut Down, Annoyed, Guilty, Eye-opener- Adapted to
Include Drugs
DAST: Drug Abuse Screening Test
DHQ/PDHQ: Drug History Questionnaire or Psychoactive Drug
History Questionnaire
DUDIT: Drug Use Disorders Identiﬁcation Test
DUS: Drug Use Screening
NMASSIST: NIDA-Modiﬁed Alcohol, Smoking, and Substance
Involvement Screening Test
SMAST-AID: Short Michigan Alcoholism Screening Test Adapted to
Include Drugs
SIP-AD: Short Inventory of Problems-Alcohol and Drugs
SDS: Severity of Dependence Scale
SSI-SA: Simple Screening Instrument for Substance Abuse
TICS: Two ItemConjoint Screen for Alcohol and otherDrug Problems
UNCOPE: Use, Neglect, Cut down, Objection, Preoccupied, Emo-
tional discomfort.
3.2. General instrument characteristics
All instruments included in the review have 28 items or less and
take at most 10 min to complete and score (Appendix A). Eight
(CAGE-AID, DAST, DHQ/PDHQ, DUDIT, SMAST-AID, SIP-AD, SDS and
TICS) are designed for self-administration by patients, three are
interviewer administered (ASSIST, DUS, and UNCOPE) and two are
either self or interviewer administered (NMASSIST and SSI-SA).
3.3. Types of instruments
Six of the thirteen instruments are conjoint screening instruments
(CAGE-AID, SMAST-AID, SIP-AD, SSI-SA, TICS and UNCOPE) (Appendix B)
which enquire simultaneously and collectively about experiences with
alcohol and other drugs (Brown, Leonard, Saunders, & Papasouliotis,
2001). For example one of the questions on UNCOPE is “Have you ever
neglected some of your usual responsibilities because of using alcohol or
drugs”. Three instruments enquire about drugs collectively and exclude
alcohol (DAST, DUDIT and SDS). An example of a question from theDAST-
28 is “Have you ever neglected your family or missed work because of
your use of drugs”. Four instruments enquire about illicit drug use in a
disaggregated manner and include alcohol, as well as tobacco in some
instances (ASSIST, DHQ/PDHQ, DUS and NMASSIST). For example, one of
the questions on ASSIST is “In your life, which of the following substances
have you ever used? a. Tobacco products (cigarettes, chewing tobacco,
cigars, etc.), b. Alcoholic beverages (beer, wine, spirits, etc.), c. Cannabis
(marijuana, pot, grass, hash, etc.), d. Cocaine (coke, crack, etc.), e.
Amphetamine type stimulants (speed, diet pills, ecstasy, etc.)…”
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3.4. Ability to distinguish between different levels of substance abuse
3.4.1. Active and inactive problems
CAGE-AID,DAST, SMAST-AID, andSSI-SAdonot distinguishbetween
active and inactive problems as they only ask about lifetime experience
with illicit drugs (Appendix B). ASSIST, DHQ/PDHQ, DUDIT, DUS,
NMASSIST, SIP-AD, SDS, TICS and UNCOPE are able to make this
distinction because they ask about illicit drug use in the past year,
6 months, 3 months or 30 days.
3.4.2. Abstainers/non-problematic use, abuse and dependence
Four of the instruments distinguish between abstainers/non-
problematic use, abuse and dependence (ASSIST, DUDIT, NMASSIST
and SSI-SA) (Appendix B).
3.5. Literature Search
Of the 794 studies identiﬁed, 265 were duplicates and 474 were
judged as irrelevant. The full papers of the remaining ﬁfty ﬁve studies
were retrieved and assessed for eligibility. Thirty four studies were
excluded at this stage (9 were not related to the aims and objectives of
this review, 7 were in adolescents, 5 looked at 1 or 2 drugs only, 4
were on alcohol use/abuse, 4 were guidelines for instrument use, 4
were conducted in substance abusers, 1 was a duplicate). The
remaining twenty one were included in the qualitative synthesis.
Below are the results from the studies that met the inclusion criteria.
3.6. Validity
Three of the included studies evaluating the validity of ASSIST cover
8 countries (Table 1). They included participants from drug treatment,
primary health care and psychiatric settings. These studies reported:
high construct validity with positive correlations of 0.40 to 0.81
(pb0.001) (Hides et al., 2009; Newcombe et al., 2005); high concurrent
validitywith positive correlations of 0.59 to 0.89 (pb0.001) between the
ASSIST and other similar instruments (Hides et al., 2009; Humeniuk
et al., 2008; Newcombe et al., 2005); and high discriminative validity
that is the ability to discriminate between non-problematic use (low
risk), abuse (moderate risk) and dependence (high risk) (Humeniuk
et al., 2008; Newcombe et al., 2005).
One study by Leonardson et al. (2005) evaluated the validity of
CAGE-AID in diabetes clinic patients in the USA and reported high
concurrent and divergent validity.
Blanchard et al. (2003) reported high concurrent validity for SIP-
AD 15 (r=0.35 to 0.59 pb0.001) in outpatient substance abuse
treatment patients in the USA. Good discriminative and convergent
validity were also reported (Blanchard et al., 2003).
Brown et al. (2001) reported high validity for TICS in a sample of
primary medical care patients in USA.
No validity studies were identiﬁed for DAST, DHQ/PDHQ, DUDIT,
DUS, NMASSIST, SIP-AD10, SMAST-AID, SDS, SSI-SA, and UNCOPE.
3.7. Reliability
The reliability of ASSIST was reported in three studies covering
11 countries and participants from drug and alcohol abuse
treatment, primary health care, psychiatric and general medical
settings (Table 2). High internal consistency was reported, with
Cronbach's alpha scores of 0.77 and above (Hides et al., 2009;
Humeniuk et al., 2008). Good to excellent test–retest reliability was
also reported with a kappa score range of 0.58 to 0.90 (WHO ASSIST
Working Group, 2002).
Leonardson et al. (2005) reported high internal consistency
(Cronbach's alpha score 0.92) for CAGE-AID in a study in diabetic
clinic patients in the USA.
The eight studies evaluating the reliability of DAST covered 3
countries: USA, Canada and India. The study populations included
psychiatric patients, adults seeking evaluation for attention deﬁcit/
hyperactivity disorder, female offenders and adult workers (drug
users and nonusers). High internal consistency was reported for
DAST-28, DAST-20, and DAST-10 with Cronbach's alpha scores of
0.86 and above (Carey et al., 2003; Cassidy et al., 2008; Cocco &
Carey, 1998; El-Bassel et al., 1997; McCann et al., 2000; Saltstone et
al., 1994; Staley & El-Guebaly, 1990). Kappa scores of 0.85, 0.71 and
0.78 were reported for DAST-28, DAST-20 and DAST-10 respec-
tively (Cocco & Carey, 1998; El-Bassel et al., 1997).
Two studies, one conducted amongmenwhohave sexwithmen and
another conducted among outpatient substance abuse treatment
patients, in the USA evaluated the reliability of SIP-AD. High internal
consistency was reported for SIP-AD 10 and SIP-AD 15 with Cronbach's
alpha scores of 0.93 and above (Blanchard et al., 2003; Hagman et al.,
2009). High test–retest reliability was also reported for SIP-AD 10
(Hagman et al., 2009).
For UNCOPE, a study among prisoners in the USA reported high
internal consistencywith Cronbach's alpha score of 0.85 (Hoffmann et al.,
2003).
Table 1
Validity.
Instrument
(Reference)
Reference test Population Country Construct
validity
Concurrent
validity
Discriminative
validity
Other
validity
ASSIST
(Humeniuk et al., 2008)
A battery of other
instruments
1047 participants from
drug treatment and
primary health care
settings
Australia, Brazil, India,
Israel, Thailand
United Kingdom
USA, Zimbabwe
r=0.48–0.76
(pb0.001)
r=0.59–0.88
(pb0.001)
High –
ASSIST (Newcombe
et al., 2005)
A battery of other
instruments
150 participants from
drug treatment and
primary health care
settings.
Australia r=0.40–0.81
(pb0.001)
r=0.67–0.89
(pb0.001)
High –
ASSIST (Hides et al.,
2009)
Structured Clinical Interview
for DSM-IV (SCID-IV) and
other instruments
214 ﬁrst episode
psychosis patients
Australia – r=0.41–0.63
(pb0.001).
– –
CAGE-AID (Leonardson
et al., 2005)
A battery of other
instruments
50 American Indians
from a diabetes clinic
USA – High – High divergent
validity
SIP-AD 15 (Blanchard,
Morgenstern,
Labouvie, Morgan, &
Bux, 2003)
SCID and Statistical Manual
for Mental Disorders and
other instruments
252 new outpatient
substance abuse
treatment patients
USA – r=0.35–0.59
(pb0.001)
Good Good
convergent
validity
TICS (Brown et al., 2001) CIDI-SAM 702 primary medical
care patients
USA High High – –
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We did not identify any eligible study on inter-rater reliability.
No eligible reliability studies were identiﬁed for the following:
DHQ/PDHQ, DUDIT, DUS, NMASSIST, SMAST-AID, SDS, SSI-SA, and
TICS.
3.8. Sensitivity, speciﬁcity and predictive values
Three studies covering 8 countries and including participants from
drug treatment, primary health care and psychiatric settings reported on
the sensitivity and speciﬁcity of ASSIST (Table 3). The reported sensitivity
was from 54% to 97% and speciﬁcity ranged from 50% to 96%, depending
on the illicit drug (Hides et al., 2009; Humeniuk et al., 2008; Newcombe
et al., 2005). The results were consistent between studies although they
measured different aspects: discriminating between abuse and depen-
dence (Humeniuk et al., 2008), discriminating between those with and
those without illicit drug use problems (Hides et al., 2009) and
discriminating between non-problematic use, abuse and dependence
(Newcombe et al., 2005). No study reported on predictive values of
ASSIST.
From two studies conducted in the USA, sensitivity of the CAGE-
AID ranged from 70% to 92% and speciﬁcity ranged from 48 to 90%
depending on the cut off score (Brown & Rounds, 1995; Hinkin
et al., 2001). The results from the two studies were markedly
different. This could be because the studies were conducted in
different populations (one in primary care patients and the other in
drug abusers and non-abusers). The reported positive predictive
value (PPV) for CAGE-AID ranged from 12% to 36% and the negative
predictive value (NPV) was at least 98% depending on the cut off
score (Hinkin et al., 2001).
For DAST-28 three studies, two in the USA and one in Canada,
reported sensitivity of at least 82% and speciﬁcity of 71% to 93.9% (El-
Bassel et al., 1997; McCann et al., 2000; Staley & El-Guebaly, 1990). The
PPV ranged from 23% to 95.7% and the NPV ranged from 74% to 98% (El-
Bassel et al., 1997; McCann et al., 2000; Staley & El-Guebaly, 1990).
Two studies in psychiatric patients, one in USA and one in Canada,
reported sensitivity ranging from 55% to 89% and speciﬁcity ranging
from 68% to 86% for DAST-20, depending on the cut off score (Cassidy
et al., 2008; Cocco & Carey, 1998). The PPV ranged from 74% to 79% and
theNPV from68% to84% for cut off scoresof 3 and6 (Cassidyet al., 2008).
For DAST-10, three studies in psychiatric patients reported a
sensitivity range of 65% to 85% and speciﬁcity range of 68% to 98%
(Carey et al., 2003; Cocco & Carey, 1998; Maisto et al., 2000). Two of the
studies were conducted in the USA and one was conducted in India.
DAST-10hadaPPV rangeof 35% to73%andanNPVrangeof 93% to99%at
different cut off scores (Carey et al., 2003; Maisto et al., 2000).
Brown and Rounds (1995) reported sensitivities ranging from 40%
to 51% and speciﬁcities of 92% to 95% using different cut off scores for
SMAST-AID in a primary care practice study conducted in the USA.
Table 2
Reliability.
Instrument
(Reference)
Reference test Population Country Internal
consistency
Cronbach's
alpha score
Test
retest
kappa
score
Inter-
rater
reliability
ASSIST (WHO ASSIST
Working Group,
2002)
A battery of other instruments 236 volunteers from drug and alcohol abuse
treatment, general medical settings, and psychiatric
facilities.
Australia, Brazil
Ireland, India, Israel
Palestinian Territories
Puerto Rico
United Kingdom
Zimbabwe
– 0.58 to
0.90
–
ASSIST (Humeniuk
et al., 2008)
A battery of other instruments 1047 participants from drug treatment and primary
health care settings
Australia, Brazil, India
Israel, Thailand
United Kingdom
USA, Zimbabwe
0.77–0.94 – –
ASSIST (Hides et al.,
2009)
(SCID-IV) and other instruments 214 ﬁrst episode psychosis patients Australia 0.90 – –
CAGE-AID (Leonardson
et al., 2005)
A battery of other instruments 50 American Indians from a diabetes clinic USA 0.92 – –
DAST-28 (Staley & El-
Guebaly, 1990)
DSM-III substance abuse diagnosis 250 Psychiatric patients Canada 0.94 – –
DAST 28 (McCann,
Simpson, Ries, & Roy-
Byrne, 2000)
Psychiatric diagnosis of substance
abuse or dependency
143 adults seeking evaluation for attention deﬁcit/
hyperactivity disorder.
USA 0.92 – –
DAST-28 (El-Bassel,
Schilling, Schinke,
Orlandi, & Sun, 1997)
Battery of questionnaires 176 adult workers (identiﬁed drug users and
nonusers).
USA 0.92 0.85
(n=20)
–
DAST-20 (Cassidy,
Schmitz, & Malla,
2008)
SCID based diagnosis. 84 ﬁrst episode psychosis patients Canada 0.998 – –
DAST-20 (Saltstone,
Halliwell, & Hayslip,
1994)
Questionnaire 540 Female offenders Canada 0.88–0.91 – –
DAST 20 (Cocco &
Carey, 1998)
Psychiatric diagnosis of substance
abuse or dependency
97 Psychiatric outpatients with Axis I mental
disorder other than substance use/dependence
USA 0.86 0.71
(n=45)
–
DAST 10 (Cocco &
Carey, 1998)
Psychiatric diagnosis of substance
abuse or dependency
97 Psychiatric outpatients with Axis I mental
disorder other than substance use/dependence
USA 0.92 0.78
(n=45)
–
DAST-10 (Carey, Carey,
& Chandram, 2003)
Discharge diagnosis of substance
use disorders
671 newly admitted psychiatric patients India 0.94 – –
SIP-AD 15 (Blanchard
et al., 2003)
SCID and statistical manual for
mental disorders and other
instruments
252 new outpatient substance abuse treatment
patients
USA 0.93–0.96 – –
SIP-AD 10 (Hagman
et al., 2009)
DSM-IV drug dependency
symptoms
469 non-treatment seeking men who have sex with
men
USA 0.956 High –
UNCOPE (Hoffmann
et al., 2003)
Diagnostic interview covering the
DSM-IV criteria
310 prisoners USA 0.85 – –
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Two studies in primary care patients in the USA reported
comparable sensitivity (78.0% and 81.1%) and speciﬁcity (76.3%
and 80.8%) for TICS (Brown et al., 1997, 2001). The reported positive
and negative predictive values were 59.2% and 92.6% respectively
(Brown et al., 1997).
Two studies reported comparable sensitivity (88% and 85%) and
speciﬁcity (83% in both studies) for UNCOPE (Campbell et al., 2005;
Hoffmann et al., 2003). Positive and negative predictive values were
85% and 83% respectively (Campbell et al., 2005).
No eligible studies were identiﬁed for the following: DHQ/PDHQ,
DUDIT, DUS, NMASSIST, SDS, SIP-AD and SSI-SA.
3.9. Acceptability, feasibility and perceived relevance
Information on acceptability was only available for ASSIST and TICS.
The ASSIST was consistent with patients' expectations for a health
interview and the questions were easy to answer in a multinational
study conducted in 11 countries within drug and alcohol abuse
Table 3
Sensitivity, Speciﬁcity, Positive Predictive values (PPV) and Negative Predictive Values (NPV).
Instrument
(Reference)
Reference test Population Country % Sensitivity
(cut off score)
% Speciﬁcity
(cut off score)
% PPV
(cut off score)
% NPV
(cut off score)
ASSIST (Humeniuk et al.,
2008)
Hair analysis compared to self-
reported use in last 3 months
1047 participants from
drug treatment and
primary care settings
Australia,
Brazil, India,
Israel,
Thailand, UK,
USA,
Zimbabwe
54–97 50–96% – –
ASSIST
(Newcombe et al., 2005)
Global continuum of risk and
substance involvement score.
150 participants from
drug treatment and
primary health care
settings.
Australia 58–90 64–91 – –
ASSIST (Hides et al., 2009) SCID-IV and other instruments 214 ﬁrst episode
psychosis patients
Australia 63–81 62–76 – –
CAGE-AID (Hinkin et al.,
2001)
DSM-III-R diagnosis for lifetime
drug abuse/dependence.
901 drug abusers and
non-abusers.
USA 92 (1)
81(2)
73(3)
48 (1)
72(2)
90(3)
12(1)
18(2)
36(3)
99(1)
98(2)
98(3)
CAGE-AID (Brown &
Rounds, 1995)
DSM-III-R diagnosis for lifetime
drug abuse/dependence
124 patients from a
primary care practice
USA 79(1)
70 (2)
77(1)
85(2)
–
–
–
–
DAST-28 (Staley & El-
Guebaly, 1990)
DSM-III substance abuse diagnosis 250 Psychiatric
patients
Canada 96–82
(5/6 to 10/11)
81–91
(5/6 to 10/11)
75–63
(5/6 to 10/11)
94–98
(5/6 to 10/11)
DAST-28 (McCann et al.,
2000)
Psychiatric diagnosis of substance
abuse or dependency
143 adults seeking
evaluation for
attention deﬁcit/
hyperactivity disorder.
USA 85(6) 71(6) 23(6) 98(6)
DAST-28 (El-Bassel et al.,
1997)
Battery of questionnaires 176 Adult workers
including identiﬁed
drug users and
nonusers
USA 80.9(6) 93.9(6) 95.7(6) 74.7(6)
DAST-20 (Cassidy et al.,
2008)
SCID based diagnosis. 84 ﬁrst episode
psychosis patients
Canada 55 (6)
85(3)
86(6)
73(3)
79(6)
74(3)
68(6)
84(3)
DAST 20 (Cocco & Carey,
1998)
Psychiatric diagnosis of substance
abuse or dependency
97 Psychiatric
outpatients with Axis I
mental disorder other
than substance use/
dependence
USA 89–84
(2/3–5/6)
68–83
(2/3–5/6)
– –
DAST 10 (Cocco & Carey,
1998)
Psychiatric diagnosis of substance
abuse or dependency
97 Psychiatric
outpatients with Axis I
mental disorder other
than substance use/
dependence
USA 95–74
(1/2–3/4)
68–86
(1/2–3/4)
– –
DAST-10 (Carey et al.,
2003)
Discharge diagnosis of substance
use disorders
1349 newly admitted
psychiatric patients
India 65(3) 98(3) 41(3) 99(3)
DAST-10 (Maisto, Carey,
Carey, Gordon, &
Gleason, 2000)
Psychiatric diagnosis of substance
abuse or
dependency.
Occurrence of symptoms for alcohol
and other drug use disorders
162 psychiatric
hospital outpatients.
USA 85(2)
80(2)
78(2)
88(2)
35(2)
73(2)
97(2)
93(2)
SMAST-AID (Brown &
Rounds, 1995)
DSM-III-R diagnostic criteria for
lifetime abuse of or dependence on
drugs.
124 patients from a
primary care practice
USA 51(1)
40(2)
92(1)
95(2)
–
–
–
–
TICS (Brown et al., 2001) CIDI-SAM 702 primary medical
care patients
USA 78.0(1) 76.3(1) – –
TICS (Brown, Leonard,
Saunders, &
Papasouliotis, 1997)
CIDI-SAM 434 primary care
patients aged 18 to
59 years
USA 81.1(1) 80.8(1) 59.2(1) 92.6(1)
UNCOPE (Hoffmann et al.,
2003)
Diagnostic interview covering DSM-
IV criteria
310 prisoners USA 88(3) 83(3) – –
UNCOPE (Campbell,
Hoffmann, Hoffmann, &
Gillaspy, 2005)
Substance Use Disorder Diagnostic
Schedule-IV (SUDDS-IV)
2097 prisoners USA 85(3) 83(3) 85(3) 83(3)
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treatment, psychiatric and general medical settings (WHO ASSIST
Working Group, 2002). For TICS, two studies in primary care patients in
the USA reported that 76% to 84% of participants were very comfortable
with the TICS interview (Brown et al., 1997, 2001). No studies reported
on the feasibility of use for any of the instruments.
4. Discussion
All instruments included in the review had 28 or less items,
required 10 min or less and did not require specialized training to
complete, score and interpret. However, lack of validity data may
make their selection for use in general hospital wards difﬁcult.
Construct and concurrent validity data was only obtained for the
ASSIST, CAGE-AID and SIP AD 15. The reported validity for these three
instruments was high. Information on instrument reliability was
available for only 6 of the 13 instruments. ASSIST, CAGE-AID, DAST
(28, 20 and 10), SIP-AD (10 and 15), TICS and UNCOPE had good to
excellent internal consistency. The DAST-28 and DAST-10 also
showed optimal test–retest reliability. The test–retest reliability
results for ASSIST suggest need for improvement.
Only two studies reported on acceptability and none reported on
feasibility, suggesting a need for studies in these two areas. The ASSIST
and TICS were reported to be highly accepted by participants, but no
studies reported on acceptability by relevant health care workers
despite this aspect being important if a screening instrument is to be
used in routine practice.
This review provides evidence of lack of extensive testing of
instruments in different populations and countries. Although this
review is for general hospital wards, only one study (WHO ASSIST
Working Group, 2002) included participants from this setting.
Compared to primary care, social and criminal justice settings,
screening for illicit drug use in hospital settings is still underdevel-
oped. There is need for studies evaluating screening instruments in
different hospital settings. Most of the reviewed studies were
conducted in the USA. The ASSIST was the only instrument with
some evidence of extensive testing, with one study conducted in 10
countries, including developed and developing countries.
When screening for illicit drug use, sensitivity and speciﬁcity can
be considered at two levels: 1) discriminating between abstainers/
non-problematic users and those with illicit drug use problems and
2) Discriminating between abuse and dependence. However, most
studies did not explicitly indicate the level at which they were
investigating sensitivity and speciﬁcity, making comparisons difﬁcult.
Moreover differences in other independent variables such as the recall
period (lifetime versus current), populations and reference tests also
make direct comparisons difﬁcult.
The sensitivity and speciﬁcity scores of the ASSIST, CAGE-AID,
DAST-20 and SMAST generally indicate the need for improvement.
Those for the DAST-28, DAST-10, TICS and UNCOPE were optimal
(~80%). The SMAST-AID questions were derived from the SMAST
questions which were selected over 30 years ago and may no longer
be as applicable to present society.
There was low reporting of predictive values. Only 9 out of 18
studies (50%) that reported on sensitivity and speciﬁcity also
reported the predictive values. The reported NPV were generally
good to excellent. For CAGE-AID, the PPV were very low. For DAST-
28 and DAST-10, the PPV ranges were very wide (23% to 95.7% and
35% to 73% respectively), which may suggest differences in
prevalence of illicit drug use in the different populations included
in the studies. The PPV for DAST-20 and UNCOPE were good. The PPV
for TICS was moderate.
Instruments such as CAGE-AID, DAST, SDS and the SMAST-AID
which focus on dependence may be of limited usefulness in general
hospital settings if the objective is to identify substance use/abuse in
non-dependent individuals. Moreover, CAGE-AID, DAST, SMAST-AID
and SSI-SA do not distinguish between active and inactive illicit drug
use. The TICS and UNCOPE cannot distinguish between abuse and
dependence and this might be problematic where the interven-
tions and/or treatment pathways of the different levels of abuse are
different.
There was very little information available for DHQ/PDHQ, DUDIT,
DUS and NMASSIST. For example, DUDIT has only been validated in a
Swedish drug-using population (Berman, Bergman, Palmstierna, &
Schlyter, 2005). Although the NMASSIST is a modiﬁcation of the
ASSIST, there is still need to evaluate its performance. It might
perform differently from the ASSIST particularly when used online
and for self administration. No study comparing the performance of
two or more of the selected instruments was identiﬁed.
For some instruments, their structuremight have a negative impact
on their routineuse in general hospitalwards. For example, the current
structure of the ASSIST with questions across ﬁve pages makes it
appear long. It could be useful modify such instruments to a one or
two paged instrument and evaluate the modiﬁed version in general
hospital wards.
One major limitation of this review is that no quality assessment
was applied for studies included in qualitative synthesis. The studies
may have methodological weaknesses such as small sample size.
One generic quality assessment tool for diagnostic studies, the
QUADAS list, was identiﬁed (Whiting, Rutjes, Reitsma, Bossuyt, &
Kleijnen, 2003). However it is mainly for classifying overall quality
across studies for each quality criterion rather than for use in
decisions on inclusion and exclusion of studies in systematic review.
Another factor to consider is uncertainty on how these instruments
would perform in general hospital settings and in different
populations as most studies were conducted outside general
hospital settings and in the United States. We might also have
missed some studies particularly those published in languages other
than English and unpublished studies.
5. Conclusion
The review identiﬁed and described 13 instruments that could be
useful in general hospital wards. This review provides evidence of lack
of extensive evaluation of illicit drug use screening instruments in
adult patients not known tohave a substance abuse problem in general
hospital wards. Currently clinicians or researchers searching for a
simple, reliable, general screening instrument for current drug use to
guide practice or research in general hospital wards do not have
enough comparative evidence to choose between the available
measures. There is therefore need for extensive evaluation of the
screening instruments in general hospital wards in different popula-
tions and countries.
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Appendix A. General characteristics of the screening instruments
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COMPREHENSIVE REVIEW
A systematic review of substance misuse assessment packages
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Abstract
Issues. Health-care systems globally are moving away from process measures of performance to payments for outcomes
achieved. It follows that there is a need for a selection of proven quality tools that are suitable for undertaking comprehensive
assessments and outcomes assessments.This review aimed to identify and evaluate existing comprehensive assessment packages.
The work is part of a national program in the UK, Collaborations in Leadership of Applied Health Research and Care.
Approach. Systematic searches were carried out across major databases to identify instruments designed to assess substance
misuse.For those instruments identified, searches were carried out using the Cochrane Library,Embase,Ovid MEDLINE® and
PsychINFO to identify articles reporting psychometric data. Key Findings. From 595 instruments, six met the inclusion
criteria: Addiction Severity Index; Chemical Use, Abuse and Dependence Scale; Form 90; Maudsley Addiction Profile;
Measurements in the Addictions for Triage and Evaluation; and Substance Abuse Outcomes Module. The most common
reasons for exclusion were that instruments were: (i) designed for a specific substance (239);(ii) not designed for use in addiction
settings (136); (iii) not providing comprehensive assessment (89); and (iv) not suitable as an outcome measure (20).
Implications. The six packages are very different and suited to different uses. No package had adequate evaluation of their
properties and so the emphasis should be on refining a small number of tools with very general application rather than creating
new ones. An alternative to using ‘off-the-shelf’ packages is to create bespoke packages from well-validated, single-construct
scales. [Sweetman J, Raistrick D, Mdege ND, Crosby H. A systematic review of substance misuse assessment
packages. Drug Alcohol Rev 2013;32:347–355]
Key words: alcohol, assessment, dependence, illicit drug, substance misuse.
Introduction
This review was undertaken as part of a program of
research, Collaborations in Leadership of Applied
Health Research and Care (CLAHRC), and accompa-
nies a review of screening tools and interventions. Nine
CLAHRC programs were established to answer specific
research questions for the National Health Service in
the UK, and all the CLAHRCs are a collaboration
between academics, clinicians and commissioners. One
CLAHRC has an addictions program within which this
review was a prerequisite of a workstream to develop
outcomes assessments.
Assessment is fundamental to the work of health-care
professionals [1–4]. For addiction services, assessment
provides an opportunity for practitioners to understand
service user needs and develop appropriate treatment
plans [5]. Addiction practitioners and service users can
also use the process to agree treatment goals, monitor
the progress of treatment and review treatment effec-
tiveness through measuring outcomes [6]. Assessment
may vary depending on the setting (e.g. primary care,
general hospital wards and mental health services) or
on the readiness for treatment. A degree of standardi-
sation of assessment, coupled with standardised
outcome reporting, would enable the comparison of
services locally, nationally and internationally [7]. In
some health-care systems, assessment is linked to treat-
ment pathways and associated funding tariffs [8].
Inconsistent or inappropriate assessment can have a
number of negative impacts. Underestimating the level
of treatment need may lead to service users not receiv-
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ing any intervention despite needing one or receiving an
intervention at an insufficient level of intensity or dura-
tion. Alternatively, overestimation of needs can result in
too high a level of treatment intensity, with which
service users may not comply [9]. In either case, there
would be associated cost implications. Service design
and delivery are constantly evolving in response to new
evidence and quality standards [10–12]. This iterative
process reflects the need to regularly reassess the instru-
ments used in practice. This review focuses on instru-
ments that are able to be used across any settings or
services where individuals with any substance misuse
problems may present. There is a consensus that the
important domains to be included in the assessment of
substance misuse include substance use and depend-
ence, psychological well-being and social well-being
[13,14].The objective of this review is to determine the
range of validated comprehensive assessment packages.
The review adheres to the PRISMA Statement on sys-
tematic reviews [15,16].
Method
The first step was to identify instruments of interest.
Two reviewers independently selected instruments to
be included using the eligibility criteria listed in
Table 1. Differences of opinion were resolved through
consensus or reference to a third reviewer. Instrument
authors were contacted to clarify specific points where
necessary. The search strategy for instrument identifi-
cation is listed in Table 2.
The second step was to search for validation articles
relating to the assessment tools of interest. Table 2
describes the search strategy. Two reviewers independ-
ently screened titles and abstracts to identify potentially
relevant articles requiring retrieval. Additionally, free-
text searches were conducted and article reference lists
screened for additional instruments or validation arti-
cles. Data extraction for each of the selected validation
articles was performed independently by two reviewers.
Information extracted included study identifiers (title,
lead author, publication year, journal), instrument of
interest, study characteristics (details of the population,
setting), validity statistics, reliability, acceptability, fea-
sibility, sensitivity and specificity statistics where these
were reported. Reviewers resolved discrepancies in data
extraction through discussion. Throughout the paper
significant findings represent P < 0.05 or better.
Results
Outcomes of searches
The initial search identified 595 instruments: 589 were
excluded for reasons outlined in Figure 1. The most
common reasons for exclusion were that instruments
were: (i) designed for a specific substance (239); (ii) not
designed for use in addiction settings (136); (iii) not
providing a comprehensive assessment (89); and (iv)
not suitable as an outcome measure (20).
The searches for validation articles for the six instru-
ments identified 608 papers, of which 349 were found
to be duplicates (identified in more than one database).
Two articles identified in free-text searches were
excluded, as they were not published in English. Initial
article screening excluded 304 articles, mainly due to
their not validating an instrument of interest to the
review or considering an inappropriate sample, such as
participants younger than 18 years, or a specific psychi-
atric sample. Following this process 45 articles were
selected for consideration on the strength of the
abstracts. After the full articles were read a further 19
were excluded for the reasons noted above.The remain-
ing 26 instrument evaluation articles were included in
this review. Of these 21 were about the Addiction Sever-
ity Index (ASI), and there was one article for each of
the other five instruments. The imbalance of validation
articles has, necessarily, influenced the presentation of
results.
Table 1. Criteria for instrument selection
Inclusion criteria Exclusion criteria
Suitable for use with an
adult population (18
years or over)
Instruments designed to be
used with populations
under the age of 18 years
Able to be used for
comprehensive
assessment and outcome
measurement purposes
Those specific to particular
drugs
Appropriate for individuals
who present for
treatment at any stage of
change
Those specifically designed
for people seeking
treatment
A generic tool able to be
used in any alcohol or
drug service
Those designed specifically
for use with dual-diagnosis
service users
Measuring current alcohol
and/or illicit drug use
and other key domains.
Instruments designed to be
used in association with a
specific method of
treatment
Freely available and easily
accessible within the
public domain
Instruments designed to be
used with a non-addiction
population
An assessment taking no
more than 1 h to
complete
Instruments specific to
individual-level care
planning, such as risk of
blood-borne virus tools or
neuropsychological
assessment tools
348 J. Sweetman et al.
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Brief description of instruments
The Minnesota Substance Abuse Problems Scale is
available from the authors; the other scales are all in the
public domain and freely available. Except for the Sub-
stance Abuse Outcomes Module (SAOM) and some
questionnaires embedded in assessment interviews the
instruments are all rater-completed packages.The item
count does not include recording of personal details or
other administrative information.Typically, completion
time is not stated, but can be inferred from the item
count and general style.
Addiction Severity Index. The ASI has 163 items with
seven subscales: physical health, employment, alcohol
use, drug use, offending, family and social circum-
stances, and mental health. The substance use section
asks for frequency in the last 30 days and lifetime use and
route of 11 drugs or classes of drug and includes items
on treatment. The style is mainly to enter numeric or
yes/no responses to questions, but no items have stem
questions whereby subsequent items might be skipped
over. Completion time is stated as approximately
50–60 min.The ASI is the most widely investigated of all
the instruments and is available in many languages,
including English, Spanish, French, Japanese and
Chinese and in ASI-Lite and EuropASI versions.
Chemical Use, Abuse and Dependence Scale. The
Chemical Use, Abuse and Dependence Scale (CUAD)
is completed in two stages.The first stage is a structured
substance use history asking about frequency, quantity,
route and duration of use for nine drugs or classes of
drug. For each of the most problematic substances (up
to four), 17 further questions tap into dependence and
related problems. Completion time varies depending on
the number of problem substances.The instrument was
designed to determine the presence or absence of a
Diagnostic and Statistical Manual of Mental Disorders-
III-R substance use disorder.
Form 90. Form 90 has 121 items across the domains
of health-care utilisation, medication, offending, motor
vehicle accidents and employment, and builds a history
of alcohol and illicit drug use over the previous 90 days.
The substance use section maps a very detailed pattern
of use for alcohol and all other substances. The style is
to use text prompts for each question, and some of
these are stem questions where a negative response
takes the interviewer forward to the next section.
Various aids, card prompts and an alcohol unit
calculator are used. The completion time can vary
markedly depending on the complexity of an individual
assessment.
Maudsley Addiction Profile. The Maudsley Addiction
Profile (MAP) is a brief, structured interview in four
sections: substance use, injecting and sexual behaviour,
physical and psychological health, and social function-
ing. The substance use section asks for quantity, fre-
quency and route of seven drugs or classes of drug.
There are 26 items and two brief self-completion scales.
The orientation is more towards illicit drugs than
alcohol. The time frame is generally the last 30 days.
The style is to use text prompts for the interviewer and
card prompts for the service users. The originators
Table 2. Search strategies
Instruments Validation articles
Key words Limitations Databases searched Instrument Key words Databases searched
Instrument
Tool
Interview
Questionnaire
Adult Substance Use Screening &
Assessment Instruments
Database, part of the
University of Washington
Alcohol and Drug Abuse
Institute library
National Institute of Drug
Abuse, USA
Centre on Alcoholism,
Substance Abuse and
Addictions
Title
Acronym
Abbreviation
substance abuse
substance misuse
substance addiction
substance dependence
substance-related disorder
drug abuse
drug misuse
drug addiction
drug dependence
alcohol abuse
alcohol misuse
alcohol addiction
alcohol dependence
Cochrane Library
(Issue 6, 2010)
Embase (1980 to
October 2011)
Ovid MEDLINE®
(1948 to October
2011)
PsycINFO (1806 to
October 2011)
Searches were carried out between May 2010 and October 2011.Validation article searches were limited to English language. No
date limits were applied.
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claim a completion time of approximately 12 min,
which is likely to be towards the low end.
Measurements in the Addictions for Triage and Evalu-
ation. The Measurements in the Addictions forTriage
and Evaluation (MATE) has seven sections: substance
use, mental and physical health, dependence, physical
complaints, personality and functioning.The substance
use section asks for quantity, frequency and lifetime use
of 12 drugs or classes of drug and gambling; the next
four sections have 44 items and lead into the Interna-
tional Classification of Functioning from the World
Health Organization (WHO) classification system [17],
which is a 27-item needs assessment of social function-
ing. Finally, there are two brief self-completion ques-
tionnaires about craving and depression, anxiety and
stress.The style is to use comprehensive guides and text
prompts for interviewers. Completion time will depend
on complexity.
Instruments identified 
by NIDA = 0 
Instruments identified 
by CASAA = 3 
Total = 595 
Instruments 
screened = 588 
Instruments excluded = 582 
239 Specific to substance 
136 Designed for non-addiction population 
89   Not providing comprehensive assessment 
50   Specific to treatment orientation 
20   Not able to be used for outcome measurement 
19   Limited accessibility  
9     Individual level care planning tool 
7     Specific to stage of change 
5     Specific to treatment population/setting
3     Not measuring current substance use 
3     Insufficient information to assess eligibility 
2     Lengthy 
Instruments with 
validation articles = 6
Instruments excluded 
= 0 
Instruments able to 
be obtained = 6 
Instrument excluded 
= 0 
Instruments included 
in this review = 6 
Instruments identified 
by ADAI library = 592 
Duplicates removed 
= 7 
Figure 1. PRISMA diagram illustrating the selection of instruments for inclusion. ADAI, Alcohol and Drug Abuse Institute; CASAA,
Center on Alcoholism, Substance Abuse, and Addictions; NIDA, National Institute on Drug Abuse.
350 J. Sweetman et al.
© 2013 Australasian Professional Society on Alcohol and other Drugs
- 83 -
Substance Abuse Outcomes Module. The SAOM has
110 items arranged as a continuous self-completion
questionnaire covering general activities and health,
friends and family, substance use, medications, depend-
ence, substance-related problems, occupation and
housing.The substance use section asks about detailed
quantity and frequency of alcohol use and other drug
use, specifying 11 drugs or classes of drug for lifetime,
3-month and 28-day time periods. The general style is
to enter numeric or yes/no responses to items. The
SAOM is designed to be used for follow up and to
assess outcomes. It is intended for computer analysis
and the manual supplies variable names and scoring
algorithms (Table 3).
Reliability of instruments
Test–retest reliability was reported for all the instru-
ments evaluated except MATE. For the ASI, retest
reliability for the alcohol and drug subscales was 0.75–
0.95 and 0.70–0.84 [18–22], respectively, and was con-
sistently high across different languages, with Chinese
[23] having the lowest correlation (0.75 and 0.70).
Reliability was also reported to be high for alcohol and
drug subscales in a homeless population (0.81 and
0.88) [24]. For the other subscales employment con-
sistently delivered the highest correlations, >0.90 in six
studies [18–24], with the lowest correlations being for
legal, 0.38 [20] and 0.68 [18]; family, 0.59 [19] and
0.55 [24]; psychiatric, 0.68 [23]; social, 0.63 [21]; and
medical, 0.48 [22]. For the CUAD, 7-day retest reli-
ability was 0.95 [25]. For Form 90, lifetime use corre-
lations were all high, but current use was less
consistent: 0.02 for inhalant use, 0.29 for hallucinogens
and 0.82 for opiates and stimulant use; general func-
tioning measures ranged between 0.60 for paid-for-
work and 0.90 for jail days [26]. For the MAP [27],
with a retest interval averaging 3.1 days, correlations for
substances assessed were 0.94 overall and 0.88 for
current users. Correlations for usual route of adminis-
tration were 0.93 for heroin and 1.0 for methadone,
benzodiazepines and cocaine. For the SAOM [28], sub-
stance use correlations were all high at >0.80; the lowest
correlations were diagnosis (0.56), impulse control
(0.53) and polydrug use (0.47). Interrater reliabilities
reported for ASI are generally high, ranging from 0.74
to 1.0 [22,23,29,30]; the exception was a Hungarian
study reporting only 0.1 correlation on the medical to
0.80 on the social subscales. Interrater reliability for
MATE substance use, mental and physical health,
dependence, physical complaints and personality sec-
tions was 0.35–0.73 and for the functionality section
was 0.75–0.92 [31].We did not find interrater reliability
reports for the other instruments.
Validity of instruments
Terminology used by different authors is not necessar-
ily consistent, and rather than attempting to harmonise
terms we have used the same nomenclature as in the
original articles. Criterion validity for the ASI subscales
has generally been low order (0.28–0.44) [18,19], but
with significantly higher correlations than the non-
criterion subscales, indicating an independence of sub-
scale constructs. In a homeless population criterion
validity for alcohol was 0.31 and for drugs 0.54 [24].
Subscale correlations are as follows: alcohol with Sever-
ity of Alcohol Dependence Questionnaire (SADQ),
0.63; alcohol with Michigan Alcohol Screening Test
(MAST), 0.16; [21] alcohol with liver enzyme
g-glutamyl transferase, 0.58 [32]; alcohol with Struc-
tured Clinical Interview for DSM-III-R (SCID), 0.29
[33]; drugs with SCID, 0.47 [33]; psychiatric with
Hamilton Depression Rating, 0.74 [21] and 0.58 [30];
psychiatric with Beck Depression Inventory (BDI),
0.51 [34], psychiatric with SCID lifetime, 0.71 [35];
and employment with Hollingshead Scale, 0.56 [30].
Expectations of strong correlations with dependence
measures were not met [36].
CUAD [25] total scores correlated with the MAST
(0.21) and Drug Abuse ScreeningTest (0.58), and there
was 79% agreement between psychiatrists and the
CUAD on the presence of a substance use disorder
diagnosis. Validation of Form 90 [26] is limited to uri-
nalysis and self-reported drug use, with findings indicat-
ing low to moderate levels of false positives and no false
negatives except for opiates. The MAP [27] reported a
90% concordance rate between self-reported substance
use and urinalysis for drug users. Additionally, physical
and psychological health were compared to self-
reported days experiencing medical problems and
anxiety and/or depressive thoughts, with resultant cor-
relations averaging 0.72. Relationship conflict measures
assessed with the Life Stressors and Social Resources
Inventory indicated high-order correlations (r = 0.74)
[27]. MATE [37] has been validated on the functionality
section, where correlations were of different elements
and ranged from 0.26 to 0.67 against theWHO disability
assessment and -0.59 to -0.71 against theWHO quality
of life. Criterion validity for the SAOM [28] found
correlations for alcohol and ASI (0.70); alcohol and
Alcohol Use Disorders Identification Test (0.81);
alcohol and Composite International Diagnostic Inter-
view (CIDI) dependence 0.72; drugs and ASI (0.38);
and drugs and CIDI dependence (0.33).
Factor structure of instruments
Only three tools had any examination of their
factor structure. For the ASI a seven-factor solution
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consistent with the ASI domains was found [38]. For
the MAP and MATE the factor structures found did
not match the structure of the original design. Explora-
tory principal components analysis of MAP found a
four-factor structure interpreted as substance use,
health risk, health problems and employment domains
[27], and factor analysis of MATE needs assessment
found two factors interpreted as limitations of basic
functioning and limitations in relationships [37].
Internal consistency of composite scores have been
reported to be variable, albeit generally satisfactory, for
the ASI [20,29,33,35,39,40]; exceptions are employ-
ment and family [24], alcohol [38], drugs [22], family
and social [32], and legal subscales [23]. Cronbach’s a
coefficients varied between 0.44 and 0.94 across scales,
subscales and composite scores, indicating acceptable
to good internal consistency [20–23,29,32,39–41].
Internal consistency held good for self-report and inter-
view, and across different versions [41,42]. Cronbach’s
a coefficients ranging from 0.58 to 0.90 across domains
were reported for the SAOM.
Discussion
From an initial trawl finding 592 instruments, the
majority (n = 375) of those excluded were instruments
concerned with specific substances or not designed to
be used with addiction populations. Although many
instruments have been published, very few have
adequate evaluation of psychometric and user accept-
ability properties. The ASI has the largest number of
studies, with 21 reported here, while the other instru-
ments have only one psychometrics report.The ASI has
been translated into a number of languages and, while
not all of these have been examined here, it does seem
likely from the studies found that not only language but
also substance use cultures need translation.The impli-
cation is that scales are often not as universal as might
have been assumed, and thorough testing is indicated
for each new application and each translation. A weak-
ness of all packages is that it is difficult to determine
psychometric properties because the instruments typi-
cally include subscales and items that are deemed
important or of interest, but do not necessarily measure
specified constructs. Inevitably, some of these subscales
and items work better than others so it is difficult to
give the whole package a definitive quality rating. The
range of reliability and, more especially, validity scores
reported is considerable, albeit understandable when
individual items are inspected.
Validation of all instruments, even the ASI, is poor.
Criterion measures are often not measuring the same
thing as the package items, and rarely is a clinical rating
used as the criterion: for example alcohol use validated
against SADQ scores or psychiatric well-being against
the BDI. Furthermore, the developers of instruments
tend not to modify and improve their package in the
light of evaluations. Ideally, there would be fewer
instruments and a commitment to continuous develop-
ment in the light of new evidence; moreover, there
should be systematic reporting of the psychometric
properties of the subscales or sections. A package has
the appeal of ease of use and consistency of style and
may suit the requirements of some clinical teams, but
this review has found scant evidence to support this
approach. An alternative is to create a bespoke set of
single-construct scales with good psychometrics; the
components of a bespoke set of measures can be
changed around with relative ease so that the clinical
service benefits from some future proofing of data col-
lection and continuous improvement of the measures in
use.
A weakness of this review is that it has not been
possible to drill down and present the detail of all the
evaluation articles. We have reported on the available
psychometric data, and readers can follow up articles
about instruments of interest. A further problem has
been to deal with the imbalance of studies about the
instruments included in the review. Paradoxically, the
more attention an instrument receives the more its
weaknesses show up, and so the ASI appears to have
more flaws than the other instruments, but this may not
be the case if the weight of evidence was more even.
Similarly, with test–retest reliability correlations, Form
90 reports low values for inhalants, but this cannot be
compared with other tools that do not ask about inha-
lants; where the drugs more likely to be used on a
regular basis, heroin and cocaine for example, are com-
pared, correlations are all high order across instru-
ments. It is difficult to compare instruments even on
the fundamentals of substance use itself because differ-
ent tools ask about different ranges of substances and
different use variables.
All instruments assess substance use in some way.
The CUAD, MATE and SAOM measure dependence,
and it is perhaps surprising that other instruments do
not. The ASI has seven subscales, including one each
for alcohol and drugs, so that usual methods of meas-
uring psychometrics can be applied; similarly, MATE
scores are summarised into seven modules. The MAP
has four sections with clear subsections; the SAOM is
not structured in sections, but subscales are created
programmatically; the CUAD and Form 90 do not have
subscales that can be analysed. In short it is difficult to
compare one instrument with another.
Conclusions
Information is available on six instruments that met
inclusion criteria for this review. Assessment packages
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have limitations in terms of both how well they fit the
needs of a particular service and the ease with which
psychometrics can be demonstrated; nonetheless, the
six scales all have merit and are likely to be suited to
different applications. In our opinion the MAP, the
CUAD and the ASI are the best candidates for routine
clinical use. The MAP is slanted to drug use, but more
comprehensive than the CUAD, which is situation-
focused with regard to identifying problems. The ASI
is more comprehensive than both, but may ask for
more information than some agencies need and yet
lack detail in specific areas that may be of concern
to a particular service. Form 90 is more of a research
tool, with detail about utilisation of public services
and, therefore, the information required for cost-
effectiveness studies. MATE has the feel of an insur-
ance assessment and is comprehensive on needs
assessment, which perhaps gives it a niche with care
coordinators. Finally, the SAOM is designed as a
computerised tool with the possibility of building
algorithms to check inconsistencies in data, predict
outcomes, automatically feed back outcomes and
so forth. All the instruments would benefit from revi-
sion in the light of the evaluations referenced in this
review.
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Background:  There  is growing  interest  in pro-active  detection  and provision  of interventions  for  heavy
alcohol  use  in  the  general  hospital  inpatient  population.  We  aimed  to determine,  from the  available
evidence,  the  effectiveness  of  interventions  in reducing  alcohol  consumption  among  general  hospital
inpatient  heavy  alcohol  users.
Methods:  The  following  databases  were  searched  for completed  and  on-going  randomised  and  non-
randomised  controlled  studies  published  up to November  2012:  MEDLINE;  C2-SPECTR;  CINAHL;  The
Cochrane  Library;  Conference  Proceedings  Citation  Index:  Science;  EMBASE;  HMIC;  PsycInfo;  Public
Health Interventions  Cost  Effectiveness  Database  (PHICED);  and  ClinicalTrials.gov.  Studies  were  screened
independently  by  two  reviewers.  Data  extraction  was  performed  by one  reviewer  and  independently
checked  by  a second.
Results: Twenty-two  studies  which  met  the inclusion  criteria  enrolled  5307  participants  in total.  All inter-
ventions  were  non-pharmacological  and alcohol  focused.  Results  from  single  session  brief  interventions
and  self-help  literature  showed  no  clear  beneﬁt  on  alcohol  consumption  outcomes,  with  indications  of
beneﬁt  from  some  studies  but  not  others.  However,  results  suggest  brief  interventions  of more  than  one
session  could  be beneﬁcial  on  reducing  alcohol  consumption,  especially  for non-dependent  patients.  No
active intervention  was  found  superior  over  another  on  alcohol  consumption  and  other  outcomes.
Conclusions:  Brief  interventions  of  more  than  one  session  could  be  beneﬁcial  on  reducing  alcohol
consumption  among  hospital  inpatients,  especially  for  non-dependent  patients.  However,  additional
evidence  is still  needed  before  more  deﬁnitive  conclusions  can be  reached.
© 2013 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
The misuse of alcohol has a major impact on population health,
health service costs and society. Alcohol consumption is the world’s
third largest risk factor for disease and disability; with 4.5% of
burden of disease (World Health Organization, 2011), 2.3 million
premature deaths (Cherpitel et al., 2009) and almost 4% of all deaths
(World Health Organization, 2011) worldwide attributed to alco-
hol. For some countries, the total costs attributable to alcohol range
from 1.3% to 3.3% of gross domestic product (Rehm et al., 2009).
Most people with alcohol misuse problems do not seek treat-
ment for a variety of reasons including lack of awareness of their
problem (Madras et al., 2009; World Health Organization, 2011).
Evidence indicates a high prevalence of heavy alcohol use among
general hospital populations including those admitted to hospital
(Saunders and Lee, 1999; Watson, 2000). Health care profession-
als across a range of hospital settings will routinely encounter
patients with alcohol misuse problems and may  be presented with
an opportunity to intervene. There is growing interest in pro-active
detection and provision of interventions for alcohol misuse prob-
lems in general hospital settings (National Institute for Health
and Clinical Excellence, 2011; World Health Organization, 2010).
When admitted to hospital, heavy alcohol users are accessible to
health care professionals and have time for an intervention (Saitz
et al., 2007). Qualitative studies have suggested that “awareness
of accumulating harms” and “triggering occurrences” are potential
catalysts for change among patients with unhealthy alcohol use
(Orford et al., 2006, 2008). In their study, Williams et al. (2010)
found that having an alcohol attributable illness at hospital admis-
sion may  catalyse intervention beneﬁts among non-dependent
unhealthy alcohol users and those who do not view their drink-
ing as problematic. Thus making the patient aware of any links that
may  exist between their hospitalisation and alcohol consumption
may  act as a catalyst for change (Soderstrom et al., 2007; Sommers
et al., 2006).
Interventions for alcohol misuse include pharmacotherapies
and non-pharmacological approaches. Previous reviews of inter-
ventions for patients identiﬁed in general hospital inpatient
environments with alcohol problems have mainly focused on brief
interventions targeted at non-alcohol dependent hazardous and
harmful drinkers (Emmen et al., 2004; McQueen et al., 2011). A
brief intervention is deﬁned as a single session or up to three ses-
sions involving an individual patient and health care practitioner
comprising information and advice, often using counselling type
skills to encourage a reduction in alcohol consumption and related
problems (McQueen et al., 2011).
A recent review of brief interventions for alcohol problems
in general hospital wards concluded they were effective for:
reducing alcohol consumption at 6 and 9 months follow-up but not
at one year; and preventing deaths at 6 and 12 months (McQueen
et al., 2011). This review however has a number of limitations.
Several of the meta-analysis were based on very few studies,
with only one or two studies in some instances, mainly because
of differences between studies in the way  the outcomes were
measured (McQueen et al., 2011). Moreover, there was  no explo-
ration of how intervention characteristics such as intervention
format, modality or design could potentially result in outcome and
effect size differences. For example interventions involving more
than one session/contact can differ in effectiveness from a single
session/contact intervention (Kaner et al., 2007; McQueen et al.,
2011); potentially due to utilisation of more behaviour change
techniques such as providing feedback on performance, or rein-
forcement of techniques. Although McQueen et al. (2011) suggest
that further investigations to determine optimal treatment expo-
sure for heavy alcohol users in general hospitals is warranted,
they did not group studies by intervention intensity (e.g., length
or number of intervention sessions). For example, brief interven-
tion beneﬁt was  reported on 6 months mean alcohol consumption
(McQueen et al., 2011) from a meta-analysis based on four stud-
ies (Antti-Poika et al., 1988; Heather et al., 1996; Holloway et al.,
2007; Mcmanus et al., 2003). However, at study level, out of the
four studies only one study evaluating an intervention of multiple
sessions showed intervention beneﬁt (Antti-Poika et al., 1988). The
remaining three, two which were evaluating interventions of one
session, did not.
Intervention effectiveness might differ when an intervention
is delivered face-to-face compared to via a computer (Walton
et al., 2010). Differences in comparisons (e.g., comparing an active
intervention to no treatment, versus comparing two active inter-
ventions) may  also explain differences in effect size. Reviews that
show a collective group of interventions to be effective without
exploring the impact of any differences in intervention character-
istics could be challenging to the user when determining which
conﬁguration, elements, or dose of the intervention to implement
for their patients or setting (Glasziou et al., 2010). In our review we
explore some of these differences in-order to determine the inter-
vention’s active components, and why some interventions are more
effective than others (Heather, 1995; Nilsen et al., 2011; Sullivan
et al., 2011).
We aimed to identify all types of interventions for heavy alcohol
use that have been evaluated for general hospital inpatient popu-
lations and determine, from the available evidence, the impact of
each of these interventions on alcohol consumption. The secondary
outcomes of interest were: alcohol questionnaire scores (i.e., scores
from tools or questionnaires used to measure self-reports of alcohol
consumption behaviour such as Alcohol Use Disorders Identiﬁca-
tion Test (AUDIT)); injury; mortality; wellbeing and quality of life;
healthcare utilisation; criminal offences; motivation/readiness to
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Table  1
Study groupings for the review.
Single session brief
intervention with an
interventionist versus
usual care/no
treatment
Brief intervention
of 2/3 sessions or
contacts versus
usual care/no
treatment
Self-help literature
(e.g., booklets,
leaﬂets) versus
usual care/no
treatment
Brief intervention
versus self-help
literature/referral
Comparison
between different
single session brief
interventions with
an interventionist
Comparing brief
interventions, one
of which is 2/3
sessions
Comparing an
intervention of 4 or
more sessions with
another
intervention
Chick et al. (1985) Antti-Poika et al.
(1988)
Watson (1999) Bager and Vilstrup
(2010)
Freyer-Adam et al.
(2008)
Forsberg et al.
(2000)
Kuchipudi et al.
(1990)
Elvy  et al. (1988) Gentilello et al.
(1999)
Holloway et al.
(2007)
Holloway et al.
(2007)
Heather et al.
(1996)
Mcmanus et al.
(2003)
Yersin et al. (1996)
Freyer-Adam et al.
(2008)
Liu et al. (2011) McQueen et al.
(2006)
Watson (1999) Sommers et al.
(2006)
Heather et al. (1996) Mcmanus et al.
(2003)
Schermer et al.
(2006)
Holloway et al. (2007) Sommers et al.
(2006)
Watson (1999)
Mcmanus et al. (2003)
Rowland and Maynard
(1993)
Saitz et al. (2007)
Shourie et al. (2006)
Tsai et al. (2009)
Tsai et al. (2011)
Watson (1999)
Total: 12 Total: 5 Total: 2 Total: 5 Total: 3 Total: 3 Total: 2
change. Our review adds to the current review evidence in several
ways: it is not restricted to brief interventions but extends to any
type of intervention delivered to general hospital inpatients; it
attempts to explore the impact of different intervention charac-
teristics such as format, modality or design on outcomes.
2. Methods
The systematic review followed the principles recommended by the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins and Green, 2008), and
the Centre for Reviews and Dissemination guidance for undertaking systematic
reviews (Centre for Reviews and Dissemination, 2009). The reporting procedures
followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) guidance (Moher et al., 2009).
2.1. Search strategy
A systematic search of literature up to November 2012 was undertaken.
We  searched MEDLINE; C2-SPECTR; CINAHL; The Cochrane Library; Conference
Proceedings Citation Index: Science; EMBASE; HMIC; PsycInfo; Public Health Inter-
ventions Cost Effectiveness Database (PHICED); and ClinicalTrials.gov. We also
scanned the reference lists of included studies. The full search strategies for each of
the  searched databases are provided as Supplementary material.1 No date, language
or geographic limits were applied.
2.2. Inclusion criteria
We included randomised controlled trials (randomised by individual (RCTs) or
cluster (CRCT)) and controlled clinical trials (CCT) recruiting participants aged ≥16
years hospitalised in general hospitals for any reason other than speciﬁcally for alco-
hol misuse treatment, and who were subsequently identiﬁed as having an alcohol
misuse problem. We included studies that speciﬁcally enrolled participants from
hospital wards, and inpatient units or departments; as well as studies conducted
in other general hospital settings, such as trauma centres or emergency depart-
ments, which speciﬁed enrolling hospitalised patients only. We excluded studies
focussing speciﬁcally on dual diagnosis patients (co-morbidity or co-occurrence in
the  same individual of a substance use disorder and another psychiatric disorder),
and pregnant women. We also excluded studies conducted in specialist psychiatric
wards/facilities, addiction services or addiction treatment programmes.
Any intervention for alcohol misuse was eligible, except those directed primarily
at  whole hospital populations without screening for alcohol misuse problems. Any
comparator/control group was eligible.
1 Supplementary material can be found by accessing the online version of this
paper. Please see Appendix A for more information.
2.3. Study selection and data extraction strategy
Two  reviewers independently screened all studies for inclusion. Data were
extracted independently by one reviewer and checked by a second. Differences in
selection decisions or data extraction were resolved by discussion. Data extracted
included study methods, setting, participant characteristics, intervention charac-
teristics, intervention behavioural change techniques (Abraham and Michie, 2007),
the intervention’s theoretical basis, comparators, outcomes, outcome measures, and
results. Studies were included if they measured any of the following outcomes:
alcohol consumption; alcohol questionnaire scores (i.e., scores from tools or ques-
tionnaires used to measure self-reports of alcohol consumption behaviour such as
Alcohol Use Disorders Identiﬁcation Test (AUDIT)); injury; mortality; wellbeing and
quality of life; healthcare utilisation; criminal offences; motivation/readiness to
change.
2.4. Quality assessment strategy
Study quality was independently assessed by two  reviewers. Disagreements
were resolved by discussion. We used the domain based approach to study qual-
ity assessment recommended by the Cochrane Handbook for Systematic Reviews
of  Interventions (Higgins and Green, 2008), and Centre for Reviews and Dissem-
ination guidance for undertaking systematic reviews (Centre for Reviews and
Dissemination, 2009). Quality assessment criteria were: presence of a power cal-
culation, adjustment for covariates in the analysis, blinding of outcome assessors,
explanation of dropouts, follow-up rates, use of intention to treat (ITT) analysis, and
adequacy of sequence generation and allocation concealment (Centre for Reviews
and Dissemination, 2009). Sequence generation was judged as adequate if it had a
random component that ensured participants were assigned to different treatment
groups in a study in a truly random manner (Higgins and Green, 2008). On average,
trials with inadequate sequence generation exaggerate estimates of intervention
effect (Torgerson and Torgerson, 2008). Allocation concealment was judged as ade-
quate if it was  clear that it prevented investigators from foreseeing intervention
allocations in advance of or during enrolment, and using this information to select
which participant receives which treatment (Centre for Reviews and Dissemination,
2009; Torgerson and Torgerson, 2008). Hewitt et al. (2005) and Wood et al. (2008)
reported that trials with inadequate allocation concealment had exaggerated inter-
vention effect estimates, suggesting subversion in these trials.
We  also recorded adequacy of follow-up (deemed to be a minimum of 12 months
(McQueen et al., 2011)) and attempts to maintain intervention ﬁdelity (i.e., inclusion
of procedures to ensure that the intervention, as delivered, was consistent with the
protocol, such as interventionist training and supervision, and intervention ﬁdelity
veriﬁcation through a review of digital recordings) (Glasziou et al., 2010).
2.5. Analysis/synthesis
Studies were grouped according to whether the intervention evaluated involved
personal contact or not; number of sessions (single session/2–3 session/4 or more
session interventions); and type of comparator/control group (Table 1).
Considerable methodological heterogeneity existed within study groups mainly
in terms of the types of outcomes reported, and how the outcomes were deﬁned and
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4090 total records idenﬁed 
3657 duplicate/ irrelev ant re cords removed
433 full-te xt arcles assessed for el igibility
22 studies included in the qualitav e synthesis
411 full -te xt arcles exc luded du e to:
364 (no t al coh ol studie s; pa rcipant s 
under 16 years ; not hospital seng; 
not RCT/CCT)
40 emerg ency department  studies
7 outpaents depart ment studies
Fig. 1. Flow of articles through the systematic review process.
measured (for example time points at which outcomes were measured). For alcohol
consumption for example, whilst some studies considered mean weekly consump-
tion, others considered reduction in weekly consumption, total consumption in the
past week or abstinence. There were also differences in inclusion/exclusion of heavy
or  dependent drinkers, baseline consumption cut-off points for inclusion, the health-
care professionals delivering the intervention, and inclusion/exclusion by gender.
A  meta-analysis was  therefore considered inappropriate and a narrative synthesis
was  conducted.
Studies that were judged as of better quality were compared with studies of
poorer quality in terms of outcomes.
3. Results
3.1. Literature search
From the 4090 records identiﬁed, 3657 were duplicates or
irrelevant, resulting in 433 full-text articles being assessed for eli-
gibility (Fig. 1). 411 were excluded (for example studies were not
controlled, or not conducted in general hospital inpatient popula-
tion). A list of studies excluded because they were judged as not
having been conducted in general hospital inpatient populations is
provided as Supplementary material.2 Twenty-two studies met  the
inclusion criteria (Table 1). All were published in English.
3.2. Study characteristics
The 22 eligible studies (14 RCTs, 3 CRCTs, and 5 CCTs) enrolled
5307 participants in total (Table 2). They all evaluated non-
pharmacological interventions targeting either drinking behaviour
or help-seeking for alcohol problems. Nine studies included
motivational interviewing techniques (Bager and Vilstrup, 2010;
Freyer-Adam et al., 2008; Gentilello et al., 1999; Heather et al.,
1996; Kuchipudi et al., 1990; Liu et al., 2011; McQueen et al., 2006;
Saitz et al., 2007; Schermer et al., 2006). Most of the remaining stud-
ies did not state clearly which behaviour change techniques were
2 Supplementary material can be found by accessing the online version of this
paper. Please see Appendix A for more information.
Fig. 2. Overall quality of studies.
utilised. Similarly, the theoretical basis of interventions was often
not speciﬁed; two studies indicated the Transtheoretical Model of
Behaviour Change (Freyer-Adam et al., 2008; Mcmanus et al., 2003).
Details on study settings, study sample characteristics, screening
methods, intervention and control condition descriptions, eligibil-
ity criteria and outcomes assessed are provided in Table 2.
3.3. Study quality
Fig. 2 shows the overall quality of the studies. Information on
individual study quality is provided as Supplementary material.3
41% of the included studies reported a power calculation, 23% had
adequate sequence generation and 23% had adequate allocation
concealment. Although for the evaluated interventions blinding
interventionists/participants could be difﬁcult, outcome assessors
could potentially be blinded. Outcome assessor blinding occurred
in 59% of studies. Fifty-nine percent of studies met  the adequate
follow-up criteria set as at least 12 months (McQueen et al., 2011).
Drop outs tended to be documented but intention-to-treat anal-
ysis was used in about 27% of studies. Sixteen of the twenty-two
included studies achieved follow-up rates of 70% or more at the end
of the follow-up period (Antti-Poika et al., 1988; Bager and Vilstrup,
2010; Chick et al., 1985; Forsberg et al., 2000; Freyer-Adam et al.,
2008; Heather et al., 1996; Holloway et al., 2007; Kuchipudi et al.,
1990; Liu et al., 2011; Mcmanus et al., 2003; Rowland and Maynard,
1993; Saitz et al., 2007; Schermer et al., 2006; Shourie et al., 2006;
Tsai et al., 2009, 2011). Of the remaining six, three achieve follow-
up rates of between 60% and 69% (Elvy et al., 1988; McQueen et al.,
2006; Watson, 1999), whilst for the other three it was  between 50%
3 Supplementary material can be found by accessing the online version of this
paper. Please see Appendix A for more information.
- 92 -
N.D. Mdege et al. / Drug and Alcohol Dependence 131 (2013) 1– 22 5
Table  2
Study characteristics.
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and
control
Outcomes assessed
Follow-up period Sample characteristics
Screening method
Antti-Poika et al.
(1988)
RCT Not stated 120 Intervention: Brief
intervention of >1
session (duration
unspeciﬁed):
counselled twice by a
nurse and one to three
times by physician
Alcohol
consumption
6  months Male only sample Control: No
intervention
Department of
Orthopaedics and
Traumatology,
Helsinki University
hospital
≥7 on MAST Age range (years):
20–64 (mean 39)
Finland Mean MAST score 18.8
Reason for hospital
visit: injury
Additional Control
Group: assessed at 1
month
Bager and Vilstrup
(2010)
RCT Not stated 50 Intervention: Brief
motivational
interviewing
intervention of >1
session (10–15 min per
contact), plus referral
to the primary health
service for alcohol
abuse: by nurses and
social workers
Alcohol
consumption
Hepatology and
Gastroenterology
department, Aarhus
University Hospital
2 months 76% male Mortality
Age range (years):
37–75 (mean 51
(standard deviation
(sd) = 7.9))
Healthcare
utilisation
Denmark Drinking on daily basis Control: Referral to the
primary health service
for alcohol abuse
Mean daily alcohol
intake (units of 10 g
alcohol): 15 (sd = 18)
Reason for hospital
visit: (Mostly)
alcohol-related disease
Chick et al. (1985) Control trial Not stated 156 Intervention: 1 session
counselling brief
intervention (60 min)
delivered in the presence
of a spouse if possible:
by nurse
Alcohol
consumption
4  Medical wards at the
Edinburgh Royal
Inﬁrmary Project
12 months Male only sample Well-being and
quality of life
UK
A  structured 10 min
interview covering
consumption,
dependence, problems
related to alcohol,
recent and distant
medical history, and
social background
Cut-off ≥2
Age range (years):
18–65 (mean not
stated)
The participants had to
have at least some
social support
Average consumption
in the past week
(units): 5.2
Reason for hospital
visit: not speciﬁed
Control: No
intervention
Elvy et al. (1988) RCT Currently in alcoholism
treatment
198 Intervention: 1 session
brief intervention
(duration unspeciﬁed)
plus attempt at
referral: by
psychologist
Alcohol
consumption
3  orthopaedic and 2
surgical wards.
Christ-church
Hospital
12 months Any whom medical
staff wanted to send
for treatment
84% male Alcohol
questionnaire
scores (CAST
scores)
New  Zealand ≥3 on CAST
(Canterbury
Alcoholism Screening
Test)
Diagnosed alcohol
dependent by a
physician
Age range (years): not
stated (mean 29)
Well-being and
quality of life
Suffering from acute
physical complications
of alcohol abuse
Average ml
ethanol/week: 212
Control: No
intervention
Mean CAST score: 6
Reason for hospital
visit: various
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Table 2 (Continued)
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and
control
Outcomes assessed
Follow-up period Sample characteristics
Screening method
Forsberg et al. (2000) RCT Anyone not meeting
criteria of risk
consumption (regularly
drinking ≥162 g absolute
alcohol (males) and 82
(females) or drinking to
intoxication ≥1.05 g of
alcohol per body weight
(males) or ≥0.90 g
(females)
186 Intervention 1: 1 session
brief assessment and
feedback on patient’s risky
alcohol consumption
(30 min): by surgical staff
and psychologists
Alcohol
consumption
Emergency surgical
ward at Danderyd’s
hospital in
Stockholm
12 months 71% male
Sweden Mm-Mast, Cage and
The Trauma Scale,
Previous alcohol
problems and present
or previous treatment.
Cut-off for alcohol
problems was  2
afﬁrmative answers in
any of questionnaires
Age range (years):
16–73 (mean 34.5)
Intervention 2: 2
sessions: ﬁrst session
as  for 1 then a further
alcohol counselling
session conducted by a
psychologist (session
varied between 1 and
2½ h): by surgical staff
and psychologists
Mean weekly alcohol
consumption 133 g
Reason for hospital
visit: not speciﬁed
Freyer-Adam et al.
(2008)
RCT Alcohol dependence 595 Intervention 1: 1
session brief
intervention (mean
duration 25 min) by
psychologists/social
worker
Alcohol
consumption
29 wards from 4
general hospitals in
W Pomerania
12 months 94% male Motivation/readiness
to change
Well-being and
quality of life
Germany Self-administered
German adaptation of
Audit (cut-off of 8) and
the Luebeck Alcohol
Dependence and Abuse
Screening Test
(LAST)(cut-off of 2)
Age range (years): not
stated (mean 41
(sd = 12.6))
Intervention 2: 1
session brief
intervention (mean
duration 25 min) by
physician
Mean score for AUDIT
12.2
Control: Usual care
Mean score for LAST 2.3
25% alcohol abusers
57% at-risk drinkers
18% heavy episodic
drinkers
Reason for hospital
visit: various
Gentilello et al. (1999) RCT Not stated 762 Intervention: 1 session
of motivational
interviewing (30 min),
plus
Alcohol
consumption
Injuries
Harborview Medical
Centre, University of
Washington (Level 1
trauma centre)
12 months 82% male Follow up letter
summarising the
session at 1 month: by
psychologist
Healthcare
utilisation
USA Positive if 1 of 5
conditions met: BAC
≥100 mg/dl; SMAST
score ≥3; BAC of
1–99 mg/dl and SMAST
score of 1 or 2; BAC of
1–99 and GGT above
normal; or SMAST
score of 1 or 2 and GGT
above normal
Age range (years): not
stated (mean 36)
Alcohol
questionnaire
scores (SMAST
scores)
Mean BAC (mg/dl) Control: Usual care Mortality
I: 153 (122); C: 151
(119)
SMAST score
0–2 I: 26.7%; C: 27.3%
3–8 I: 53.4%; C: 57.7%
9–13 I: 19.8%; C: 15.1%
GGT abnormal
I: 29.8%; C: 24.4%
Reason for hospital
visit: Injury
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Table  2 (Continued)
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and
control
Outcomes assessed
Follow-up period Sample characteristics
Screening method
Heather et al. (1996) Controlled trial Too high dependence
(SADD = 30+) or organic
condition requiring
total abstinence from
alcohol or
current/previous
treatment for alcohol
problems
174 Intervention 1: 1
session brief
intervention based on
motivational
interviewing
(30–40 min) by
psychologist, nurse or
chief investigator
Alcohol
consumption
Four  teaching hospitals
in Sydney – range of
wards including
orthopaedic, surgical,
gastrointestinal,
cardiac and medical
Mean 32.11 weeks
(range 24–60)
Male only sample
Australia Self-reported
consumption of >28
standard units/week or
>11 units (1 unit = 10 g
ethanol) in single
session on at least 1
occasion per month
Age range (years):
17–73 (mean 34.4
(sd = 13.4))
Intervention 2: 1
session skills-based
counselling brief
intervention
(30–40 min) by
psychologist, nurse or
chief investigator
SADD Mean 8.61 (5.09),
Range 0–27
Control: Usual care
that may have included
advice about drinking
from medical or
nursing staff
Low dependence (0–9):
65%
Medium dependence
(10–19): 30%
High dependence: (5%)
Reason for hospital
visit: not speciﬁed
Holloway et al. (2007) CRCT Evidence of alcohol
dependence in medical
records or admitted
with conditions
considered primarily
alcohol-related
215 (36 clusters of
2–16 patients)
Intervention 1: 1
session self-efﬁcacy
enhancement brief
intervention (20 min):
by mental health nurse
Alcohol
consumption
Seven general medical,
six general surgical,
two  otolaryngology
wards and one
dermatology ward of
a large teaching
hospital in Scotland.
6 months 85% male Motivation/readiness
to change
UK  Self-report of
exceeding weekly
alcohol limits of 21
units for men, 14 units
for women based on a
7 day retrospective
drinking diary
Age range (years): not
stated (mean
43.7–45.5)
Intervention 2:
Self-help booklet:
“That’s the limit: a
guide to sensible
drinking”
Weekly alcohol units
(median and IQR): I1:
34 (27.45, 48.5)
Control: Usual care
I2: 32(25, 52.5)
C: 38(24, 52.75)
Reason for hospital
visit: various
Kuchipudi et al. (1990) RCT Participation in
alcoholism treatment
in previous 8 weeks
114 Intervention 1: 4 individual
sessions + 1 group
discussion per
week + monthly follow up
visits (duration not stated):
by a variety of
professionals
Alcohol
consumption
51  bed acute medical
unit, Edward Hines Jr
Hospital, Illinois
Length of follow-up
period unclear
Healthcare
utilisation
USA Comprehensive
Drinker Proﬁle (1984)
Proportions by gender
not speciﬁed
Age range (years): not
stated (mean 52)
Intervention 2:
Medical + social worker
evaluation for
aftercare + development of
aftercare plan; alcoholism
therapy and planning of
therapy
available + monthly follow
up visits (duration not
stated): by a variety of
professionals
Participants had many
years of drinking with
very little sobriety
Reason for hospital
visit: recurrent episode
of pancreatic, alcoholic
liver disease or peptic
ulcer with gastritis
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Table 2 (Continued)
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and
control
Outcomes assessed
Follow-up period Sample characteristics
Screening method
Liu et al. (2011) RCT Current speciality
treatment for an alcohol
use disorder
616 Intervention: 2 session
brief intervention (+
optional 3rd) (30 min  each)
plus self-help brochure: by
social worker
Alcohol
consumption
Medical and surgical
wards in a medical
centre in Taipei
12 months Male only sample
Taiwan 7-day TLFB for
consumption in the
most recent seven days
of drinking
Age range (years): not
stated (mean 41.2)
Control: Usual care
Cut off: ≥14
drinks/week
Proportion with:
alcohol
dependence = 49.6%;
heavy drinking = 18.8%;
alcohol abuse = 31.6%
Reason for hospital
visit: not speciﬁed
Mcmanus et al. (2003) Controlled trial (by
time period)
Chronic physical problems
(alcohol related only).
Current or recent contact
with an alcohol service
170 Intervention 1: 1 session
counselling brief
intervention (60 min)
+written information: by
alcohol counsellor
Alcohol
consumption
General medical wards,
teaching hospital,
Manchester, and at
the patients’ home
6 months 88.8% male
UK Daily drinking diary.
Excessive drinking: ≥50
units/33 drinks per week
(men) or ≥35 units/23
drinks per week (women)
Age range (years): not
speciﬁed (mean 52.7)
Intervention 2: Brief
intervention of 2 sessions
(60 min  each) +written
information: by alcohol
counsellor
Mean number of units
of alcohol per week:
115
Reason for hospital
visit: not speciﬁed
Control: No
intervention
McQueen et al. (2006) RCT Already known to
community addiction
teams or deemed to be
alcohol dependent by
medical staff
40 Intervention 1: 1 session of
motivational counselling
(≤40 min): by occupational
therapy staff
Alcohol
consumption
Medical wards of 2
general hospitals in
West of Scotland
3 months 82% male Alcohol
questionnaire
scores (FAST score)
UK  ≥3 on Fast Alcohol
Screening Tool (FAST)
Age range (years):
21–85 (mean 50)
Intervention 2: Alcohol
and health leaﬂet
Mean pre Fast Alcohol
Screening Tool (FAST)
score: 7.07
Reason for hospital
visit: various
Rowland and Maynard
(1993)
CRCT Not stated 435 Intervention: 1 session
brief intervention
comprising of alcohol
education (duration
unspeciﬁed): by nurses
and a researcher
Alcohol
consumption
4  general medical and
5 orthopaedic wards
at York District
Hospital (YDH)
12 months 92% male Alcohol
questionnaire
scores (CAGE score)
UK Alcohol Screening
Questionnaire (ASQ)
positive on
consumption ≥36 units
per wk (men) and ≥24
units per wk (women)
or binge drinking ≥14
units once a month
(men) and ≥9 once a
month (women) or 2 or
more afﬁrmative
responses on modiﬁed
CAGE questionnaire
Age range (years): not
stated (mean 38.6)
Control: No
intervention (but
medical staff were
informed of unsafe
drinkers and could give
advice)
Well-being and
quality of life
ASQ: alcohol
consumption at unsafe
levels: I: 43%, C: 42%
Drinker’s diary: mean
consumption (units): I:
41, C: 45
Alcohol-related
admission: I: 20%, C:
18%
Reason for hospital
visit: various
Saitz et al. (2007) RCT Not stated 341 Intervention: 1 session
brief motivational
counselling (30 min):
by counselling and
clinical psychology
doctoral students
Alcohol
consumption
Inpatient medical unit.
Urban teaching
hospital
12 months 71% male Healthcare
utilisation
- 96 -
N.D. Mdege et al. / Drug and Alcohol Dependence 131 (2013) 1– 22 9
Table  2 (Continued)
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and control Outcomes assessed
Follow-up period Sample characteristics
Screening method
USA ≥8 on AUDIT Age range (years): not stated
(mean 4.5)
Control: Usual care Motivation/readiness
to change
67%  had AUDIT score ≥12 Well-being and
quality of life
Median drinks per day C:
3(1–8) I: 4(1–9)
>75% had current alcohol
dependence
Reason for hospital visit:
various.
Schermer et al. (2006) RCT Not stated 126 Intervention 1: 30 min
discussion in style of
motivational interviewing:
by social worker or trauma
surgeon
Criminal offences
University of New
Mexico hospital
Trauma Centre
Minimum−
Maximum = 180–1279
days
69% male
USA Admission BAC of
≥80 mg/dL or AUDIT
≥8
Age range (year): not stated
(mean 32.9)
Intervention 2: List of
phone numbers of
alcohol treatment
organisations near
their homes
Mean BAC for drivers was
163.3 mg/dL and for passengers
129.2 mg/dL
Mean AUDIT score 15.1 for
drivers and 15.8 for passengers
Reason for hospital visit: Motor
vehicle crash injury
Shourie et al. (2006) Controlled trial Not stated 136 Intervention: 1 session
brief intervention using
WHO  Drink-less package.
Tailored for
non-dependent and
dependent patients.
(Duration unspeciﬁed):
(interventionist
unspeciﬁed)
Alcohol
consumption
Pre-admission clinics
at The Royal Prince
Alfred Hospital and
the Concord General
Repatriation
Hospital, Sydney
6 months 80.1% male Alcohol
questionnaire
scores (AUDIT C
score)
Australia ≥5 on AUDIT-C Age range (years): not stated
(mean 53)
Control: Usual care Well-being and
quality of life
They  had to be drinking
≥60 g daily (men);
≥40 g daily (women).
Mean AUDIT-C score: 8.26 Healthcare
utilisation
Mean daily consumption
(g/day): 71.4
Current alcohol dependence
(DSM-IV): 12.5%
Reason for hospital visit:
surgery
Sommers et al. (2006) RCT Attended an alcohol
treatment programme
in the past year
187 Intervention 1: Simple
Advice (SA)
Alcohol
consumption
Evidenced signs and
symptoms of alcohol
withdrawal. Received
advice from their
health care provider in
the past 3 months to
reduce alcohol use.
Drank >150 g per day
Printed self-help
manual + 5 min
feedback session on
risky drinking + 1
month after discharge
telephone booster
repeating simple
advice
Well-being and
quality of life
Within  2 level 1
trauma centres in
SW Ohio and booster
session on phone
after discharge
12 months ≥2 on any or all of the
3  alcohol dependence
items on AUDIT
77% male Criminal offences
USA  BAC ≥10 mg/dL Age range (years): not stated
(mean 29.03 (sd = 7.96))
Intervention 2: 20 min
hospital brief counselling
(BC). Non-confrontational
manner using FRAMES and
reﬂective
listening + self-help manual
as  for Intervention
1 + booster phone
intervention 1 month after
discharge (20 min)
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Table 2 (Continued)
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and control Outcomes assessed
Follow-up period Sample characteristics
Screening method
Mean drinks per month: 56.80
(63.69)
Both interventions
delivered by nurse
clinicians
Mean binges per month: 5.79
(6.98)
Mean BAC = 165.18 (65.65) Control: No intervention
Reason for hospital visit: injury
after a motor vehicle crash
Tsai et al. (2009) CRCT Level 1 (AUDIT
score < 8) only
recruited in 1st month
389 Intervention: 1 session
brief intervention (15 min):
Tailored to AUDIT score
Alcohol
consumption
18  surgical and medical
units at a medical
centre in northern
Taiwan
12 months 82% male Level 1: Alcohol education Alcohol
questionnaire
scores (AUDIT
score)
Taiwan Chinese version of
AUDIT based on
previous 6 months
Age range (years): 19–89
(mean intervention = 48.2;
control = 51.1)
Level 2: Simple advice
Level 3: Simple advice plus
brief counselling
Level 1 (AUDIT score < 8) Level 4: Simple advice plus
brief counselling. Referral
to diagnosis and treatment
I:  38.4%, C: 35.8% Health promotion booklet
Level 2 (AUDIT score 8–15)
I: 20.3%, C: 30.7% Delivered by a psychiatry
nurse
Level 3 (AUDIT score 16−19)
I: 17.4%, C: 16.8% Control: No treatment
Level 4: (AUDIT score ≥20)
I: 23.9%, C: 16.8%
Reason for hospital visit:
various
Tsai et al. (2011) RCT Level 1 (AUDIT
score < 8)
95 Intervention: 1 session
brief intervention
(15 min) tailored to
AUDIT score.
Participants were also
provided with a
handbook that served
as a learning tool and
reference when
researchers provided
care and guidance for
them
Alcohol
consumption
Surgical and medical
units at a medical
centre in northern
Taiwan
6 months 90.5% male Alcohol
questionnaire
scores (AUDIT
score)
Taiwan Chinese version of
AUDIT
Age range (years): Not stated
(mean: not stated)
Level 2: Education about
alcohol consumption plus
direct suggestions about
individuals’ alcohol use
Level 2 (AUDIT score 8–15):
35.1%
Level 3: Short term
counselling in addition to
intervention for level 2
Level 3 (AUDIT score 16−19):
28.4%
Level 4: In addition to
interventions for level 3
individuals were referred
to specialised treatment
centres for further
treatment
Level 4 (AUDIT score ≥20):
36.5%
Delivered by an
experienced psychiatry
nurse
Reason for hospital visit:
various
Control: No special
psychosocial intervention
except routine nursing care
Watson (1999) Controlled trial Patients who had
previously received
treatment for an
alcohol problem
150 Intervention 1:
Self-help booklet:
“That’s the limit: a
guide to sensible
drinking”
Alcohol
consumption
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Table  2 (Continued)
Study and setting Study design Alcohol related
exclusion criteria
Sample size Intervention and control Outcomes assessed
Follow-up period Sample characteristics
Screening method
General medical,
general surgical,
orthopaedic and
short-stay wards of a
large general
hospital in the West
of Scotland
12 months 74.2% male Well-being and
quality of life
UK Structured interview
schedule (less than 5 mins)
tested for reliability and
validity. Measured
previous week’s alcohol
consumption and had
items relating to
biographical data.
Erythrocyte mean cell
volume (MCV), y-glutamyl
transferase (GGT) and
aspartate transaminase
(AST) also assessed. Cut-off
21 units for men  or 14
units for women
Age range (years): 18–77
(mean 42.5 (sd = 16.8))
Intervention 2: 1 session
brief advice (10–15 min):
by the researcher
Healthcare
utilisation
Alcohol consumption in
previous week
Men: 22–315 units (mean 47.6,
median 35)
Intervention 3: 1 session
brief advice (10–15 min)
plus booklet: by the
researcher
Women: 15–140 units (mean
31.3, median 20)
AUDIT Score (whole sample):
range = 1–35; mean 14.6(7.3);
median 12
Control: No treatment
Reason for hospital visit:
various
Yersin et al. (1996) RCT Patients seeking help
spontaneously
52 Intervention 1: >1 session:
Psychological and social
evaluation.
Multidisciplinary meeting
to decide on psychological
and/or social therapy
(duration not stated): by
multidisciplinary team
Alcohol
consumption
General medical ward,
teaching hospital in
Lausanne
12 months 81% male Well-being and
quality of life
Switzerland ≥5 on MAST (French
version)
Age range (years): 33–68
(median 53)
Intervention 2:
20–30 min  of
abstinence counselling:
by senior supervisor of
ward
Weekly intake of ethanol,
median (range): 604
(140–1680)
MAST score, median (range):
13 (5–37)
MAST score, mean: 16
Mostly alcohol dependent with
86.5% ≥1 alcohol-related
disease
Mean duration of alcohol
consumption: 31years
23% previously undergone
speciﬁc treatment for
alcoholism
Reason for hospital visit:
various
and 59% (Gentilello et al., 1999; Sommers et al., 2006; Yersin et al.,
1996). Where groups differed at baseline the majority of studies
accounted for potential moderating variables in the analysis.
Ten studies did not specify any methods of ensuring inter-
vention ﬁdelity (Antti-Poika et al., 1988; Chick et al., 1985; Elvy
et al., 1988; Forsberg et al., 2000; Gentilello et al., 1999; Kuchipudi
et al., 1990; Schermer et al., 2006; Shourie et al., 2006; Watson,
1999; Yersin et al., 1996). Of the remaining 12 studies training of
interventionists was speciﬁed in all 12 (Bager and Vilstrup, 2010;
Freyer-Adam et al., 2008; Heather et al., 1996; Holloway et al.,
2007; Liu et al., 2011; Mcmanus et al., 2003; McQueen et al., 2006;
Rowland and Maynard, 1993; Saitz et al., 2007; Sommers et al.,
2006; Tsai et al., 2009, 2011); supervision in ﬁve (Freyer-Adam
et al., 2008; Liu et al., 2011; Mcmanus et al., 2003; Saitz et al.,
2007; Sommers et al., 2006); intervention ﬁdelity veriﬁcation in
four (Freyer-Adam et al., 2008; Heather et al., 1996; Liu et al., 2011;
Saitz et al., 2007); and the use of a manual to guide intervention
delivery in four studies (Liu et al., 2011; Sommers et al., 2006; Tsai
et al., 2009, 2011).
3.4. Intervention effectiveness
Results are presented narratively within the study groups indi-
cated in Table 1. There was no clear difference in the direction of
effect (i.e., the presence of intervention beneﬁt versus no interven-
tion beneﬁt) according to any of the quality criteria (for example
randomised studies versus non-randomised studies). We  there-
fore did not group studies according to any quality criteria when
reporting results. For each group an overall summary of results
is presented ﬁrst, followed by a detailed account of the results
with the outcomes of interest speciﬁed in Section 2.3 (i.e., alco-
hol consumption; alcohol questionnaire scores (i.e., scores from
tools or questionnaires used to measure self-reports of alcohol
consumption behaviour such as Alcohol Use Disorders Identiﬁ-
cation Test (AUDIT)); injury; mortality; wellbeing and quality of
life; healthcare utilisation; criminal offences; motivation/readiness
to change) as subheadings where reported. Only the results for
6–12 months follow-up periods are presented in the narratives
below. Twelve months is recommended as the adequate minimum
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Table 3
Summary of results by study.
Study Results
Antti-Poika et al. (1988) Consumption of alcohol decreased in the intervention group but not in the control group (308 g, range 0–1500 g versus 736 g,
range 45–3455 g; p < 0.05)
No statistically signiﬁcant differences were noted between groups at 6 months in terms of biochemistry results. In the
intervention groups serum aspartate transaminase (AST) was decreased (p < 0.01) from admission to 1 month. Both serum
gamma-glutamyl transpeptidase (GGT) and AST increased (p < 0.01) from 1 month to 6 months to the same level as on admission.
(Details available in the paper)
22 (45%) of intervention group and 8 (20%) of control group improved (X2 = 6.109, p < 0.05)
13  (26%) of intervention group and 12 (30%) of control group were unchanged
14  (29%) of intervention group and 20 (50%) of control group were worse (X2 = 4.283, p < 0.05)
Bager and Vilstrup (2010) 17 patients (68%) were abstinent in the motivational interviewing (MI) group and 10 (40%) in the control group (p = 0.09)
At  12 months post-study, survival and hospital admission rate showed no difference between groups (data not shown in article)
80%  of participants in both groups had failed to be in contact with the public alcoholism centres
Chick et al. (1985) There was no signiﬁcant difference in the mean weekly alcohol consumption between intervention (n = 69) and control group
(n  = 64)
No signiﬁcant difference on the proportion of patients reporting at least 50% reduction in alcohol consumption (44 (64%) in
intervention group and 31 (48%) in the control group) (p = 0.07)
No signiﬁcant difference between the intervention (n = 65) and control groups (n = 59) on changes in mean cell volume and GGT
There  was a signiﬁcant difference between intervention patients and control on improvement on score of problems related to
alcohol (41% versus 14% mean fall in problems score respectively) (p = 0.03)
There was also a signiﬁcant improvement in the counselling group on problems related to alcohol (p < 0.001); and GGT activity
(p  < 0.05). The control group did not show any signiﬁcant improvement in these two measures
Of  the 124 interviewed for whose complete blood tests were available, 34(52%) in the counselling group and 20(34%) of controls
were  categorised as deﬁnitely improved (p = 0.038). (Improvement: no alcohol related symptoms or problems over the past year
or  if recruited on heavy alcohol consumption alone needed to report consumption had fallen by 50%. Improvement needed to be
supported by blood tests and/or relatives report)
Both groups signiﬁcantly: reduced their mean weekly intake; and improved on consumption in the past week (p < 0.001)
Both groups did not show any signiﬁcant improvement in mean cell volume
Elvy et al. (1988) 12 months:
The referred group (n = 61) improved signiﬁcantly more than the control group (n = 86) in terms of:
–  time since last drinking (proportion) (p < 0.05):
<24 h (Control = 48; intervention = 25)
1–4 days (Control = 28; intervention = 38)
>5 days (Control = 24; intervention = 38)
–  desire to drink less (proportion of patient), (Control: 38% from 43%; Intervention: 30% from 61%) (p < 0.01)
–  happiness with the amount drunk (proportion of patients), (Control: 64% from 63%; Intervention: 67% from 43%) (p < 0.05)
–  CAST score (mean values), (Control: 5.8 from 5.6; Intervention: 5.1 from 6.4) (p < 0.05)
–  work problems (mean values), (Control: 5.2 from 5.0; Intervention: 4.8 from 5.5) (p < 0.01)
–  a number of personal happiness scale items:
In  good spirits (proportion), (Control: 43% from 44%; Intervention: 54% from 33%) (p < 0.05)
Happiness (proportion), (Control: 55% from 50%; Intervention: 50% from 30%) (p < 0.05)
Optimistic about future (proportion), (Control: 60% from 49%; Intervention: 59% from 30%) (p < 0.05)
Happy with sex life(proportion), (Control: 50% from 69%; Intervention: 53% from 32%) (p < 0.01)
No  difference on:
– feeling content (proportion)
– cost of drinking in the last week (mean)
18 months:
The referred group (n = 48) improved signiﬁcantly more than the control group (n = 72) in terms of:
–  desire to drink less (proportion of patient), (Control: 25% from 43%; Intervention: 21% from 61%) (p < 0.05)
–  happiness with the amount drunk, (proportion of patients), (Control: 73% from 63%; Intervention: 77% from 43%) (p < 0.05)
–  a number of personal happiness scale items:
Happy with sex life (proportion), (Control: 63% from 69%; Intervention: 50% from 32%) (p < 0.05)
Feeling content, (proportion), (Control: 56% from 61%; Intervention: 67% from 41%) (p < 0.01)
Cost  of drinking in the last week (mean), (Control: 14.2 from 17.0; Intervention: 9.7 from 16.2) (p < 0.05)
No  difference on:
– time since last drinking
– CAST score
–  work problems
–  a number of personal happiness scale items:
In  good spirits
Happiness
Optimistic about future
Forsberg et al. (2000) Brief intervention showed a statistically signiﬁcant higher reduction in peak amount at 6 months compared to extended alcohol
counselling (p = 0.03) but at 12 months there was no difference. There were no differences in other outcomes by group
Signiﬁcant positive results in terms of reduction in alcohol consumption and readiness to change were reported for the whole
sample from baseline to follow up (data not extracted)
No differences were noted for brief intervention between delivery by regular surgical staff and psychologists
Freyer-Adam et al. (2008) Longitudinal analysis showed a signiﬁcant stronger increase in readiness to change (from 53 to 76 versus 46 to 46) and a less
profound drop of readiness to seek help (from 27 to 21 versus from 37 to 16) among those who received the intervention (both
intervention groups combined) when compared with control
Changes in other measures were not signiﬁcantly different between groups. Intervention groups drank a mean of 258.16 g of
alcohol over the previous week whilst controls drank 274.01 g. 147(56.54%) had an alcohol problem at follow up in the
intervention group whilst 84(54.19%) had a problem in the control group
All groups decreased their alcohol consumption signiﬁcantly
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Gentilello et al. (1999) At 12 months the intervention group decreased weekly consumption by 21.8(3.7) standard drinks whereas the control group
decreased their intake by 6.7(5.8) drinks (p = 0.03)
There was a non-signiﬁcant difference in reduction in new injuries requiring either emergency department treatment or
readmission to the trauma centre between the intervention group and controls after controlling for covariates (HR = 0.53; 95% CI:
0.26–1.07)
There  was a non-signiﬁcant difference in reduction in inpatient hospital readmissions for treatment of a new injury (up to 3 years
follow up) (HR = 0.52; 95% CI: 0.21–1.29)
Death rate was 2.7% in the intervention group and 2.3% in controls (difference not statistically signiﬁcant)
There was no intervention beneﬁt in patients with a negative SMAST score (0–2) who entered the study on the basis of elevated
BAC (data not shown). There was  no beneﬁt in patients with very high SMAST scores (9–13 associated with severe dependence).
Patients with intermediate scores (3–8) in the intervention group reduced drinking by 21.6 (4.2) drinks per week compared with
an  increase of 2.3 (8.3) drinks per week in the controls (p < 0.01). Both intervention and controls in the intermediate category
decreased alcohol consumption. The intervention group continued to decrease intake whilst the controls increased back to
baseline
Injury type (intentional versus unintentional) did not affect response to the intervention (data not extracted). Other secondary
outcomes not extracted
Heather et al. (1996) Patients who received an intervention reduced mean weekly consumption more than those who did not (31.4(22.9) versus
30.7(18.4))
Differences between brief motivational interviewing (BMI) and skills based counselling (SBC) were not statistically signiﬁcant
(27.6(20.6) versus 35.5(24.7))
There was no statistically signiﬁcant difference in changes in alcohol consumption according to stage of change and type of
counselling received (data not extracted)
When analysis was  conﬁned to patients ‘not ready to change’, patients who received BMI  reduced mean consumption more than
those who received SBC (27.5(20.8) versus 37.6(23.6))
Holloway et al. (2007) There was a greater reduction in self-reported weekly alcohol consumption in both intervention groups compared to usual care
control group:
Self-efﬁcacy versus usual care:
–  10.1 (−16.1, −4.1), (p = 0.001)
Self-help booklet versus usual care:
– 10.0 (−16.0, −3.9), (p = 0.001)
There was no evidence that self-efﬁcacy enhancement was superior to the self-help booklet (p = 0.96)
Similar ﬁnding for change in maximum units consumed in 1 day were noted:
Self-efﬁcacy versus usual care:
–  1.8 (−3.9, −0.3), (p = 0.016)
Self-help booklet versus usual care:
– 3.1 (−5.1, −1.0), (p = 0.016)
For no of drinking days there was  no difference between interventions and control and between intervention groups:
Self-efﬁcacy versus usual care:
–  0.4 (−0.8, 0.1), (p = 0.19)
Self-help booklet versus usual care:
– 0.3 (−0.8, 0.1), (p = 0.19)
Both the self-efﬁcacy intervention and the self-help booklet improved self-efﬁcacy scores more than usual care:
Self-efﬁcacy versus usual care:
12.4 (7.7, 17.2), (p < 0.001)
Self-help booklet versus usual care:
6.4 (1.6, 11.1), (p < 0.001)
Self-efﬁcacy intervention had a greater effect on efﬁcacy score than self-help booklet (p = 0.011)
There was no evidence of interaction between intervention and clinical area (p > 0.05, data not shown)
Kuchipudi et al. (1990) Number of participants undertaking alcoholism treatment were not signiﬁcantly different between treatment groups
Completed 28 days inpatient programme (Intervention (I) = 5; Control (C) = 6)
Kept at least one outpatient appointment (I = 7, C = 3)
Number of participants sober was  not signiﬁcantly different between treatment groups. (Intervention = 19 veriﬁed, 2 unveriﬁed;
Control = 16 veriﬁed, 4 unveriﬁed)
Liu et al. (2011) 12 months: n = 616 (ITT)
Using TLFB there was a signiﬁcant difference on weekly alcohol consumption (p < 0.05), drinking days in previous week (p < 0.001)
and  heavy drinking episodes in previous week (p < 0.01), in favour of intervention overall, as well as in dependent patients
(n  = 305) (p < 0.05; p < 0.01; p < 0.05, respectively)
Signiﬁcant group × time interactions were found for number of drinking days, indicating sustained beneﬁts in the intervention
while control participants gradually drank on more days (p = 0.04 overall; and p = 0.03 for dependent drinkers)
The results were similar using the QDS. Signiﬁcant difference on alcohol consumption in previous 3 months (p < 0.05), drinking
days in previous 3 months (p < 0.001) and heavy drinking episodes in previous 3 months (p < 0.001), in favour of intervention
overall, as well as in dependent patients (p < 0.05; p < 0.01; p < 0.05 respectively)
Mcmanus et al. (2003) Six months (133 participants, 78% of baseline)
There was a statistically signiﬁcant reduction in alcohol consumption for the two  groups who received counselling between
baseline and 6 months. No signiﬁcant differences were observed between phase 2 and phase 3 groups, suggesting no additional
beneﬁt from receiving two sessions instead of one. No signiﬁcant improvement was observed in the control group
Alcohol consumption for each phase, median units per week (IQR)
Phase 2:
Baseline: 78(54–171)
Six months: 29(15–49)
p < 0.001
Phase 3:
Baseline: 70(55–109)
Six months: 22(3–46)
- 101 -
14 N.D. Mdege et al. / Drug and Alcohol Dependence 131 (2013) 1– 22
Table 3 (Continued)
Study Results
p < 0.001
Phase 1:
Baseline: 68.45(52–105)
Six months: 64(46–109)
p = 0.648
McQueen et al. (2006) Mean post FAST score (range)
Intervention = 5.3(1–16); Control = 6(4–14)
Mean change FAST score
Intervention = −1.77; Control = −1.07
Alcohol consumption
Reduced: Intervention = 9; Control = 7
Stayed same: Intervention = 2; Control = 1
Increased: Intervention = 2; Control = 6
Comparisons between FAST scores in the intervention and control groups, and individual change in scores over time revealed no
statistically signiﬁcant changes (p = 0.16)
Rowland and Maynard (1993) There were no signiﬁcant differences between treatment groups for dependency, harm and self-perception scores (data not
extracted)
There was a signiﬁcant reduction in alcohol-related health problems between groups
Increase: Intervention = 22(17.2%); Control = 31(15.1%)
Decrease: Intervention = 40(31.3%); Control = 44(21.5%)
Same: Intervention = 66(51.6%); Control = 130(63.4%)
(p = 0.02)
(Based on 214 patients with complete data)
Mean consumption of units of alcohol before study:
Intervention = 40.86; Control = 44.27
Mean reduction of units consumed after the study:
Intervention = 9.6; Control = 7.25(NS)
(Based on 278 patients with complete data)
Regular consumption:
Increase: Intervention = 12(11%); Control = 10(5.9%)
Decrease: Intervention = 25(22.9%); Control = 47(27.8%)
Same: Intervention = 72(66.1%); Control = 112(66.3%)
(Based on 285 patients with complete data)
Quantity/variability
Increase: Intervention = 19(9.3%); Control = 8(4.7%)
Decrease: Intervention = 17(15.9%); Control = 48(28.4%)
Same: Intervention = 80(74.8%); Control = 113(66.9%)
(Based on 208 patients with complete data, inc 36 treatment patients)
Modiﬁed CAGE score:
Increase: Intervention = 3(2.8%); Control = 8(4.7%)
Decrease: Intervention = 16(15.1%); Control = 23(13.4%)
Same: Intervention = 17(82.1%); Control = 141(82%)
There were no differences in knowledge about alcohol at follow up between groups (data not shown)
Numbers were too small to analyse differences between groups in relation to problems at work
Analyses were also conducted on patients who recalled receiving advice (data not extracted)
Saitz et al. (2007) Three months
There were no differences between the intervention and control groups on proportion of patients who received alcohol assistance:
Among dependent patients (n = 204), 49% in the intervention and 44% in control groups received alcohol assistance (adjusted OR
1.2  [95% CI 0.6–2.5]; intervention control difference 5% [95% CI −8% to 19%]; p = 0.55)
Among patients with AUDIT scores of 12 or greater (n = 183), 48% in the intervention and 43% in control groups received alcohol
assistance (adjusted OR 1.3 [95% CI, 0.6–2.7]; intervention control difference 6% [95% CI, −9% to 20%]; p = 0.55)
The  types of assistance did not signiﬁcantly differ among the groups
12 months (n = 287)
There was no signiﬁcant difference between the groups on:
–  decrease in number of drinks per day (mean adjusted group difference −1.5 (95% CI, −3.7 to 0.6)[p = 0.169]), although this
decreased in both groups
–  decrease in heavy drinking episodes, (mean adjusted group difference −1.7 (95% CI, −4.4 to 0.9) [p = 0.193])
The  increase in number of days abstinent favoured the control group (mean adjusted group difference −2.9 (95% CI, −5.7 to −0.1)
[p  = 0.042])
At 12 months, there was no difference between the groups on: readiness to change, alcohol problems, physical or mental health
related quality of life, emergency department visits, or days hospitalized
Schermer et al. (2006) 14 of 64(21.9%) control patients and 7 of 62(11.3%) intervention patients had an arrest of driving under the inﬂuence (DUI)
In  multivariate regression brief intervention was the strongest protective factor for DUI (OR = 0.32; 95% CI: 0.11, 0.96). Prior no of
DUIs  and age were also associated with DUI arrest but AUDIT screening score was not
Shourie et al. (2006) Within ﬁve days following surgery
Signiﬁcantly more complications overall (any complication) occurred in the intervention group ((20(44.4%)) than in the control
(23(25.3%)) (X2 = 5.118; p = 0.024)
Signiﬁcantly more major postoperative complications occurred in the intervention group than in the control (X2 = 7.16; p = 0.007).
The  difference disappeared when adjusted for gender
No statistically signiﬁcant difference between groups on:
Minor complications–intervention (X2 = 0.661; p = 0.42)
Patients requiring repeat surgery (X2 = 1.985; p = 0.16)
Length of hospital stay (t = 0.643; p = 0.52)
Tachycardia during surgery (X2 = 0.336; p = 0.57)
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Administration of benzodiazepines (X2 = 0.274; p = 0.60)
Age was a signiﬁcant predictor of post-operative complications after controlling for gender, major surgery, and smoking status
(t  = 2.060; p = 0.026)
Age (p = 0.02) and diagnosis of cancer (p = 0.045) were signiﬁcant predictors of length of hospital stay, after controlling for gender,
baseline consumption, and smoking status
Six months follow-up
Average daily consumption fell for the whole sample by 63% (from 70 g/day to 26 g/day) (t = 25.6; p < 0.0001)
No  difference between groups on:
Average daily consumption (t = 2.8; p = 0.9). Intervention = 28.7 g/day; control = 23.7 g/day
Mean AUDIT-C score (t = −1.57, p = 0.12). Intervention = 6.7; control = 7.4
Current alcohol dependence (DSM-IV) (X2 = 0.005, p = 0.95). Intervention = 12.2%; control = 10.2%
Mortality (X2 = 0.30, p = 0.59). 1.3% control; 2.4% intervention)
Number of visits to general practitioner (p = 0.56). Median 4 for both groups
Days unable to work following surgery (mean = 0 for both groups) (p = 0.39)
Hospital admissions (median = 0 in both groups) (p = 0.17)
Ability to do physical activity (p = 0.84)
Sommers et al. (2006) No differences were noted between treatment conditions for the main analyses relating to alcohol consumption (reduction in
drinks and binges)
However a signiﬁcant interaction between treatment condition and driver/passenger status revealed that drivers consumed
similar levels of drinks across treatment conditions whereas passenger consumption varied across the treatment conditions:
Mean consumption
Simple Advice (SA): Driver 40.75(48.30); Passenger 55.99(62.01)
Brief counselling (BC): Driver 42.45(44.04); Passenger 17.49 (18.07)
Control (C): Driver 31.27(35.32); Passenger 75.47(90.86)
There was a signiﬁcant interaction between treatment condition and driver/passenger status for binge drinking. Drivers had
similar levels of binging across treatment conditions whereas passenger binges varied across the treatment conditions:
Mean binges
SA: Driver 1.51(1.86); Passenger 2.90(1.97)
BC: Driver 1.83(1.72); Passenger 0.79(1.05)
C: Driver 1.16(1.69); Passenger 2.98(2.13)
There were no differences between treatment groups in driving events and health status changes (data not reported by treatment
group). However only the BC group demonstrated signiﬁcant changes over time in the proportion reporting ≥1 day of limited
physical activity because of illness (p = 0.003)
At 3, 6 and 12 months all participants decreased numbers of drinks and binges (data not extracted as not broken down by
treatment group)
Tsai et al. (2009) At 6 months AUDIT scores decreased signiﬁcantly from baseline in both groups. (Intervention (I): Pre-test mean 11.6(9.9),
Post-test mean 4.4(7.3); Control (C): Pre-test mean 10.8(8.5), Post-test mean 5.0(7.8). However there were no differences
between groups (F = 1.32, df = 1, p = 0.25)
At 12 months AUDIT scores decreased signiﬁcantly from baseline in both groups. (I: Pre-test mean 11.6(9.9), Post-test mean
3.1(5.8); C: Pre-test mean 10.8(8.5), Post-test mean 4.7(6.3). There was a signiﬁcant difference between groups (F = 6.44, df = 1,
p  = 0.01) favouring the intervention
Further analysis found statistically signiﬁcant mean changes between groups for symptoms of dependence at 6 months (t = 2.80,
p  = 0.01), 12 months scores of alcohol dependence (t = 2.71, p = 0.01) and 12 months total AUDIT scores (t = 2.22, p = 0.03) (data in
full  below)
Six months follow up
(AUDIT scale mean (SD) % improved)
Quantity
I:  3.2(4.5) 57.1
C: 3.1(4.3) 54.4
Symptoms of dependence
I:  1.3(2.8) 72.2
C: 0.5(1.7) 50.0
Related problems
I: 2.6(3.9) 61.9
C: 2.2(3.9) 53.7
Total
I: 7.1(9.7) 61.2
C: 5.8(8.8) 53.7
12 months follow up
(AUDIT scale mean (SD) % improved)
Quantity
I:  3.9(4.4) 69.6
C: 3.0(3.9) 52.6
Symptoms of dependence
I:  1.5(2.5) 83.3
C: 0.8(1.7) 80.0
Related problems
I: 3.1(3.6) 73.8
C: 2.4(4.2) 58.5
Total
I: 8.5(9.2) 73.3
C: 6.1(8.3) 56.5
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Differences between groups were noted on a small no of individual AUDIT questions (data not extracted)
At  the 12 months follow up (but not the 6 months) more participants in the control group stayed at the same drinking level or
worsened compared to participants in the experimental group. (X2 = 7.14, p < 0.05) (data shown below)
Six  months follow up
(Drinking status n(%))
Improved
I: 73(52.9)
C: 54(39.4)
No change
I: 62(44.9)
C: 77(56.2)
Worse
I: 3(2.2)
C: 6(4.4)
12 months follow up
(Drinking status n(%))
Improved
I: 76(55.1)
C: 62 (45.3)
No change
I: 61(44.2)
C: 67(48.9)
Worse
I: 1(0.7)
C: 8(5.8)
Compared with participants at level 4, those at level 1 improved the least in their AUDIT scores, followed by participants at level 2
and  3 (data not available)
Tsai et al. (2011) 6 months follow-up
SCORES
Total AUDIT Score (mean(sd))
I = 6.47(7.97); C = 10.88(7.75) (Z = −2.14, p = 0.033)
Amount of alcohol consumption (mean(sd))
I  = 3.56(4.27); C = 6.00(4.70) (p = 0.053)
Drinking habits and dependence (mean(sd))
I  = 0.62(1.94); C = 1.10(1.95) (p = 0.160)
Alcohol-related problems (mean(sd))
I = 2.29(2.82); C = 3.78(3.42) (p = 0.075)
IMPROVEMENT SCORES
Total AUDIT Score (mean(sd)[%])
I = 12.47(9.42)[65.63]; C = 6.05(9.72)[35.73] (Z = 3.21, p = 0.001)
Amount of alcohol consumption (mean(sd)[%])
I  = 6.38(4.84)[64.19]; C = 3.28(4.86)[35.34] (Z = 2.62, p = 0.009)
Drinking habits and dependence (mean(sd)[%])
I  = 2.53(3.84)[80.32]; C = 0.58(1.84)[34.52] (Z = 2.62, p < 0.001)
Alcohol-related problems (mean(sd)[%])
I = 3.44(3.60)[59.93]; C = 2.15(4.02)[0.056] (p = 0.056)
Watson (1999) No one group reported a signiﬁcantly greater reduction in alcohol consumption than any of the others
Booklet: Baseline 45.7(57.6); Follow-up 33.7(27.4)
Advice: Baseline 41.0(21.0); Follow-up 28.9(29.8)
Advice and booklet: Baseline 44.6(30.8); Follow-up 24.0(17.1)
Control: Baseline 45.2(42.9); Follow-up 30.5(30.0)
Entire sample: Baseline 44.3(41.1); Follow-up 30.0(26.9)
GGT and AST values decreased signiﬁcantly across the sample but no group differences were found. MCV  values showed no effect
of  time or group (data not extracted)
There was a statistically signiﬁcant effect for time across all groups for alcohol-related problems (p < 0.001). However no one
group reported a signiﬁcantly greater reduction than any of the others (data not extracted)
No signiﬁcant differences were found between groups in terms of health rating, no of appointments with GP and hospital
attendances (data not shown in full)
There was a statistically signiﬁcant effect for time across all groups for alcohol consumption based on self-report (p < 0.001)
Yersin et al. (1996) Results suggest that a single session to ﬁrmly counsel abstinence or a multiaxial evaluation aimed at individualising therapeutic
proposals is associated with a favourable impact on alcohol consumption, related consequences and outcomes 1 year later
Number abstinent
Multidisciplinary Individualised Programme (MIP): 7
Abstinence counselling (ABC): 5
Referral (REF): 5
Mean duration of abstinence in weeks
MIP: 37
ABC: 12
REF: 17
Alcohol intake, g (difference between baseline and follow-up)
MIP: 567
ABC: 811
REF: 428
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follow-up period (McQueen et al., 2011). Results from follow-up
periods of at least 6 months but less than 12 months are also
important to show the shorter term outcomes. Table 3 provides
a summary of results from each study for all follow-up periods for
which results were reported.
3.4.1. Single session brief intervention with an interventionist
versus usual care/nointervention. Twelve studies compared a sin-
gle session brief intervention to usual care or no intervention
(see Table 1). The results showed no clear intervention beneﬁts
on alcohol consumption, well-being and quality of life, and alco-
hol questionnaire scores (such as AUDIT scores); with indications
of beneﬁt from some studies but not others. Results suggested
no intervention beneﬁt on healthcare utilisation or laboratory
markers (for example gamma-glutamyl transpeptidase (GGT)).
However, these interventions could potentially increase motiva-
tion/readiness to change.
3.4.1.1. Alcohol consumption. Twelve month follow-up: No statisti-
cally signiﬁcant differences between the intervention and control
were demonstrated at 12 months follow-up for the following
(Table 3): mean weekly alcohol consumption (Chick et al., 1985;
Watson, 1999); reduction in alcohol consumption (Watson, 1999);
proportion of patients reporting at least 50% reduction in alcohol
consumption (Chick et al., 1985); reduction in amount of alcohol
consumed in the past week (Freyer-Adam et al., 2008; Rowland
and Maynard, 1993); decrease in the number of drinks per day in
the past 30 days (Saitz et al., 2007); average daily consumption
(Freyer-Adam et al., 2008); and the quantity/frequency subscale of
the AUDIT questionnaire at 12 months follow-up (Tsai et al., 2009).
Studies also found no statistically signiﬁcant difference between
groups on proportion of patients who had ceased binge drinking
in the year since discharge from hospital (Rowland and Maynard,
1993); number of heavy drinking episodes, decrease in heavy drink-
ing episodes in the past 30 days, and proportion of patients drinking
risky amounts (Saitz et al., 2007); and reduction in symptoms of
dependence (Tsai et al., 2009). Two studies reported no statistically
signiﬁcant difference between intervention and control groups on
changes in gamma-glutamyl transpeptidase (GGT) (Chick et al.,
1985; Watson, 1999), mean cell volume (MCV) (Chick et al., 1985;
Watson, 1999), and aspartate transaminase (AST) (Watson, 1999).
Statistically signiﬁcant differences between groups favouring
the intervention groups at 12 months were reported for the fol-
lowing: time since last drinking (Elvy et al., 1988); and alcohol
dependence scores (Tsai et al., 2009). In the study by Tsai et al.
(2009) more participants in the control group stayed at the same
drinking level or worsened compared to the intervention group.
However, another study reported no statistically signiﬁcant differ-
ence between groups on dependence at 12 months (Rowland and
Maynard, 1993). In the study by Saitz et al. (2007) the increase in
number of days abstinent in the past 30 days favoured the control
group.
Follow-up of at least 6 months but less than 12 months: Studies
showed statistically signiﬁcant differences between groups favou-
ring the intervention groups on the following: reduction in alcohol
consumption at 6 months (Holloway et al., 2007; Mcmanus et al.,
2003; Tsai et al., 2011), as well as at mean follow-up of 32.11 weeks
(Heather et al., 1996); improvement in drinking habits (Tsai et al.,
2011), and reduction in symptoms of dependence at 6 months (Tsai
et al., 2009, 2011).
Studies showed no statistically signiﬁcant differences between
the intervention and control on mean weekly alcohol consump-
tion at 6 months (Holloway et al., 2007) and at mean follow-up of
32.11 weeks (Heather et al., 1996). Studies also showed no statisti-
cally signiﬁcant differences between the intervention and control
on the following at 6 months follow-up: number of drinking days
and change in maximum number of units consumed in one day in
the past week (Holloway et al., 2007); average daily consumption
(Shourie et al., 2006); the quantity/frequency subscale of the AUDIT
questionnaire (Tsai et al., 2009, 2011); drinking habits and depend-
ence measured on the AUDIT questionnaire (Tsai et al., 2011);
and proportion of participants with current alcohol dependence
(Shourie et al., 2006).
3.4.1.2. Alcohol questionnaire scores. AUDIT and AUDIT-C: Tsai et al.
(2009) reported a signiﬁcant difference between groups on AUDIT
scores at 12 months favouring the intervention group (F = 6.44,
df = 1, p = 0.01). Tsai et al. (2011) reported a signiﬁcant differ-
ence between groups on AUDIT scores (Z = −2.14, p = 0.033), and
improvement in AUDIT scores (Z = 3.21, p = 0.001) at 6 months
favouring the intervention group. However two  other studies
reported no statistically signiﬁcant difference between groups for
AUDIT scores (Tsai et al., 2009) and mean AUDIT-C scores (Shourie
et al., 2006) at 6 months.
Canterbury Alcoholism Screening Test (CAST): Elvy et al. (1988)
reported that improvement on CAST scores favoured the interven-
tion group at 12 months (control: 5.8 from 5.6; intervention: 5.1
from 6.4, p < 0.05).
3.4.1.3. Well-being and quality of life. Twelve months follow-up:
Whilst Chick et al. (1985) reported a statistically signiﬁcant dif-
ference favouring the intervention group on reduction in alcohol
related problems at 12 months (mean reduction: intervention 41%;
control 14%, p = 0.03), a number of studies reported no statisti-
cally signiﬁcant difference between groups (Freyer-Adam et al.,
2008; Saitz et al., 2007; Tsai et al., 2009; Watson, 1999). Chick
et al. (1985) also found a signiﬁcantly higher proportion of patients
in the intervention group reporting complete freedom from alco-
hol related symptoms/problems over the past year at 12 months
(intervention: 52%; control 34%, p = 0.038). Rowland and Maynard
(1993) found a statistically signiﬁcant difference in reduction in
alcohol-related health problems favouring the intervention group
at 12 months (p = 0.02). However, a number of studies reported
no statistically signiﬁcant differences between groups on physical
and mental health related quality of life (Saitz et al., 2007), health
ratings (Freyer-Adam et al., 2008; Watson, 1999), and patients’
self-perception (Rowland and Maynard, 1993) at 12 months.
Six months follow-up: Three studies reported no statistically sig-
niﬁcant difference between groups at 6 months on alcohol related
problems (Tsai et al., 2011); reduction in alcohol related problems
(Tsai et al., 2009, 2011); and ability to undertake physical activity
and days unable to work following surgery (Shourie et al., 2006).
3.4.1.4. Healthcare utilisation and mortality. Studies reported no
statistically signiﬁcant difference between groups on the following
at 12 months follow-up: emergency department visits (Saitz et al.,
2007); hospital attendances (Watson, 1999); length of hospital stay
(Saitz et al., 2007); and GP visits (Watson, 1999).
Shourie et al. (2006) reported no statistically signiﬁcant differ-
ence between groups at 6 months on hospital admissions, GP visits
and mortality.
3.4.1.5. Motivation/readiness to change. The increase in readiness to
change score was signiﬁcantly stronger for the intervention group
compared to the control in one study (intervention: 53–76; control:
no change, using the Readiness to Change Questionnaire) (Freyer-
Adam et al., 2008) but not in another (Saitz et al., 2007) at 12 months
follow-up. Freyer-Adam et al. (2008) also reported a less profound
drop of readiness to seek help, using the Treatment Readiness Tool,
among those who received the intervention (from 27 to 21) than
the control (from 37 to 16). Other studies found intervention ben-
eﬁts on improvement in: the desire to drink less at 12 months
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(Elvy et al., 1988) and self-efﬁcacy scores at 6 months follow-up
(Holloway et al., 2007).
3.4.2. Two to three sessions/contacts with an interventionist versus
usual care/no intervention. Five studies evaluated brief interven-
tions delivered in 2–3 sessions/contacts with an interventionist
versus usual care/no intervention (see Table 1). Results from these
studies suggest these interventions could be beneﬁcial in reduc-
ing alcohol consumption. However there was no clear intervention
beneﬁt for alcohol dependent patients. For these ﬁve studies, no
beneﬁts were demonstrated on other outcomes for both dependent
and non-dependent patients.
3.4.2.1. Alcohol consumption. Twelve months follow-up: Statistically
signiﬁcant differences between groups favouring the intervention
group were reported for: decrease in mean weekly consumption
(by 21.8 in intervention; and 6.7 in control, p = 0.03) (Gentilello
et al., 1999); and weekly alcohol consumption, alcohol consump-
tion in previous 3 months, as well as drinking days and heavy
drinking episodes in the previous week/3 months (Liu et al., 2011).
Liu et al. (2011) also reported a signiﬁcant group by time inter-
action for number of drinking days, indicating sustained beneﬁts
in the intervention while control participants gradually drank on
more days.
Sommers et al. (2006) reported no statistically signiﬁcant differ-
ence between groups on number of standard drinks consumed and
number of binges in the previous month after 12 months follow-
up, with a decrease being observed for all participants. Whilst one
study reported no intervention beneﬁt for alcohol consumption
among patients with very low alcohol consumption and those with
severe dependence (Gentilello et al., 1999) another reported a ben-
eﬁt even for alcohol dependent patients (p < 0.05) (Liu et al., 2011).
Six month follow-up: Statistically signiﬁcant differences between
groups favouring the intervention group were reported for
decrease in mean weekly consumption after 6 months (Antti-Poika
et al., 1988; Mcmanus et al., 2003). Antti-Poika et al. (1988) reported
no statistically signiﬁcant differences between groups at 6 months
on biochemistry results.
3.4.2.2. Injuries and healthcare utilisation. Gentilello et al. (1999)
reported no statistically signiﬁcant differences between groups
on: injuries requiring either emergency department treatment or
trauma-centre readmission at 12 months; and inpatient hospital
readmission for a new injury after up to three years follow-up.
3.4.2.3. Well-being and quality of life, and mortality. Sommers et al.
(2006) reported no statistically signiﬁcant difference between
groups on health status changes. Gentilello et al. (1999) showed a
statistically insigniﬁcant difference between groups on death rates
at 12 months.
3.4.2.4. Criminal offences. Sommers et al. (2006) found no differ-
ence between groups on change in driving offences one year after
motor vehicle crash.
3.4.3. Self-help literature (e.g., booklets, leaﬂets) versus usual care/no
intervention. Two studies evaluated the effectiveness of a booklet
containing information on alcohol consumption (see Table 1). The
results showed no clear intervention beneﬁt on alcohol consump-
tion or on any other outcomes.
3.4.3.1. Alcohol consumption. Twelve months follow-up: No statis-
tically signiﬁcant differences between groups were reported on
mean units of alcohol consumed per week and reduction in alcohol
consumption (Watson, 1999). Watson (1999) also reported no sta-
tistically signiﬁcant difference between groups on changes in GGT,
MCV, and AST at 12 months.
Six months follow-up: Holloway et al. (2007) found intervention
beneﬁts on reduction in mean weekly consumption (−10.0 [95% CI
−16.0, −3.9], p = 0.001) and maximum number of units consumed
in one day in the past week (−3.1 [95% CI −5.1, −1.0], p = 0.016) at
6 months. However, there was  no signiﬁcant difference between
groups on mean units of alcohol consumed per week and number
of drinking days in the past week (Holloway et al., 2007).
3.4.3.2. Well-being and quality of life, and healthcare utilisation.
Watson (1999) reported no statistically signiﬁcant differences
between groups on alcohol related problems, health ratings, hos-
pital attendances, and GP visits at 12 months.
3.4.3.3. Motivation/readiness to change. Holloway et al. (2007)
reported signiﬁcantly higher improvement in self-efﬁcacy scores
in the intervention than the control group at 6 months.
3.4.4. Brief intervention versus self-help literature (e.g., booklets,
leaﬂets)/referral. Five studies compared a brief intervention with
or without self-help literature/referral against self-help litera-
ture/referral alone (Table 1). The results suggest no beneﬁt of
one intervention over another on alcohol consumption and other
outcomes. However patients could beneﬁt more from brief inter-
ventions than self-help literature on self-efﬁcacy and drinking
under the inﬂuence arrests.
3.4.4.1. Alcohol consumption. Twelve months follow-up: One  study
found no statistically signiﬁcant differences after 12 months
follow-up on: reduction in mean weekly consumption; and changes
in GGT, AST and MCV  values (Watson, 1999).
Six months follow-up: One study found no statistically signiﬁcant
differences at 6 month follow-up on: reduction in mean weekly
consumption, maximum units consumed in one day and number
of drinking days in the past week (Holloway et al., 2007).
3.4.4.2. Well-being and quality of life, healthcare utilisation, and
mortality. Watson (1999) reported no statistically signiﬁcant dif-
ference between interventions on reduction in alcohol related
problems, health ratings, number of appointments with GP  and
hospital attendances at 12 months. Another study found no statisti-
cally signiﬁcant differences between groups on hospital admission
and survival rates 12 months post-study (Bager and Vilstrup, 2010).
3.4.4.3. Criminal offences. Schermer et al. (2006) reported statisti-
cally signiﬁcantly lower driving under the inﬂuence arrests within
three years of hospital discharge in the brief intervention group
than the control (OR = 0.32 [95% CI 0.11, 0.96]).
3.4.4.4. Motivation/readiness to change. Holloway et al. (2007)
reported a greater effect on efﬁcacy scores for the self-efﬁcacy
intervention than the self-help booklet (p = 0.011).
3.4.5. Comparisons between two different single session brief inter-
ventions with an interventionist. Overall, the results suggest no
beneﬁt of one single session brief intervention over another single
session brief intervention on alcohol consumption as well as other
outcomes (Freyer-Adam et al., 2008; Heather et al., 1996; Watson,
1999).
3.4.5.1. Alcohol consumption. Twelve months follow-up: Studies
reported no statistically signiﬁcant difference between groups on:
reduction in mean weekly consumption (Watson, 1999); mean
alcohol intake over the previous week (Freyer-Adam et al., 2008);
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and changes in GGT, AST and MCV  values at 12 months (Watson,
1999).
Follow-up of 6 months to less than 12 months: One study reported
no statistically signiﬁcant difference between groups on: reduc-
tion in mean weekly consumption after a mean follow-up of 32.11
weeks (Heather et al., 1996).
3.4.5.2. Well-being and quality of life, and healthcare utilisation.
Studies reported no statistically signiﬁcant difference between
groups on alcohol related problems (Freyer-Adam et al., 2008); and
reduction in alcohol related problems, health ratings, number of
appointments with GP and hospital attendances (Watson, 1999) at
12 months.
3.4.6. Comparison between two different brief interventions where at
least one is two or three sessions with an interventions. Results from
the three studies in this group (Table 1) suggest no beneﬁt of a two
session brief intervention over a one session brief intervention, or
another two session brief intervention of shorter session duration,
on alcohol consumption outcomes.
3.4.6.1. Alcohol consumption. Twelve months follow-up: Studies
noted no statistically signiﬁcant difference between the inter-
ventions under comparison on: reduction in number of drinks
consumed and number of binges at 12 months (Sommers et al.,
2006); and frequency of alcohol consumption, average daily
amount, sober days, frequency of intoxication, and weekly con-
sumption (Forsberg et al., 2000). Forsberg et al. (2000) reported no
statistically signiﬁcant difference between groups on peak amount
of alcohol consumed (p = 0.23).
Six months follow-up: Studies noted no statistically signiﬁcant
difference between the interventions under comparison on: reduc-
tion in alcohol consumption (Mcmanus et al., 2003); reduction
in number of drinks consumed and number of binges (Sommers
et al., 2006); and frequency of alcohol consumption, average daily
amount, sober days, frequency of intoxication, and weekly con-
sumption (Forsberg et al., 2000) at 6 months. However, Forsberg
et al. (2000) reported a statistically signiﬁcant difference between
groups on peak amount of alcohol consumed favouring a two
session over a one session intervention at 6 months follow-up
(p = 0.03).
3.4.6.2. Well-being and quality of life. Sommers et al. (2006) noted
no signiﬁcant difference between the two active treatments on
health status change at 6 and 12 months.
3.4.6.3. Criminal offences. Sommers et al. (2006) reported no sig-
niﬁcant difference between the two active treatments on driving
offences at 6 and 12 months.
3.4.7. Interventions of four or more sessions with an interventionist.
Kuchipudi et al. (1990) compared an intervention of four sessions
with various interventionists, plus a group discussion, medical
evaluation and aftercare planning, to a control arm comprising of
medical evaluation and aftercare planning alone. There were no
statistically signiﬁcant differences between the two interventions
on number of participants undertaking alcoholism treatment, and
number of participants sober (Kuchipudi et al., 1990).
Yersin et al. (1996) compared an individualised management
proposal by a multidisciplinary team against a single session of
abstinence counselling. They however did not compare the effec-
tiveness of the two interventions.
4. Discussion
This review did not ﬁnd a clear intervention beneﬁt from single
session brief interventions and self-help literature (e.g., booklets,
leaﬂets) on alcohol consumption outcomes, with indications of
beneﬁt from some studies but not others. However, studies found
intervention beneﬁts from single session brief interventions on
motivation/readiness to change. Results suggest that brief inter-
ventions of more than one session are more effective than usual
care/no intervention on reducing alcohol consumption, especially
for non-dependent patients. It is possible that brief interventions of
more than one session work by ﬁrst increasing the patients’ motiva-
tion/readiness to change during the ﬁrst session, and then effecting
reduction in alcohol consumption in the follow-up contact sessions.
Brief interventions of more than one session therefore merit further
investigation. Comparisons between any two  active interventions
did not show superiority of one intervention over another on any
outcome. Research on interventions for alcohol misuse in general
hospital wards have mostly been on brief interventions, especially
single session brief interventions. We  identiﬁed seven on-going
studies on interventions for alcohol problems through the search
of databases and information from authors and experts in the ﬁeld.
Details of these on-going studies is provided as Supplementary
material.4
Whilst the methodological quality of the included studies was
mixed, there was  no clear difference in the direction of effect (i.e.,
the presence of intervention beneﬁt versus no intervention bene-
ﬁt) according to any of the quality criteria (for example randomised
studies versus non-randomised studies). There was also variability
of quality within studies with most studies judged as adequate in
only some of the quality criteria; even when restricted to criteria
with research evidence showing an impact on effect size (adequate
randomisation, allocation concealment, and blinding of outcome
assessors) (Hewitt et al., 2005; Higgins and Green, 2008). Two stud-
ies (Liu et al., 2011; Saitz et al., 2007) that were judged as adequate
on randomisation, allocation concealment, and blinding of outcome
assessors did not differ from the other studies in their group in
terms of the overall direction of effect.
Much of the current literature speculates that interventions for
alcohol problems for hospital populations could reduce healthcare
utilisation, including alcohol related hospital admissions, and result
in cost savings (Bray et al., 2011). However, our review showed no
evidence of superiority of one intervention over usual care/no treat-
ment/another active intervention on healthcare utilisation and
mortality. A recent systematic review by Bray et al. (2011) also sug-
gested screening and brief interventions for alcohol problems have
little or no effect on inpatient or outpatient healthcare utilisation.
It is however important to note that most of studies included in our
present review focused on short-term outcomes (mostly 12 months
or less). There could be a time-lag between reduction in alcohol con-
sumption and reduction in healthcare utilisation including alcohol
related hospital admissions, as well as mortality. There is there-
fore a need for longer term follow-up of study participants. Our
review found no differences between groups on well-being and
quality of life, as well as alcohol questionnaire scores (i.e., scores
from tools or questionnaires used to measure self-reports of alcohol
consumption behaviour such as the AUDIT). Out of the two studies
that reported on criminal offences (Schermer et al., 2006; Sommers
et al., 2006) only one study comparing a brief intervention to provi-
sion of a list of phone numbers of alcohol treatment organisations
reported signiﬁcantly lower driving under the inﬂuence arrests for
the brief intervention (Schermer et al., 2006).
4 Supplementary material can be found by accessing the online version of this
paper. Please see Appendix A for more information.
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The inability to statistically synthesis the data was  mainly due
to the different measures used to assess alcohol consumption. This
will remain a challenge unless consensus is reached regarding
the preferred means of assessing alcohol consumption (McQueen
et al., 2011). Researchers should also report the behaviour change
techniques utilised within interventions to facilitate replication;
as well as adhere to the CONSORT Statement for reporting of tri-
als or the relevant extension (Campbell et al., 2012; Piaggio et al.,
2006; Schulz et al., 2010). The following measures to improve and
assess ﬁdelity are recommended: designing the intervention using
a recognised theoretical framework; use of treatment manuals and
standardised guidelines for intervention delivery; intervention-
ist training and supervision; veriﬁcation through interventionist
observations or recorded intervention sessions, interventionists
self-report through evaluation forms/checklists completed after
consultations; interviews with intervention recipients; providing
support material for trial participants that promotes adherence;
and monitoring and testing study participants’ acquisition of treat-
ment skills (Bellg et al., 2004; Glasziou et al., 2010; Shadish, 2002;
Spillane et al., 2007). Glasziou et al. (2010) also recommends that
studies report any drift away from ﬁdelity during the trial. We  rec-
ommend that, in their study reports, authors should also clearly
provide information on: how participants were identiﬁed includ-
ing the procedures undertaken and any tools used, which health
professionals were involved, and the setting from which patients
were identiﬁed; the setting within which interventions were deliv-
ered and which health professionals delivered the interventions;
number of intervention sessions and length of each session; and
whether there was any exclusion criteria related to alcohol con-
sumption. This information is essential for exploring the impact of
different intervention characteristics. It is also useful to policy mak-
ers and healthcare providers when implementing interventions.
A number of studies found a signiﬁcant improvement in all study
groups for some outcomes including: alcohol consumption (Chick
et al., 1985; Forsberg et al., 2000; Freyer-Adam et al., 2008; Heather
et al., 1996; Mcmanus et al., 2003; Sommers et al., 2006; Watson,
1999); AUDIT scores (Tsai et al., 2009); and well-being (Watson,
1999). In some instances this was the case even for no intervention
(Chick et al., 1985; Mcmanus et al., 2003; Sommers et al., 2006; Tsai
et al., 2009; Watson, 1999) and usual care groups (Freyer-Adam
et al., 2008; Heather et al., 1996). This highlights the possibility
of: self-reporting of behaviour through completion of screen-
ing/assessment questionnaires leading to reduction in alcohol
consumption (screening/assessment reactivity) (Bien et al., 1993;
Clifford and Maisto, 2000; McCambridge, 2009; McCambridge and
Day, 2007; McCambridge and Kypri, 2011; Walters et al., 2009);
change in behaviour in response to being observed (the Hawthorne
effect) (McCambridge and Kypri, 2011); or regression to the mean
(Torgerson and Torgerson, 2008). These issues warrant further
investigation (McQueen et al., 2011).
Our conclusions on the effectiveness of brief interventions dif-
fer from those from the review by McQueen et al. (2011) mainly
because of differences in the way that studied were grouped. They
concluded brief interventions in general hospital wards were effec-
tive in reducing alcohol consumption at 6 and 9 months follow-up
but not at one year (McQueen et al., 2011). In contrast our review
where studies were grouped according to number of intervention
sessions found intervention beneﬁt on alcohol consumption from
multiple session brief interventions, but no clear beneﬁt from one
session brief interventions. Our review has strength in this regard
as it highlights that a one session brief intervention might not be
adequate to effect a reduction in alcohol consumption in alcohol
misusing hospital inpatients. Questions still remain however on
the required optimal treatment exposure.
A systematic review of interventions targeting alcohol problems
in emergency departments found that they did not reduce alcohol
consumption but reduced alcohol-related injuries (Havard et al.,
2008). However these conclusions were based on meta-analyses
with signiﬁcant heterogeneity between studies (Havard et al.,
2008). Another review which focused on interventions for alcohol
problems among patients presenting to emergency departments
with injuries noted improvements in both intervention and con-
trol groups in most of the included studies but differences were not
always statistically signiﬁcant between treatment groups (Nilsen
et al., 2008). Similar to our current review, Nilsen et al. (2008)
also noted that the heterogeneity of the studies made it difﬁcult
to draw ﬁrm conclusions on effectiveness. Other previous reviews
not restricted to general hospital inpatients have concluded that:
bibliotherapy is effective compared to control in reducing at-risk
and harmful drinking (Apodaca and Miller, 2003); interventions for
problem drinking could reduce injuries and their antecedents (e.g.,
falls and motor vehicle crashes) (Dinh-Zarr et al., 2004); and brief
interventions appear to reduce mortality (Cuijpers et al., 2004).
These ﬁndings are inconsistent with our ﬁndings mainly because,
whilst our review focused on interventions for general hospital
inpatients, these reviews included studies from various healthcare
settings, with very few studies in general hospital inpatient popula-
tions [2 out of 9 (Apodaca and Miller, 2003); 2 out of 22 (Dinh-Zarr
et al., 2004); and 7 out of 32 (Cuijpers et al., 2004)].
In conclusion, brief interventions of more than one session
could be beneﬁcial in reducing alcohol consumption among hospi-
tal inpatients, especially for non-dependent patients. However, the
conclusions are based on a narrative synthesis as it was  not possi-
ble to conduct a quantitative analysis. There is need for additional
evidence before more robust conclusions can be made. There is also
a need for research evidence on other non-brief interventions for
alcohol problems among general hospital inpatients.
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Abstract
Issues.Research evidence indicates a high prevalence of substance abuse among patients presenting in general hospital settings.
Such misuse of alcohol and illicit drugs has a major impact on population health and on costs to health services and to society
at large.This review aimed to identify the interventions for alcohol or illicit drug misuse problems that have been evaluated for
hospital outpatient populations. Approach. Thirteen electronic databases including MEDLINE, EMBASE and PsycInfo
were searched for published and unpublished studies in any language up to August 2011.Reference lists of included studies and
reviews were also hand-searched.We included randomised and controlled clinical trials of any intervention for adult participants
identified as having alcohol and/or drug problems presenting to hospital outpatient settings other than addiction or psychiatric
units. Participants could be attending hospital for any reason other than treatment for substance abuse. A narrative synthesis
was conducted. Key Findings. There is some evidence to suggest that interventions based on motivational techniques might
be effective in treatment of alcohol misuse in oral–maxillofacial clinics but not in general outpatient departments.The evidence
is insufficient to allow any conclusions to be derived on the effectiveness of interventions in the treatment of drug misuse and
combined alcohol–drug misuse in outpatient settings. Conclusions.Further research is needed to investigate interventions for
alcohol and drug misuse in outpatient settings.Additionally, problems remain in terms of study quality. Procedures to ensure the
rigour of a study were often poorly reported. [Watson JM, Fayter D, Mdege N, Stirk L, Sowden AJ, Godfrey C.
Interventions for alcohol and drug problems in outpatient settings: A systematic review. Drug Alcohol Rev
2013;32:356–367]
Key words: alcohol problem, drug problem, outpatient, treatment.
Background
Alcohol consumption is reported as the world’s third
largest risk factor for disease and disability, with almost
4% of all deaths worldwide attributed to alcohol [1]. In
addition, the misuse of illicit drugs accounts for the loss
of 11.6 million disability-adjusted life years annually
worldwide, which is 0.8% of the total burden of disease
[2].
Although an increasing awareness of recommended
safe drinking limits has developed in England, it is
estimated that over 24% of the adult population are
hazardous drinkers [3], and alcohol-related hospital
admissions have risen by 69% from 2002 to 2007/2008,
now standing at 863 300 [4]. Likewise, around four
million people use illicit drugs each year in the UK, and
a total of 42 170 admissions with a primary or second-
ary diagnosis of drug misuse were noted in 2008/2009
[5].
Health-care professionals across a range of hospital
settings will regularly encounter patients with substance
misuse problems and may have an opportunity to inter-
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vene. If a condition is potentially related to misuse of
alcohol and/or illicit drugs, some patients may, on dis-
cussion, realise the association between their substance
misuse and their ill-health, potentially providing what is
known as a ‘teachable moment’ [6].
Treating substance misuse can result in substantial
cost savings, with recent estimates suggesting that for
every £1 spent on treatment for drug problems, at least
£9.50 can be saved in criminal justice and health costs
[7]. In 2008, the Department of Health estimated that
the costs to the health service because of alcohol misuse
were in the region of £2.7 billion per year [8].There is
growing interest and need for early detection of patients
with such substance misuse problems [9].
A number of systematic reviews already exist in the
field of drug and alcohol misuse [10–13]. However,
none focus solely on outpatient settings and often
consider a single type of intervention (e.g. brief inter-
vention). In this review, we were interested in the
effectiveness of any intervention offered in hospital out-
patient settings to patients who might not know they
have an alcohol or drug misuse problem and/or might
not seek help.
Methods
This review was undertaken according to the principles
recommended in the Centre for Reviews and Dissemi-
nation guidance [14].This includes the production of a
detailed protocol, which is available at: http://www.
york.ac.uk/healthsciences/trials-unit/arias/links/.
Search strategy
The following electronic databases were searched for
controlled trials (randomised and non-randomised)
published up to August 2011: MEDLINE;
C2-SPECTR; CINAHL; Cochrane Central Register of
Controlled Trials; Cochrane Database of Systematic
Reviews; Conference Proceedings Citation Index -
Science; DARE; EMBASE; HMIC; HTA Database;
NHS Economic Evaluations Database; PsycInfo; and
Public Health Interventions Cost Effectiveness Data-
base. Full search strategies for each database searched
are provided in Appendix S1.
The reference lists of included papers were assessed
for additional relevant studies, and ongoing studies
were identified from ClinicalTrials.gov (via website
at: http://www.clinicaltrials.gov/). Where necessary,
authors of ongoing or unpublished studies were con-
tacted for further information so as to assess eligibility
for the review.
Identification of included studies
Two reviewers independently screened all titles and
abstracts. The full manuscripts of potentially relevant
studies were retrieved and assessed for relevance inde-
pendently by two reviewers according to the inclusion
criteria. Discrepancies were resolved by discussion or
by referral to the project team when necessary.
Inclusion criteria
We included studies recruiting participants aged 16 or
above, identified as having an alcohol and/or drug
problem (as per each study’s inclusion criteria) present-
ing to an acute hospital outpatient setting for any
reason other than specifically for alcohol or illicit drug
misuse treatment. All levels of severity of alcohol abuse
were eligible including severe dependence.We included
randomised controlled trials (RCT) (individual or
cluster) and controlled clinical trials (CCTs). Any type
of intervention was eligible for inclusion and could have
one or more components, pharmacological and non-
pharmacological, be delivered to individuals or groups
face to face or using the telephone or other media.
Comparator interventions could include no treatment
(assessment only without referral), waiting list control,
‘usual care’ or other active treatments. Studies where
referral to specialist services was the purpose were
included. Outcomes could include: a measure of
alcohol consumption (e.g. quantity/frequency, percent-
age of time abstinent and alcohol questionnaire scores);
a measure of drug use (e.g. number of days used and
drug questionnaire scores); biochemical measures of
alcohol use; injury; mortality rates; quality of life meas-
ures; numbers seeking specialist treatment for alcohol/
drug misuse; criminal offences (e.g. driving while
intoxicated and assault) and motivation/readiness to
change. Published and unpublished studies from any
country and reported in any language were eligible for
inclusion.
Interventions directed primarily at whole hospital
populations without screening for alcohol or drug prob-
lems and those screening patients solely to ascertain
prevalence of substance misuse problems were not eli-
gible.We also excluded: studies focusing specifically on
participants with a dual diagnosis and abuse of pre-
scription medications and studies set in specialist psy-
chiatric wards/facilities, addiction services or addiction
treatment programmes. Studies focusing specifically on
pregnant women were also excluded as we considered
them to be a separate group and one that has been
adequately reviewed elsewhere [15,16].
Data extraction
Following piloting of a selection of studies to ensure
consistency, data were extracted independently by one
reviewer and checked by a second reviewer. Discrepan-
cies were resolved by discussion, with involvement of a
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third reviewer when necessary. Data extracted included
study methods, setting, participant characteristics,
intervention, comparators, outcomes, outcome meas-
ures and results.
Quality assessment
Quality was assessed by one reviewer and independ-
ently checked by a second reviewer. Disagreements
were resolved by consensus, and a third reviewer con-
sulted if necessary. Items assessed included: presence of
a power calculation, adequacy of randomisation and
allocation concealment, appropriate adjustment for
covariates, blinding of outcome assessors, adequacy of
follow up (deemed to be a minimum of 12 months) and
explanation of dropouts and use of intention to treat
analysis. Details of attempts to maintain intervention
fidelity were recorded (e.g. adequacy of training for
those delivering the intervention, use of checklists,
audio or video taping patient interviews, direct obser-
vation, etc.).
Methods of analysis
Significant methodological heterogeneity existed
among the studies, predominately regarding the out-
comes reported, how they were defined and meas-
ured. Various measures include: number of drinking
days in the past 30 days; alcohol consumption in the
past 3 months; mean drinks per drinking day; and
change in alcohol consumption at 12 months. There
were also differences in baseline consumption levels
for eligibility, the health-care professionals delivering
the intervention and inclusion/exclusion by gender.
Given the diversity of the studies included in this
review, it was considered that a meta-analysis was
inappropriate. A narrative synthesis was conducted
and evidence summaries created incorporating an
evaluation of the quality of the evidence. This review
has been reported in accordance with the PRISMA
statement [17].
Results
The search identified 3699 potentially relevant refer-
ences (Figure 1), which were screened, and 396 were
retrieved for detailed evaluation. Of these, 334 were
excluded due to not being related to drug or alcohol
problems, not in a general hospital setting, or not an
RCT or controlled clinical trial. A further 55 were
excluded for being conducted in emergency (n = 34)
and inpatient settings (n = 21).
Seven were conducted in outpatient settings and are
presented in this paper.
Titles and abstracts screened from
electronic searches n = 3631
Full papers screened
n = 396
Included in full review
n = 7
Excluded
n = 389
(Not drug or alcohol
problems, not an RCT or CCT
participants under 16, not a
general hospital setting;
emergency or inpatient
setting)
Interventions for alcohol
misuse
n = 5
Interventions for drug
misuse
n = 1
Interventions for alcohol
and drug misuse
n = 1
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Ongoing studies identified
from ClinicalTrials.gov n = 2
Papers identified from
checking reference lists n = 68 Excluded n = 3303
(Duplicates; not relevant)
Figure 1. Flow chart showing the number of potentially relevant references identified during the searches and the number included in
the review.
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Description of included studies (Table 1)
Five studies investigated the effectiveness of interven-
tions for excessive alcohol use [18–22]; one investigated
interventions for drug misuse [23]; and one for both
excessive alcohol and illicit drug use [24]. Three were
conducted in the USA [20,23,24], two in the UK)
[18,19], one in the Netherlands [21] and one in
Sweden [22].
Interventions for alcohol misuse
Five RCTs including a total of 1058 adult participants
were included in the review [18–22]. Study interven-
tions were compared with usual care (which may have
included advice on alcohol) [19,21]; provision of a
standard alcohol information leaflet [18]; assessment
interview only [20]; and, in one study, no contact for 12
months [22]. Results are presented in a narrative syn-
thesis. It was hoped to divide the studies according to
the behavioural change techniques used in the interven-
tions, following the framework proposed by Abraham
and Michie [25]. However, this was hampered due to
poor reporting of intervention content and behaviour
change techniques.
Effectiveness of the evaluated interventions for
alcohol misuse
Alcohol consumption. One of the two studies con-
ducted in oral and maxillofacial outpatient clinics
found no statistically significant treatment differences
at 3 months (based on 103 of 195 participants ran-
domised) regarding changes in number of drinking
days or number of standard drinks per drinking day
[18]. However, at 12, months there was a statistically
significant difference between the treatment groups in
favour of the motivational intervention in terms of
change in drinking days (P = 0.007) and heavy drinking
days (P = 0.03).This was not the case for the number of
standard drinks per drinking days (P = 0.2) [18]. In the
second study, there was a significantly greater reduction
in the percentage of hazardous drinkers in the motiva-
tional intervention group compared with the control
group [19]. Although the number of days abstinent did
not vary significantly between groups, at 12 months,
only 27% of the intervention group were drinking
above the guidelines of 21 units per week [decrease
from 45/75 (60%) to 16/60]; in the control group, 51%
were drinking above the guidelines [decrease from
41/76 (54%) to 31/61] [19].There was also a significant
interaction effect for time and treatment for this
outcome favouring the motivational intervention
(F = 3.60, P < 0.029), with significant differences
between the treatment groups at both 3 and 12 months
[19]. This pattern was repeated for alcohol consump-
tion in a typical week with a significant main effect for
time (F = 4.59, P < 0.011) and significant interaction
for time and treatment (F = 3.30, P < 0.039) [19].
Within the studies conducted in various outpatient
clinics, the all-female study comparing assessment
interview plus brief intervention versus assessment
interview only found no significant differences between
treatment groups for all drinking outcomes at 12
months [20]. The mean difference in change in drinks
per drinking day (adjusted) was -0.06 (-0.3, 0.18)
P = 0.63; mean difference in change in percentage
drinking days (adjusted) was 3.0 (-0.1, 6.0) P = 0.07;
mean difference in change in number of binge episodes
(adjusted) was -2.2 (-4.9, 0.54) P = 0.11; and mean
difference in change in number of weeks exceeding
sensible drinking limits (adjusted) was 0.27 (-1.2,
0.65) P = 0.57. Similarly, the study set in a general
internal medicine outpatient clinic reported, at a mean
follow-up of 28 weeks, a reduction in alcohol consump-
tion over time but no significant differences between
the Dutch Motivational Drinkers Check-up (Doorlich-
ting, Voorlichting Alcoholgebruik; DVA) and the
control, routine hospital care [DVA change 0.81 (2.0);
control change 0.84 (2.61) units per day, P = 0.46]
[21].There were no differences in percentage change of
carbohydrate-deficient transferrin (appears in serum
after high alcohol intake, where some of the transferrin
molecules appear to lack two to four of their terminal
tri-saccharides: hence the name carbohydrate-deficient
transferrin [26]) [DVA change 0.052 (0.32); control
change 0.051 (0.88), P = 0.69] [21].
Conversely, the study conducted in five different out-
patient clinics comparing assessment and frequent
follow-ups and feedback versus no contact [22] found a
significant reduction in the mean amount of alcohol
consumed per week from 179 g ( 106 SD) to 117 g
( 101 SD) (P < 0.005) in the intervention group at 12
months but did not report changes in the control group.
In the intervention group, gamma glutamyl transfease
(a well-established biomarker of excessive alcohol con-
sumption and liver dysfunction [27]) values were also
significantly reduced from baseline but did not differ
significantly from those of the controls.
Alcohol questionnaire scores. Assessing hazardous
drinking using the Alcohol Use Disorders Identification
Test questionnaire (AUDIT), Smith et al. [19] found
that in the intervention group, the percentage of haz-
ardous drinkers dropped from 95% at baseline to 58%
at 12-month follow-up. The corresponding figures in
the control group were 96% and 81%. The same
authors found a main effect of time (F = 98.32.
P < 0.001) but no effect of intervention in terms of
Brief Alcohol Problem Questionnaire scores [19].
Outpatient alcohol and drug interventions 359
© 2013 Australasian Professional Society on Alcohol and other Drugs
- 114 -
T
ab
le
1.
S
um
m
ar
y
of
th
e
st
ud
ie
s
co
nd
uc
te
d
in
ou
tp
at
ie
nt
se
tti
ng
s
in
cl
ud
ed
in
th
e
re
vi
ew
A
ut
ho
rs
(y
ea
r)
A
lc
oh
ol
or
dr
ug
m
is
us
e?
C
ou
nt
ry
,
sc
re
en
in
g
se
tt
in
g
P
ar
ti
ci
pa
nt
s:
nu
m
be
r
ra
nd
om
is
ed
(%
m
al
e)
;
m
ea
n
ag
e;
ba
se
lin
e
da
ta
In
te
rv
en
ti
on
an
d
co
nt
ro
l
O
ut
co
m
es
as
se
ss
ed
G
oo
da
ll
et
al
.
(2
00
8)
[1
8]
A
lc
oh
ol
U
K
T
hr
ee
or
al
an
d
m
ax
ill
of
ac
ia
l
ou
tp
at
ie
nt
cl
in
ic
s
n
=
19
5
(9
1%
m
al
e)
;
M
ed
ia
n
ag
e
=
38
fo
r
w
om
en
;
28
fo
r
m
en
;
A
U
D
IT
sc
or
e
8–
40
(m
ed
ia
n
15
);
72
%
ha
d
be
en
as
sa
ul
te
d
In
te
rv
en
ti
on
:
B
ri
ef
In
te
rv
en
ti
on
(m
ot
iv
at
io
na
l)
de
liv
er
ed
by
re
se
ar
ch
nu
rs
e:
no
fu
rt
he
r
de
ta
il
gi
ve
n
C
on
tr
ol
:
S
ta
nd
ar
d
al
co
ho
l
in
fo
rm
at
io
n
le
afl
et
A
t
3
an
d
12
m
on
th
s:
N
um
be
r
of
dr
in
ki
ng
da
ys
in
th
e
pa
st
30
da
ys
N
um
be
r
of
ab
st
in
en
t
da
ys
in
th
e
pa
st
30
da
ys
N
um
be
r
of
he
av
y
dr
in
ki
ng
da
ys
.
N
um
be
r
of
st
an
da
rd
dr
in
ks
/d
ri
nk
in
g
da
y.
S
m
it
h
et
al
.
(2
00
3)
[1
9]
A
lc
oh
ol
U
K
O
ra
l
an
d
m
ax
ill
of
ac
ia
l
su
rg
er
y
de
pa
rt
m
en
t
ou
tp
at
ie
nt
cl
in
ic
n
=
15
1
(1
00
%
m
al
e)
;
M
ea
n
ag
e
=
24
;A
U
D
IT
>
95
.4
%
sc
or
ed
ov
er
8;
B
A
P
Q
—
55
.7
%
sc
or
ed
be
tw
ee
n
2
an
d
6;
A
D
D
-S
F
—
72
.2
%
cl
as
se
d
as
lo
w
-l
ev
el
de
pe
nd
en
ce
,
21
.2
%
m
ed
iu
m
-l
ev
el
,
2.
7%
hi
gh
-l
ev
el
;
80
%
of
in
ju
ri
es
w
er
e
as
sa
ul
t
re
la
te
d
In
te
rv
en
ti
on
:
M
ot
iv
at
io
na
l
In
te
rv
ie
w
in
g:
du
ra
ti
on
an
d
in
te
ns
it
y
un
kn
ow
n,
de
liv
er
ed
by
tw
o
se
ni
or
ge
ne
ra
l
nu
rs
es
C
on
tr
ol
:
U
su
al
ca
re
A
t
3
an
d
12
m
on
th
s:
A
U
D
IT
B
ri
ef
A
lc
oh
ol
P
ro
bl
em
s
Q
ue
st
io
nn
ai
re
(B
A
P
Q
)
(fi
ve
it
em
s)
S
ho
rt
-F
or
m
A
lc
oh
ol
D
ep
en
de
nc
e
D
at
a
(A
D
D
-S
F
)
90
I
dr
in
k
di
ar
y
se
ct
io
n—
al
co
ho
l
co
ns
um
pt
io
n
in
pa
st
3
m
on
th
s
D
et
ai
ls
of
lif
e
ev
en
ts
C
ha
ng
et
al
.
(2
01
1)
[2
0]
A
lc
oh
ol
U
S
A
O
ut
pa
ti
en
t
cl
in
ic
s
at
a
w
om
en
’s
ho
sp
it
al
n
=
51
1
(0
%
m
al
e)
;
m
ea
n
ag
e
=
45
.1
;
m
ea
n
dr
in
k
pe
r
dr
in
ki
ng
da
y
=
2.
2;
m
ea
n
pe
rc
en
ta
ge
dr
in
ki
ng
da
ys
=
23
;
m
ea
n
nu
m
be
r
of
bi
ng
e
ep
is
od
es
=
7.
35
;
m
ea
n
w
ee
ks
>
st
an
da
rd
da
ily
lim
it
s
=
3.
8
In
te
rv
en
ti
on
:A
n
as
se
ss
m
en
t
in
te
rv
ie
w
an
d
B
ri
ef
In
te
rv
en
ti
on
(3
0
m
in
s)
de
liv
er
ed
by
ph
ys
ic
ia
n
an
d
in
te
rv
ie
w
s
at
3,
6
&
12
m
on
th
s
C
on
tr
ol
:A
n
as
se
ss
m
en
t
in
te
rv
ie
w
w
it
h
a
si
ng
le
12
-m
on
th
in
te
rv
ie
w
to
ob
ta
in
fo
llo
w
-u
p
da
ta
A
t
3,
6
an
d
12
m
on
th
s
fo
r
B
ri
ef
In
te
rv
en
ti
on
gr
ou
p
an
d
at
12
m
on
th
s
fo
r
co
nt
ro
l
gr
ou
p:
M
ea
n
dr
in
ks
pe
r
dr
in
ki
ng
da
y
P
er
ce
nt
ag
e
dr
in
ki
ng
da
ys
N
um
be
r
of
bi
ng
e
ep
is
od
es
(f
ou
r
or
m
or
e
dr
in
ks
pe
r
oc
ca
si
on
)
N
um
be
r
of
w
ee
ks
ex
ce
ed
in
g
N
at
io
na
l
In
st
it
ut
e
on
A
lc
oh
ol
A
bu
se
an
d
A
lc
oh
ol
is
m
(N
IA
A
A
)
st
an
da
rd
da
ily
lim
it
s.
E
m
m
en
et
al
.
(2
00
5)
[2
1]
A
lc
oh
ol
T
he
N
et
he
rl
an
ds
G
en
er
al
in
te
rn
al
m
ed
ic
in
e
ou
tp
at
ie
nt
cl
in
ic
n
=
12
3
(7
6%
m
al
e)
;
37
%
pr
ob
ab
le
or
ce
rt
ai
n
al
co
ho
l-
re
la
te
d
m
ed
ic
al
di
ag
no
si
s;
m
ea
n
ag
e
=
50
.0
in
in
te
rv
en
ti
on
gr
ou
p;
47
.9
in
co
nt
ro
l
gr
ou
p
In
te
rv
en
ti
on
:
B
ri
ef
M
ot
iv
at
io
na
l
In
te
rv
en
ti
on
an
d
as
se
ss
m
en
t
(9
0
m
in
)
an
d
fe
ed
ba
ck
(6
0
m
in
)
se
ss
io
n
1–
2
w
ee
ks
la
te
r
C
on
tr
ol
:
U
su
al
ca
re
F
ol
lo
w
-u
p
at
23
–3
6
w
ee
ks
(m
ea
n
28
w
ee
ks
;
S
D
=
2.
39
,
ra
ng
e
23
–3
6)
:
S
el
f-
re
po
rt
ed
ch
an
ge
in
al
co
ho
l
co
ns
um
pt
io
n
as
un
it
s/
da
y
C
ha
ng
e
in
ca
rb
oh
yd
ra
te
-d
efi
ci
en
t
tr
an
sf
er
ri
n
fr
om
ba
se
lin
e
C
ha
ng
e
in
re
ad
in
es
s
to
ch
an
ge
dr
in
ki
ng
be
ha
vi
ou
r
R
ed
uc
ti
on
s
fr
om
ab
ov
e
to
be
lo
w
he
al
th
lim
it
s
360 J. M. Watson et al.
© 2013 Australasian Professional Society on Alcohol and other Drugs
- 115 -
P
er
ss
on
&
M
ag
nu
ss
on
(1
98
9)
[2
2]
A
lc
oh
ol
S
w
ed
en
F
iv
e
di
ff
er
en
t
ou
tp
at
ie
nt
cl
in
ic
s
n
=
78
(7
8%
m
al
e)
;
58
(7
4%
)
de
fin
it
e
pr
ob
le
m
dr
in
ki
ng
;
20
(2
6%
)
pr
ob
ab
le
pr
ob
le
m
dr
in
ki
ng
;
m
ea
n
ag
e
no
t
st
at
ed
In
te
rv
en
ti
on
:
P
hy
si
ca
l
ex
am
in
at
io
n
an
d
cl
in
ic
al
as
se
ss
m
en
t.
M
on
th
ly
fo
llo
w
-u
p
fo
r
12
m
on
th
s
by
he
al
th
pr
of
es
si
on
al
s
w
he
re
al
co
ho
l
co
ns
um
pt
io
n
an
d
la
bo
ra
to
ry
va
lu
es
w
er
e
di
sc
us
se
d
an
d
fe
ed
ba
ck
w
as
gi
ve
n.
C
on
tr
ol
:
N
o
in
it
ia
l
co
nt
ac
t
an
d
no
di
sc
us
si
on
ab
ou
t
al
co
ho
l
A
t
12
m
on
th
s:
C
ha
ng
e
in
al
co
ho
l
co
ns
um
pt
io
n
S
ic
kn
es
s
be
ne
fit
s
V
is
it
s
to
ou
tp
at
ie
nt
cl
in
ic
s.
H
os
pi
ta
l
ad
m
is
si
on
s
L
ab
or
at
or
y
pa
ra
m
et
er
s
B
er
ns
te
in
et
al
.
(2
00
5)
[2
3]
D
ru
gs
U
S
A
T
hr
ee
ou
tp
at
ie
nt
cl
in
ic
s
(U
rg
en
t
ca
re
,
W
om
en
’s
C
lin
ic
,
H
om
el
es
s
C
lin
ic
)
n
=
11
75
(7
0.
6%
m
al
e)
;
46
%
w
er
e
ho
m
el
es
s;
83
%
no
t
cu
rr
en
tl
y
w
or
ki
ng
;
m
ea
n
ag
e
=
37
.8
in
in
te
rv
en
ti
on
gr
ou
p;
38
.1
in
co
nt
ro
l
gr
ou
p
In
te
rv
en
ti
on
:
M
ot
iv
at
io
na
l
In
te
rv
ie
w
(1
0
to
45
m
in
-
av
er
ag
e
20
m
in
)
ta
ilo
re
d
to
in
di
vi
du
al
,
ac
ti
ve
re
fe
rr
al
s
an
d
w
ri
tt
en
ha
nd
-o
ut
an
d
de
liv
er
ed
by
pe
er
s
(e
xp
er
ie
nc
ed
su
bs
ta
nc
e
ab
us
e
ou
tr
ea
ch
w
or
ke
rs
in
re
co
ve
ry
).
B
oo
st
er
ph
on
e
ca
ll
10
da
ys
la
te
r
(5
–1
0
m
in
s)
C
on
tr
ol
:W
ri
tt
en
ha
nd
-o
ut
on
ly
A
t
6
m
on
th
s:
A
bs
ti
ne
nc
e
fr
om
co
ca
in
e
an
d/
or
he
ro
in
as
m
ea
su
re
d
by
ra
di
oi
m
m
un
oa
ss
ay
of
ha
ir
(a
ls
o
re
du
ct
io
n
in
us
e)
C
on
ta
ct
s
w
it
h
su
bs
ta
nc
e
ab
us
e
tr
ea
tm
en
t
sy
st
em
A
dd
ic
ti
on
S
ev
er
it
y
In
de
x
G
ilb
er
t
et
al
.
(2
00
8)
[2
4]
A
lc
oh
ol
an
d
dr
ug
s
U
S
A
F
iv
e
ou
tp
at
ie
nt
H
IV
cl
in
ic
s
n
=
47
6
(7
9%
m
al
e)
;
m
ea
n
ag
e
=
44
.1
;
18
2
(3
9%
)
re
po
rt
ed
ri
sk
y
dr
in
ki
ng
;
20
0
(4
2%
)
re
po
rt
ed
ill
ic
it
dr
ug
us
e
In
te
rv
en
ti
on
:
T
ai
lo
re
d
ri
sk
-r
ed
uc
ti
on
co
un
se
lli
ng
fr
om
a
‘V
id
eo
D
oc
to
r’
pr
og
ra
m
m
e,
pr
in
te
d
w
or
ks
he
et
an
d
di
sc
us
si
on
w
it
h
he
al
th
pr
of
es
si
on
al
.
B
oo
st
er
se
ss
io
n
af
te
r
3
m
on
th
s
C
on
tr
ol
:
U
su
al
ca
re
A
t
3
an
d
6
m
on
th
s:
C
es
sa
ti
on
ve
rs
us
an
y
on
go
in
g
ri
sk
y
be
ha
vi
ou
r
(i
lli
ci
t
dr
ug
us
e;
ri
sk
y
dr
in
ki
ng
;
un
pr
ot
ec
te
d
an
al
or
va
gi
na
l
se
x)
Outpatient alcohol and drug interventions 361
© 2013 Australasian Professional Society on Alcohol and other Drugs
- 116 -
Health-care utilisation. Persson and Magnusson did
not find a significant difference between groups in
terms of health-care consultations, and due to the small
number, were unable to analyse admissions to hospital
wards [22].
Motivation/readiness to change. Emmen et al. found
that although in total, 32% of those patients who were
drinking above health limits at follow up did change to
a high motivational stage, no statistically significant dif-
ferences between the two groups were found (interven-
tion group 39.3%, control group 25.0%, P = 0.091)
[21].
Interventions for drug misuse
We identified only one study evaluating interventions
for drug misuse in an outpatient setting [23] where
motivational interviewing plus a hand-out and a follow-
ing booster session was compared with a control (hand-
out only). Participants were mostly male (70.6%), and
those undergoing treatment for drug abuse were
excluded [23].
Effectiveness of the evaluated intervention for drug misuse
Abstinence. Participants who had received the motiva-
tional interview, hand-out and booster telephone call
were more likely than the controls to be abstinent at 6
months from cocaine [22.3% vs. 16.9%, odds ratio
(OR) 1.51; 95% confidence interval (CI) 1.01, 2.24,
P = 0.045] and from opiates (40.2% vs. 30.6%, OR
1.57; 95% CI 1.00, 2.47, P = 0.050) [23]. Abstinence
from both drugs did not differ between groups (17.4%
vs. 12.8%, OR 1.51; 95% CI 0.98, 2.26, P = 0.052)
[23].
Reduction in drug levels and self-reported contact with
treatment services. Although levels of cocaine and
heroin measured in hair samples were significantly
lower at follow-up for the whole study sample, the
differences between groups on levels of cocaine merely
bordered on significance, and there was no significant
difference for heroin. No differences were seen between
groups regarding contact with substance abuse treat-
ment services at 6 months (39% in intervention group,
37% in the control group). For the majority, however,
this consisted of detoxification only. In all Addiction
Severity Index subscale scores, both the intervention
and control groups improved. On the drug subscale,
there was a 49% reduction in the intervention group
and a 46% reduction in the control group (P = 0.06),
and on the medical subscale, a 56% reduction in the
intervention group and 50% reduction in the control
group (P = 0.055) [23].
Interventions for alcohol and drug misuse
Only one study investigating the effectiveness of inter-
ventions for both excessive alcohol and illicit drug use
in outpatient settings was identified [24]. The study
evaluated a Positive Choice ‘Video Doctor’ intervention;
a laptop-based interactive programme with risk-
reduction messages based on the principles of Motiva-
tional Interviewing [24]. This was followed up by a
booster session 3 months after the first session. An
‘Educational Worksheet’ was given to the patient with
questions for self-reflection, harm reduction tips and
local resources. A ‘Cueing Sheet’ allowed the health
professional to indicate whether a discussion had taken
place on the various areas. The intervention was tai-
lored to participant’s gender, risk profile and readiness
to change. The control group did not use the ‘Video
Doctor’ nor receive the Educational Worksheet and
Cueing Sheet. Instead, after the risk assessment, they
received usual care [24].
There was no exclusion criterion for very heavy/
dependent drinkers, or dependent drug users and none
specified for those who had previously received or were
currently receiving treatment for excessive alcohol
and/or illicit drug use [24]. Information was not
reported on the proportion of participants who fell into
these categories.
Effectiveness of the evaluated intervention for alcohol and
drug misuse
The authors reported that the intervention group was
statistically significantly less likely than the usual care
group to report any ongoing drug use at 3 months
(67% vs. 82%, relative risk (RR) 0.81, 95% CI: 0.689,
0.957, P = 0.014) and at 6 months (56% vs. 86%, RR
0.65, 95% CI: 0.540, 0.785, P < 0.001) [24]. There
was, however, no statistically significant different
between the groups at both those time points on: reduc-
tion in total days of any drug use in the previous month
and cessation of risky drinking [24].
Study quality and fidelity (Table 2)
Of the two alcohol trials set in oral and maxillofacial
outpatient settings, the study by Smith et al. [19]
appeared to be of better quality than that of Goodall
et al. [18]. Although dropouts did occur in both trials,
Smith et al. [19] clearly reported dropout reasons
(19%), whereas Goodall et al. did not (31%) [18].
Goodall et al. also failed to make it clear as to whether
they had used intention-to-treat analysis.
Of the three alcohol trials set in general outpatient
settings [20–22], only one provided a power calculation
to determine sample size [21]. None clearly explained
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the methods of randomisation or allocation conceal-
ment, nor were any outcome assessors blinded [20–22].
Emmen et al. [21] did not conduct adequate follow-up
(12 months), although intention-to-treat analysis was
used and reasons for dropout was explained. Dropout
was reported by Chang et al. [20] as 4% and 9% in the
trial by Emmen et al. [21].
In the drug study conducted by Bernstein et al., allo-
cation concealment was not adequately reported [23].
The study only had a 6-month follow-up (dropout of
18%) and did not use an intention-to-treat analysis
[23]. When reporting their alcohol and drugs study,
Gilbert et al. provided the most information [24],
although follow-up was only for 6 months and loss to
follow-up at the end of the study was 17.6% [24].
With regard to fidelity, Smith et al. described the
training given to the interventionists and how they had
maintained intervention fidelity through supervision
and review of audio-taped intervention sessions [19].
Goodall et al. reported only training of interventionists
[18]. Both Chang et al. and Emmen et al. reported
methods used to ensure intervention fidelity (including
training staff and reviewing interventions using obser-
vations or checklists) [20,21]. Persson and Magnusson
did not report any such measures of intervention fidel-
ity [22].
In the trial conducted by Bernstein et al., extensive
attempts were made to ensure the integrity and fidelity
of the interventions delivered [23].These included role-
plays, supervised patient interviews and form comple-
tion demonstrating completion of key elements of the
intervention. In the study by Gilbert et al., the interven-
tion used a computerised ‘Video Doctor’, which stand-
ardised messages, which the authors report may have
helped increase fidelity to the principles of Motivational
Interviewing [24].
Discussion
The objective of this review was to identify the inter-
ventions for alcohol or illicit drug misuse problems
evaluated for hospital outpatient populations and deter-
mine, from the available evidence, which of these
interventions can be effectively delivered for these
populations.
Interventions for alcohol misuse
The results from this review suggest that interventions
based on motivational techniques may be effective
among patients with alcohol problems identified in
oral–maxillofacial clinics. However, the optimum
nature and duration of the intervention in this popula-
tion group is unclear and would be worthy of further
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research. Nor is it clear if women would respond
equally to the intervention as the samples comprised
mainly of men.
The three other trials [20–22], conducted in diverse
settings, did not generally find positive effects of brief
interventions to decrease alcohol consumption and
related outcomes. Chang et al. suggest their findings
were due to reactivity to the assessment that lasted an
hour; regression to the mean; and presence of medical
conditions that may motivate changes in drinking in
both groups [20]. Similarly, the study by Emmen et al.
also included a lifestyle assessment that was received by
both groups [21].
Nonetheless, these findings cannot be taken as
definitive as most of the trials had weaknesses, includ-
ing issues with randomisation and inadequate
follow-up periods. Importantly, most of the studies
failed to provide adequate detail about the intervention
content, duration, intensity and delivery. Such lack of
clarity raises issues when trying to compare interven-
tions. There is a need for further good quality studies
with adequate follow-up and full reporting of interven-
tion content. The authors of the included studies also
identified issues that need to be taken into account in
the planning of future research. These are: reactivity to
the assessment, the possible exclusion of those with
severe alcohol dependence and ensuring that controls
do not receive part of the intervention.The evidence is,
therefore, currently insufficient to state whether or not
interventions to reduce alcohol consumption and
related outcomes are helpful in general outpatient
settings.
The transferability of findings from other health-care
settings, including inpatient and emergency settings
with their different systems, into an outpatient setting is
not clear, but it may be interesting to compare our
findings with that of primary care where both settings
provide a similar type of time-limited consultation situ-
ation. A review conducted by Kaner et al. [28] consid-
ered studies evaluating the effectiveness of brief
interventions delivered in primary care settings, pub-
lished up to early 2007.Their meta-analysis of 22 RCTs
found that intervention participants had lower alcohol
consumption than control participants after follow-up
of 1 year. However, the benefits for women were
unclear, and the authors recommended further
research to establish the most effective components of
brief interventions.
We are aware of two ongoing trials evaluating inter-
ventions for alcohol misuse in outpatient settings that
have not yet reported results [29,30]. One of these is an
intensive three-arm family-based intervention study for
young people [30], comparing a Multidimensional
Family Therapy [an outpatient family-based treatment
for troubled youths of 3 months duration with an
average of two sessions (60–90 min) per week with
additional extra-familial work and phone contacts as
needed], Family Motivational Interviewing (two home
sessions within 72 h of the incident, and link with group
treatment lasting 3 months) and standard care (two
90-min group sessions per week for 3 months). The
other is in HIV-positive women [29], looking to
compare a brief counselling intervention including two
sessions that review drinking patterns and behaviour
change strategies, plus two telephone calls to reinforce
session content versus standard care. There is a clear
need for trials of interventions for alcohol misuse in
outpatient settings.
Interventions for drug misuse
The evidence for interventions to reduce drug misuse
in hospital outpatient settings is limited to one trial
[23], and currently, the evidence is insufficient to allow
any conclusions to be derived about effectiveness. The
suggestion that motivational interviewing with a
booster call might be more effective than written advice
for adults in outpatient settings would be strengthened
by a trial with longer follow-up (12 months or more)
analysed on an intention-to-treat basis. Further
research is necessary. There appears to be no ongoing
research investigating interventions for drug misuse in
outpatient settings.
Interventions for both alcohol and drug misuse
The evidence on interventions to address both alcohol
and drug problems in outpatient settings is limited to
one trial [24], which showed an impact on ongoing
drug use but not on cessation of risky drinking. More
studies evaluating this intervention are needed, and
therefore it is not yet possible to draw conclusions on
the effectiveness of interventions for both alcohol and
drug use in this setting with adults or young people.
Further research is needed to consider the effectiveness
of combined interventions for alcohol and drug misuse
across in outpatient settings, particularly as we did not
identify any ongoing research investigating interven-
tions for both alcohol and drug misuse in this setting.
Interventions for drugs alone and drugs in addition
to alcohol appear to be very under-researched areas,
and there is a need for much more practical ground-
work in terms of identifying likely areas where
approaching these groups may be feasible and research
achievable.
Poor reporting of methodology, including randomi-
sation and allocation concealment procedures, is a
common problem across the clinical trial literature
[31]. Follow-up was too short (<12 months) in three
studies reviewed here [21,23,24], making it difficult to
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determine long-term effects. The lack of detail and
clarity regarding the actual content of interventions,
duration, delivery mode and personnel delivering the
treatment was challenging. Additionally, it was often
unclear on what theoretical framework the interven-
tions were based or the behavioural techniques actually
used. Related to this is the reporting of intervention
fidelity, crucial for complex interventions. Adherence to
an intervention delivery protocol can influence effec-
tiveness [32–36]. Ensuring fidelity can reduce the risk
of erroneous conclusions such as concluding that the
intervention is ineffective, when in fact it was not imple-
mented correctly [37,38]. Across this review, reporting
was mixed.
In addition, where studies appeared to have used the
same type of intervention (e.g. motivational interview-
ing), the interpretation of that intervention can be very
different. Even where core principles are used, differ-
ences may occur in the delivery of the intervention
(timing, duration, intensity and interventionist),
although often it was difficult to tell differences and
similarities due to lack of reported detail.
The range of outcomes investigated in the included
studies demonstrates the variety of measures for alcohol
consumption currently utilised, and it would be benefi-
cial to reach consensus on the most useful measures.
Additionally, various authors have highlighted the issue
of assessment reactivity [39,40], a feature that should
not be ignored and given due consideration in study
design and analysis. In outpatient settings, where most
are not actively seeking treatment for their alcohol con-
sumption, and additional health problems may be con-
tributing to their reason for attendance, identification
and recruitment of research participants may be a likely
problem and one where screening and assessment can
play an important part.
Future studies should bear in mind the quality issues
highlighted in the review of the current evidence. In
addition, the theoretical framework on which the inter-
ventions are based, as well as the behaviour change
mechanisms underpinning them, should be reported.
Attention is also required regarding who should deliver
the intervention, mode of delivery, level of patient
contact and intervention intensity. It would be of inter-
est in future to investigate the effect on outcomes other
than alcohol or drug consumption (e.g. injury rates and
criminal offences). Studies exploring how particular
subgroups respond differently to the intervention (e.g.
women and dependent drinkers) would be worth atten-
tion, as would the impact of interventions on social
health inequalities. Practitioners may want to give some
consideration to particular initiatives aimed at areas
where there are high levels of specific alcohol problems
(e.g. injuries). Researching implementation schemes
that deliver interventions in such areas and that are
geared towards local needs may prove highly interest-
ing. In addition, with none of the included studies
incorporating a cost-effectiveness analysis, more
thought needs to be given to this aspect of alcohol/drug
misuse prevention interventions in outpatient settings.
Strengths and weakness of this review
This review was conducted according to national guid-
ance [14]. Searches included electronic and print
sources and of grey literature. As interventions for
alcohol and drug misuse are an active area of primary
research, authors of ongoing and unpublished studies
were contacted, and details of these are included. Study
selection, data extraction and quality assessment were
conducted by more than one reviewer with disagree-
ments resolved by consensus or referral to the project
team. Therefore, our results should have a low risk of
bias. Despite our best efforts, it is possible that studies
have been missed particularly those reported in lan-
guages other than English.
Conclusions
Further research is needed to investigate interventions
for alcohol and drug misuse in outpatient settings. The
type of intervention(s) needed to reduce consumption
of alcohol and/or drugs for different groups of patients
in diverse hospital settings is still to be determined.
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COMPREHENSIVE REVIEW
Predictors of study setting (primary care vs. hospital setting) among
studies of the effectiveness of brief interventions among heavy
alcohol users: A systematic review
NOREEN DADIRAI MDEGE1 & JUDITH WATSON1,2
1Addiction Research Group, Department of Health Sciences, University ofYork, York, UK, and 2York Trials Unit,
Department of Health Sciences, University ofYork, York, UK
Abstract
Issues. The aim of this study is to compare studies by their setting in order to identify design differences between studies on
brief interventions (BI) for heavy alcohol use conducted in primary care and those in hospital settings. Approach. Potential
studies were extracted from 16 reviews and from systematically searching literature up to October 2011.We assessed whether the
following factors were statistically significant predictors of study setting: exclusion of very heavy/dependent drinkers; mean age
of study sample; gender composition of study samples; sample size; total intervention delivery time; number of sessions;
interventionist (physician vs. non-physician); various study design and intervention fidelity aspects; accounting for screening/
assessment reactivity; and control condition utilised. Key Findings. Seventy-six studies (30 in primary care and 46 in
hospital settings) met the inclusion criteria.The following factors were statistically significant predictors of study setting: number
of sessions {odds ratio [OR] = 0.281 [95% confidence interval (CI) 0.081, 0.979; P = 0.046]}, exclusion of very heavy/
dependent drinkers [OR = 0.052 (95% CI 0.004, 0.716,P = 0.027)] and gender composition of study samples [OR = 1.063
(95% CI 1.005, 1.125; P = 0.033)]. Implications. Researchers developing hospital setting BIs for excessive alcohol
consumption should take into account methodological issues that could explain differences in the consistency of findings between
hospital setting studies and primary care setting studies where BIs have been more consistently found effective in reducing alcohol
use. Conclusion. The observed study design differences between hospital and primary care settings might partly explain the
disparity in the consistency of findings on effectiveness of BIs between these settings. [Mdege ND, Watson J. Predictors of
study setting (primary care vs. hospital setting) among studies of the effectiveness of brief interventions among heavy
alcohol users: A systematic review. Drug Alcohol Rev 2013;32:368–380]
Key words: brief intervention, primary care, hospital, effectiveness, systematic review.
Introduction
Opportunistic screening and brief interventions (BI)
have been more consistently found effective in reducing
alcohol use in patients with excessive alcohol consump-
tion in primary care settings than in hospital settings.
As a result, systematic reviews have concluded that BIs
are effective in reducing alcohol use in patients with
excessive alcohol consumption in primary care settings
[1–3], whereas most systematic reviews of studies con-
ducted in hospital settings have reported inconclusive
findings [4–6]. BIs have therefore been advocated as
part of population alcohol strategies in primary care
settings [7]. On the other hand, it is unclear whether
they should be encouraged in hospital settings even
though these settings provide an opportunity to engage
with heavy drinkers [8], especially those who might not
be well represented in primary care settings such as
men [9,10]. Some differences in the consistency of
outcomes between these settings in general could
indeed be due to the contextual differences in the loca-
tions from which patients are identified, interventions
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are delivered, as well as variations in patient popula-
tions, intervention characteristics and study research
methods [6]. Some of these issues are discussed below.
Intervention characteristics
The term ‘brief intervention’ has been used to describe
a heterogeneous family of interventions of varying
intensity, duration, mode of delivery (e.g. computer
based, face to face), as well as personnel delivering the
intervention [11,12]. These factors can influence the
effectiveness of an intervention. For example, effective-
ness may differ between multiple and single session
interventions [5]. BIs can be delivered by different pro-
fessionals, including nurses, physicians, psychologists
or substance abuse specialists. Huibers et al. suggest
that physician delivered interventions in primary care
setting could work better than non-physician-delivered
interventions because of an already established rela-
tionship between physician and patient and familiarity
with physician’s office rather than visiting an unknown
non-physician primary care worker [13]. A recent
review of non-physician-delivered BIs reported a
modest intervention effect, with a pooled effect size
smaller than that observed for other clinician-based
interventions in primary care settings [but within the
95% confidence intervals (CI) (1.7 vs. 2.7 (95% CI
1.6-3.9) fewer standard drinks per week)] [14].
Screening/assessment reactivity
Identifying eligible patients for BIs often involves the
self-reporting of alcohol consumption behaviour
through completion of screening or assessment ques-
tionnaires, which may in itself lead to self-reflection and
reduction in alcohol consumption [15,16]. This phe-
nomenon, often referred to as reactivity, has been high-
lighted as one possible explanation in studies where all
participants complete such screening/assessment ques-
tionnaires, and the whole sample reduces their alcohol
consumption with no significant difference observed
between groups [5]. A recent systematic review of
studies specifically designed to test reactivity however
only found equivocal evidence of small effects on some
outcomes, such as Alcohol Use Disorders Identification
Test (AUDIT) score and total weekly drinking but not
others such as quantity per drinking day [16]. A recent
study by Hester et al. among college students provides
strong experimental evidence of the possibility of
screening/assessment reactivity, in addition to typical
spontaneous comments such as ‘I never realised how
much I was drinking’ or ‘I never added it all up before’
made by participants in the control group after their
assessments [17]. Although randomisation may protect
the true intervention effect if reactivity is similar
between groups, it is possible for screening and assess-
ment to interact with an intervention, either strength-
ening or weakening its effects [18,19].
Some studies minimise the impact of screening/
assessment reactivity by masking the alcohol focus
through ‘camouflaging’ the alcohol questions within a
broader health survey, or blinding participants to the
study hypothesis [20,21]. However, because most of the
interventions are alcohol focused, with time, partici-
pants may deduce that the study is about alcohol. Some
studies have used trial designs with at least three arms
to assess both intervention effectiveness and the impact
of screening/assessment [16].
Intervention fidelity
Adherence to intervention delivery protocol can influ-
ence effectiveness [22–24]. Ensuring fidelity can reduce
the risk of erroneous conclusions such as concluding
that the intervention is ineffective, when in fact it was
not implemented correctly [25,26]. However, the
dynamic, individualised and flexible nature of most
psychotherapies (such as BIs), usually seen as a
strength, also makes them difficult to evaluate in the
context of a clinical trial [27]. This is due to problems
of developing, identifying, documenting and reproduc-
ing such complex interventions [28]. Some trial
designs, particularly effectiveness trials, do recognise
that in ‘real world settings’, the treatment will be imple-
mented less robustly, and therefore may leave imple-
mentation to vary according to contingencies of
practice [29]. Despite this, there are usually still core
components that need to be adhered to, and therefore
methods of capturing and presenting the dynamics of
the intervention should be included [30].
Procedures used to promote intervention fidelity
include use of treatment manuals and standardised
guidelines for intervention delivery, interventionist
training and supervision. In addition, verification of
intervention fidelity, consisting of procedures used to
assess and measure adherence to intervention delivery
protocol, can be conducted through: interventionist
observations, assessment of recorded intervention ses-
sions, interventionists self-report through evaluation
forms completed after consultations, interviews with
intervention recipients, as well as monitoring and
testing study participants’ acquisition of treatment
skills [24,26,29].
Sequence generation, allocation concealment, blinding and
incomplete data
Other methodological issues specific to trials may lead
to incorrect conclusions if not considered during study
design. These include: ensuring adequate random
sequence generation; allocation sequence concealment
to minimise selective enrolment; keeping participants,
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personnel and outcome assessor blinded to the inter-
vention received; and using statistical techniques, such
as intention to treat analysis to minimise risk of bias due
to incomplete data [31,32]. Adequate sequence genera-
tion has a random component that ensures participants
are assigned to different study treatment groups in a
truly random manner [33]. Adequate allocation con-
cealment prevents investigators from foreseeing inter-
vention allocations in advance of or during enrolment
and thereby ‘selecting’ which participant receives which
treatment [31,32]. Both, if inadequate, can lead to
exaggeration of estimates of intervention effect [32].
For BIs, although blinding of participant or personnel
delivering the intervention may not be feasible, blinding
of outcome assessors is possible. Incomplete outcome
data may result from some participants being omitted
from the analysis despite the outcome data being avail-
able, or attrition where outcome data for some partici-
pants is not available, for example, if they were lost to
follow-up [33]. This may result in bias if participants
excluded in one arm are systematically different from
those who are included in the analysis in that arm [32].
Patient characteristics
Differences in patient populations between studies can
result in disparity in findings. For studies on BIs,
including or excluding patients by level of alcohol con-
sumption, gender or age can potentially influence the
intervention’s effectiveness [5,34]. Although the effec-
tiveness of BIs for alcohol-dependent patients remains
unknown, many studies looking at BIs target non-
dependent patients, particularly in primary care set-
tings, based on the conjecture that dependent patients
would benefit from more intensive specialist treatment
[35]. Some studies however have not excluded patients
with very heavy alcohol consumption or dependence
[36–39]. One such study reported no BI benefits [40],
whereas another reported BI benefits [41], among
dependent drinkers. Although currently available evi-
dence is inconclusive on gender effects, in some cases
where data is available by gender, the effectiveness of
BIs is clear in men but not in women [3,5]. A number
of studies have explored the impact of age on the
effects of BIs on alcohol consumption, with some
reporting a significant impact [42], whereas others did
not [20,43–46].
Study design differences may exist between studies
conducted in primary care and those in hospital set-
tings because of differences in operational realities and
patient population [47]. For example, more studies in
hospital than primary care settings might have explored
if BIs can be effectively delivered by non-physicians.
When compared with physicians in primary care,
because of less control over patient volume and flow,
physicians in hospital settings may have more con-
strains regarding time to address the patient’s drinking
if not their main reason for the hospital visit [47]. In
addition, differences in staff and skills mix may exist
between primary care and hospital settings. In the UK,
for example, there are specialist alcohol workers within
many general hospital settings, unlike primary care set-
tings where general practitioners and practice nurses
are expected to deliver alcohol interventions [48,49].
Physicians in hospital settings therefore infrequently
provide interventions for alcohol problems, making it
more relevant to explore if BIs can be effectively deliv-
ered by non-physicians in this setting [14]. The estab-
lished relationship between patient and physician in the
primary care setting could make continued engagement
with patients easier when compared with the hospital
setting [13], particularly after patient discharge from
hospital.Thus, more studies conducted in primary care
could have evaluated BIs comprising of more than one
session with longer follow-up periods, compared with
the hospital setting where one-session BIs and shorter
follow-up periods may be more common. Hospital
populations generally have more severe medical condi-
tions and diseases than primary care [4]. For alcohol
problems, this could mean studies in hospital settings
deal with populations with higher proportions of very
heavy/dependent drinkers than primary care studies.
The aim of this review is to compare studies by their
setting in order to identify study design differences
between studies on BIs for heavy alcohol use conducted
in primary care settings and those in hospital settings.
Methods
Search strategy
We identified potential studies from reviews of studies
on BIs for alcohol problems in primary care
[1–3,14,35,50–53]; hospital settings, that is inpatient
medical care, trauma centres, hospital outpatients and
emergency departments [4,5,54,55]; and others that
were not specific to any particular setting [56–58].The
electronic databases CINAHL; The Cochrane Library
(including: Cochrane Database of Systematic Reviews;
Database of Abstracts of Reviews of Effects; Cochrane
Central Register of Controlled Trials; Health Technol-
ogy Assessment database); C2-SPECTR; EMBASE;
MEDLINE; and PsycINFO were also searched for
studies published until October 2011.The search string
used for MEDLINE is shown in Appendix 1. This was
adapted accordingly for use in each database.
Study selection criteria
We defined a brief intervention as comprising of one to
four sessions of engagement with a patient and the
provision of information/advice designed to reduce
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© 2013 Australasian Professional Society on Alcohol and other Drugs
- 125 -
risky alcohol consumption or alcohol-related problems
or to provide referral to additional care [34,35]. We
included controlled clinical trials and randomised con-
trolled trials that were comparing patients with
unhealthy alcohol use (as identified by screening)
receiving BIs, with patients receiving no intervention,
usual care or other active treatments. Studies were eli-
gible if set in: hospital inpatient, outpatient, accident
and emergency department; trauma centre; or primary
care settings. Studies recruiting adult participants aged
18 years and above, presenting to acute hospital settings
for any reason other than specifically for alcohol misuse
treatment, were included. We only included studies
published in English because we did not have the capa-
bility or resources for translating studies reported in
other languages into English.
Excluded studies were: focusing specifically on par-
ticipants with dual diagnosis (comorbidity or the
co-occurrence in the same individual of a psychoactive
substance use disorder and another psychiatric disorder)
and those conducted in specialist psychiatric facilities,
addiction services or addiction treatment programmes.
Study selection and data extraction strategy
Two reviewers independently screened all studies for
inclusion using the inclusion/exclusion criteria. Data
extraction was independently done by two reviewers.
Differences in selection decisions or data extraction
were resolved by discussion. Data extracted included
study methods, setting, participant characteristics,
intervention, comparators, outcomes, outcome meas-
ures and results.
Data analysis
We were interested in differences between hospital
setting studies and primary care studies in the following
factors: exclusion of very heavy/dependent drinkers;
mean age of study sample; gender composition of study
sample (measured as proportion of males); total time
taken delivering the intervention to each participant
(intervention duration); number of sessions; personnel
delivering the intervention (physician vs. non-
physician); adequate sequence generation, allocation
concealment, blinding of outcome assessor and dealing
with incomplete data; length of follow-up period;
sample size; use of a manual during intervention deliv-
ery, training interventionists, supervision of interven-
tionists and verification of intervention fidelity;
accounting for screening/assessment reactivity in the
study design; and the control condition utilised (usual
care/no intervention vs. a comparison between two
active interventions).
However, we anticipated the possibility of identify-
ing a small number of studies that would make the 18
covariates too many compared with the number of
observations. This could lead to a very large variation
in the estimates of the regression parameters, and
some parameters would not be estimated. Data analy-
sis was done using stata version 12 (StataCorp LP,
College Station, Texas, USA). Data were entered,
cleaned and checked for obvious errors, logical errors,
outliers and missing data documented, and descriptive
statistics computed. Separate regression models were
fitted to the data for each of the factors of interest
described above, with the factor of interest as the
independent variable and the study setting (hospital
settings = 1 and primary care settings = 0) as a
dependent variable [59]. For these separate regression
models, we used two-sided significance tests at the
25% significance level to select statistically significant
independent variables to include in a multiple logistic
meta-regression model. The multiple meta-regression
model was fitted in stata 12, and two-sided signifi-
cance tests at the 5% significance level were used.
After model fitting, diagnostics for checking fit and
outlying observations was done. The correlation
matrix of the independent variables included in the
multiple meta-regression model was also inspected.
Interpretation of the analytical results followed from
the fitted models.
For personnel delivering the intervention, where part
of the intervention was delivered by a physician and the
other by a non-physician, we classified the study under
physician delivery only if the major component(s) of the
interventions was delivered by the physician; otherwise,
it was classified under non-physician delivery. Person-
nel delivering the intervention was divided into physi-
cian versus non-physician due to the existence of
literature suggesting the effectiveness of an intervention
when delivered by a physician may differ from when it
is delivered by a non-physician [13,14].
The primary analysis considered the hospital setting
as a single group when in reality the emergency depart-
ment for example is likely to be different from inpatient
wards/units. A secondary analysis was therefore per-
formed exploring differences between studies con-
ducted among general hospital inpatient and those
conducted in the emergency department. This second-
ary analysis utilised the same analysis strategy as the
primary analysis but used two-sided significance tests at
the 20% significance level to select statistically signifi-
cant independent variables from the separate regression
models to include in a multiple logistic meta-regression
model. This was because using the 25% significance
level yielded too many covariates for the multiple logis-
tic meta-regression model compared with the number
of observations.
A sensitivity analysis was conducted for both the
primary and secondary analysis. For the primary analy-
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sis, two-sided significance tests at the 30%, 20% and
10% significance levels were used to select statistically
significant independent variables from the separate
regression models to include in multiple logistic meta-
regression. For the secondary analysis, only the 10%
significance level was used.
Results
Literature search and study selection
Figure 1 shows the flow of articles through the review
process. Of a total of 3705 records identified, 1244 were
duplicates and 2288 were irrelevant, resulting in 173
full-text articles that were assessed for eligibility.
Ninety-seven articles were ineligible (23 qualitative
studies; 17 reviews; 15 not evaluating BIs; 10 surveys;
seven in specialist settings; seven not primary research;
five recruited from multiple settings and results not
analysed by setting; five not controlled studies or ran-
domised controlled trials; four recruiting adolescents;
three recruited from community settings; one recruited
psychiatric patients. Seventy-six studies (30 studies in
primary care and 46 in hospital settings) met the inclu-
sion criteria. Of those conducted in hospital settings, 23
were in the emergency department, 18 for hospital
inpatients and five in hospital outpatients. None of the
assessed 173 full-text articles were excluded on the
3647 records identified through 
database searching 
58 records identified from previous 
reviews 
3705 total records   
1244 duplicates removed 
2288 irrelevant records excluded 
173 full-text articles assessed for eligibility 
76 studies included in the analysis 
97 full-text articles excluded due to: 
23 qualitative studies 
17 reviews 
15 not on brief interventions 
10 surveys 
15 not specifically in primary or hospital 
settings 
7 not primary research 
5 not a controlled clinical trial  
4 conducted among adolescents 
1 recruited psychiatric patients 
30 Primary care studies 46 Hospital setting studies: 
    23 emergency department 
    18 hospital inpatients 
      5 hospital outpatients 
Figure 1 Flow of articles through the systematic review process.
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basis of language. A list of the included studies is pro-
vided as Supporting Information Table S1 for online
publication.
Comparing primary care studies to hospital setting studies
The univariate logistic meta-regression with the 18
independent variables revealed 10 statistically signifi-
cant predictors (at 25% significance level) of whether a
study was conducted in hospital settings or in primary
care settings: personnel delivering the intervention
(physician vs. non-physician); number of sessions;
accounting for screening/assessment reactivity in the
study design; supervision of interventionists; verifica-
tion of intervention fidelity; length of follow-up period;
exclusion of very heavy/dependent drinkers; gender
composition of study sample (measured as proportion
of males); mean age of study sample; and dealing with
incomplete data (Table 1).
On analysis of the correlation matrix from the 10
independent variables, only one of the observed rela-
tionships was strong and statistically significant: verifi-
cation of intervention fidelity and supervision of
interventionists (r = 0.62; P < 0.0001). Verification of
intervention fidelity was included in the next analysis
stage as it is considered as the gold standard of evidence
of intervention fidelity [60], whereas supervision of
interventionists, which is only one of the elements for
Table 1. Descriptive statistics and results from the univariate regression models for the 18 potential predictors (characteristics) of study
setting as independent variables
Characteristic Primary care Hospital settings
Odds ratiosa
(95% CI) P-value
Age, mean (SD) 41.61 (9.35)
n = 25
37.69 (8.93)
n = 35
0.95 (0.89, 1.01) 0.113
Mean proportion of male participants,
mean (SD)
62.93% (26.89)
n = 29
76.58% (17.34)
n = 44
1.03 (1.00, 1.06) 0.020
Sample size: mean (SD) 323.20 (266.91)
n = 30
374.59 (327.39)
n = 46
1.00 (0.999, 1.002) 0.471
Exclusion of dependent/heavy drinkers,
n/N (%).
21/30 (70%) 10/46 (22%) 0.12 (0.04, 0.34) <0.001
Intervention duration, mean (SD) 37.87 (31.66)
n = 23
38.60 (30.23)
n = 35
1.00 (0.98, 1.02) 0.928
Number of sessions, median (range) 2 (1–4)
n = 30
1 (1–4)
n = 44
0.39 (0.21, 0.70) 0.002
Interventionist, proportion with
physicians as interventionists (%)
17/30 (57%) 2/46 (4%) 0.035 (0.007, 0.171) <0.001
Adequate sequence generation,
proportion (%)
Yes: 16/30(53%)
No/unclear: 14/30 (47%)
Yes: 19/46 (41%)
No/unclear: 27/46 (59%)
0.62 (0.24, 1.56) 0.305
Adequate allocation concealment,
proportion (%)
Yes: 5/30 (17%)
No/unclear: 25/30 (83%)
Yes: 11/46 (24%)
No/unclear: 35/46 (76%)
1.57 (0.49, 5.09) 0.451
Dealing with incomplete data Yes: 14/30 (47%)
No/unclear: 16/30 (53%)
Yes: 15/46 (33%)
No/unclear: 31/46 (67%)
0.55 (0.21, 1.42) 0.220
Blinding outcome assessors,
proportion (%)
Yes: 16/30 (53%)
No/unclear: 14/30 (47%)
Yes: 28/46 (61%)
No/unclear: 18/46 (39%)
1.36 (0.54, 3.45) 0.516
Length of follow-up period,
mean (SD) in months
13.15 (7.32)
n = 30
9.29 (4.90)
n = 46
0.88 (0.79, 0.98) 0.023
Use of manual for intervention
delivery, proportion (%)
Yes: 15/30 (50%)
No: 15/30(50%)
Yes: 17/46(37%)
No: 29/46(63%)
0.59 (0.23, 1.49) 0.262
Training of interventionists, proportion
(%)
Yes: 23/30 (77%)
No: 7/30(23%)
Yes: 34/46 (74%)
No: 12/46(26%)
0.86 (0.30, 2.52) 0.786
Supervision of interventionists,
proportion (%)
Yes: 4/30 (13%)
No: 26/30(87%)
Yes: 22/46 (48%)
No: 24/46(52%)
5.96 (1.79, 19.81) 0.004
Verification of intervention
fidelity, proportion (%)
Yes: 9/30 (30%)
No: 21/30 (70%)
Yes: 23/46 (50%)
No: 23/46 (50%)
2.33 (0.88, 6.16) 0.087
Considering reactivity in study design Yes: 23/30 (77%)
No: 7/30 (23%)
Yes: 14/46 (30%)
No: 32/46(70%)
0.13 (0.05, 0.38) <0.001
Control condition, proportion with
active control (%)
9/30 (30%) 12/46 (26%) 0.82 (0.30, 2.29) 0.709
aFor categorical variables = the odds of a study judged as ‘yes’ to that characteristic being conducted in a hospital setting rather
than a primary care setting; for continuous variables = the change in the odds of a study being conducted in a hospital setting
rather than a primary care setting for each unit increase in the value of the variable. CI, confidence interval.
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ensuring intervention fidelity, was dropped. Thus, nine
independent variables were included in multiple logis-
tic meta-regression.
Of the nine independent variables included in the
multiple logistic meta-regression, three were statisti-
cally significant at 5% significance level: number of
sessions [odds ratio (OR) = 0.281 (95% CI 0.081,
0.979; P = 0.046)]; exclusion of very heavy/dependent
drinkers [OR = 0.052 (95% CI 0.004, 0.716,
P = 0.027)] and gender composition of study sample
(measured as proportion of males) [OR = 1.063 (95%
CI 1.005, 1.125; P = 0.033)] (Table 2).The smaller the
number of sessions, the higher the likelihood of the
study having been conducted in hospital settings than
in primary care settings. Only 10/46 (22%) of studies
conducted in hospital settings excluded dependent or
very heavy drinkers compared with 21/30 (70%) of
studies conducted in primary care settings. Studies with
a higher proportion of male participants were more
likely to have been conducted in hospital settings than
in primary care settings.
Sensitivity analysis: primary care versus hospital
setting studies
Number of sessions, exclusion of very heavy/dependent
drinkers and gender composition of study sample
(measured as proportion of males) were statistically
significant predictors when the 10%, 20% or 30% sig-
nificance levels were used to select covariates to include
in the multiple logistic meta-regression. In addition,
when using the 10% significance level, personnel deliv-
ering the intervention (physician vs. non-physician)
also became statistically significant [OR = 0.057 (95%
CI 0.006, 0.579; P = 0.015)]. When using the 30%
significance level verification of intervention fidelity
also became statistically significant [OR = 26.06 (95%
CI 1.298, 0.523.069; P = 0.033)].
Comparing general hospital inpatients studies with
emergency department studies
From univariate logistic meta-regression, statistically
significant predictors (at 20% significance level) were:
supervision of interventionists, verification of interven-
tion fidelity, length of follow-up period, use of a manual
during intervention delivery, training interventionists,
gender composition of study sample (measured as pro-
portion of males), mean age of study sample, sample
size, adequate randomisation sequence generation and
control condition utilised (usual care/no intervention
vs. a comparison between two active interventions).
However, none of these variables were statistically sig-
nificant predictors of study setting in the multiple logis-
tic meta-regression model. In addition, utilising the
10% significance level to select covariates resulted in no
statistically significant independent variables from the
multiple logistic meta-regression model.
Discussion
The observed statistically significant predictors of
whether the study was conducted in primary care or
hospital settings from the multiple logistic meta-
regression model were: number of sessions, exclusion
of heavy/dependent drinkers and gender composition
of study sample. The predictive value of the number of
sessions was moderate, with an increase of one session
resulting in a 72% decrease in the odds of a study being
conducted in a hospital rather than in primary care
setting, when all the other covariates are fixed. This is
the same for excluding very heavy/dependent drinkers
Table 2. Results from multiple logistic meta-regression model with the potential predictors of study setting (those that were significant at 25%
significance level from the univariate regression models) as independent variables (characteristic)
Characteristic Odds ratioa 95% CI P-value
Personnel delivering the intervention (physician vs. non-physician) 0.103 0.007, 1.511 0.097
Exclusion of very heavy/dependent drinkers, yes versus no 0.052 0.004, 0.716 0.027
Number of sessions 0.281 0.081, 0.979 0.046
Accounting for screen/assessment reactivity, yes versus no 0.174 0.017, 1.782 0.141
Verification of intervention fidelity, yes versus no 12.935 0.804, 207.900 0.071
Length of follow-up period 0.831 0.677, 1.020 0.077
Gender composition of study samples (proportion of males) 1.063 1.005, 1.125 0.033
Mean age of sample 0.950 0.840, 1.074 0.416
Dealing with incomplete data 2.644 0.169, 41.341 0.488
aFor dichotomised variables = the odds of a study judged as ‘yes’ to that characteristic being conducted in a hospital setting rather
than a primary care setting; for continuous variables = the change in the odds of a study being conducted in a hospital setting
rather than a primary care setting for each unit increase in the value of the variable. CI, confidence interval.
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where the odds of a study that excluded such drinkers
having been conducted in a hospital as opposed to
primary care setting is 95% lower than of a study that
did not. The predictive strength of gender composition
was however very weak, with a 6.3% increase in the
odds of a study being conducted in the hospital rather
than primary care for each percentage increase in the
proportion of males. The associated confidence inter-
vals for these estimates were however very wide, poten-
tially as a result of a small number of studies used in the
analysis.
Studies comprising of fewer intervention sessions
were more likely to have been conducted in hospital
settings than in primary care settings. Recent debates
within the brief intervention field have focused on the
need to determine the optimal treatment exposure
that is most likely to have an impact on alcohol con-
sumption [5]. Kaner et al. suggest that intervention
intensity (length/number of sessions) can influence the
effectiveness of BIs for alcohol problems [34].
Research in other areas such as smoking cessation has
also suggested a dose–response relationship between
intensity of counselling (length or number of treat-
ment sessions) and cessation success [61–63]. More
studies in primary care than those in the hospital
setting could have potentially benefited from addi-
tional treatment sessions. Although number of ses-
sions was a statistically significant predictor of setting,
total time taken delivering the intervention to each
participant (intervention duration) was not. This
could mean that more studies in primary care, where
continued patient engagement is relatively easier, uti-
lised BIs with higher numbers of sessions of shorter
duration, whereas more in hospital settings utilised
longer sessions with fewer number of sessions.
A number of studies in hospital settings enrolled a
large proportion of very heavy/dependent drinkers as a
result of not excluding this population from the study
[39,64–69]. For example, Saitz et al. reported that more
than 75% of the study sample was alcohol dependent
[64], and this was approximately 50% for Liu et al.
[66].There is not enough evidence to either support or
refute the effectiveness of BIs among very heavy/
dependent drinkers. Although some researchers have
reported they are effective in reducing alcohol con-
sumption among heavy/dependent drinkers [41,66],
others have found them ineffective [40].The severity of
drinking and alcohol problems may explain the more
inconsistent results on BIs effectiveness in hospital set-
tings when compared with primary care settings where
the results have been more consistent.The cut-off point
for exclusion of very heavy/dependent drinkers differed
from study to study, and for the review we applied each
study’s classification. For example, Anderson and Scott
excluded those consuming more than 1050 g of alcohol
per week [44]; Fleming et al. excluded those drinking
more than 50 drinks per week [70,71], whereas others
excluded those with an AUDIT score of 15 and above
[72,73].
Studies with a higher proportion of male participants
were more likely to have been conducted in hospital
settings than primary care settings.Two reviews reported
that in some cases where data is available by gender, the
effectiveness of BIs is clear in men but not in women
[3,5]. From this, the expected impact of having higher
proportions of males in hospital setting studies would
have been to increase the intervention effect size.
However, where hospital setting studies have reported
outcomes by gender, some concluded that gender had
no impact on intervention effects [69,74–76], whereas
others did show an impact, favouring females [42,77].
One reported a significant treatment effect for women
receiving a brief motivational intervention with a booster
but not for men [77].Another reported that women aged
22 years receiving some advice were the most likely to
decrease their heavy drinking episodes [42]. In the study
by Monti et al., men showed statistically significantly
higher scores on alcohol consumption and alcohol prob-
lems than women after 12 months of follow-up [75]. For
some studies conducted in primary care, gender did
not account for difference in alcohol consumption
[70,71,78]. Fleming et al. however reported a greater
reduction in consumption by women in the intervention
group than men in the same group [70]. Rubio et al.
reported a greater intervention effect for women,
whereas Richmond et al. reported the opposite [79,80].
Senft et al. reported a gender effect favouring men at 6
months but not at 12 months [81]. Two other studies
also reported similar findings, although it was unclear
which gender benefited more from the intervention
[38,82]. In light of this, it could be useful to explore the
impact of gender on the effectiveness of BIs. If a gender
impact exists, it could also be useful to explore whether
it varies by setting.
Although in theory, the various components for
ensuring and measuring intervention fidelity potentially
have an impact on intervention effect size, research
exploring whether this is indeed the case is limited;
indicating more is needed. Monitoring the quality of
the delivery of psychological interventions is central to
clinical governance of routine clinical practice, super-
vision and psychotherapy research, and therefore
should not be considered elective [60,83]. Some exem-
plars for monitoring and evaluation of intervention
fidelity exist [84–86]. However, practical guidelines for
such evaluations are lacking [58,84]; thus, practice may
vary widely [84]. Santacroce et al. consider the gold
standard of evidence of intervention fidelity as consist-
ing of a randomly selected sample of recorded sessions
stratified in terms of interventionists, condition and site
BIs: primary care and hospital settings 375
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assessed by trained raters to ensure ongoing reliability
[60]. It is also useful to explore whether including
process data in the main analysis of intervention effec-
tiveness has an impact on the intervention effect size.
Currently, although some studies might measure inter-
vention fidelity and report their findings, often these
data are reported separate from the main effectiveness
results.
Other important issues that were not examined in
this review include: mode of intervention delivery,
theory behind the intervention and behaviour change
techniques (BCTs) included in the intervention. For
the mode of intervention delivery, there was not enough
variation to make comparisons. All studies in primary
care, the interventions were delivered face to face as
were 45/50 studies conducted in hospital settings. The
theory behind the intervention was not always reported,
with eight studies reporting using the Transtheoretical
Model of Behaviour Change, two studies reporting
using more than one theory and 35 studies reporting
using Motivational Interviewing. BCTs were also not
always reported, and the terminology used was incon-
sistent across studies. Michie et al. have proposed a
consistent terminology for specifying BCTs utilised in
interventions for reduce excessive alcohol consumption
[87]. However, to our knowledge, this taxonomy is yet
to be validated. Another issue not explored due to poor
reporting was the differences in proportions of partici-
pants in the intervention group who actually received
the intervention. There could also be a difference
between primary care and hospital setting studies
because of general environmental factors such as: pres-
sure of work; practical and logistical difficulties in con-
ducting screening and BIs in hospital settings as
compared with primary care settings; and the ability to
continue engaging with the patient particularly if there
is a delay between randomisation and delivery of the
brief intervention, for example a patient may be dis-
charged from hospital before the intervention is deliv-
ered, and it could be difficult to re-engage with them for
the study.
The present review focused on comparing studies by
their setting in order to identify study design differences
between BI studies conducted in primary care settings
and those in hospital settings. Future work exploring
the extent to which each of the potential moderators
identified here may actually explain the variation in
effect size through meta-regression techniques would
be a valuable contribution to the literature. Calculation
of the effect sizes would also provide quantitative infor-
mation on the aggregate efficacy of treatments con-
ducted in primary care versus hospital settings.
Studies focusing specifically on participants with
dual diagnosis (comorbidity or the co-occurrence in an
individual of a psychoactive substance use disorder and
another psychiatric disorder) were excluded from this
review. However, dual diagnosis is common among
patients with alcohol use problems [88,89]. Although
some studies take efforts to exclude dual diagnosis
patients, some do not, which might result in many
participants having a co-occurring psychiatric disorder.
For example, in the study by Saitz et al., more than 70%
of patients had current generalised anxiety disorders,
more than 70% had current substantial depressive
symptoms and approximately 40% had current sub-
stantial posttraumatic stress disorder symptoms [64].
In the study by Liu et al., approximately 19% of par-
ticipants had a diagnosis of at least one of the following
in the previous year: current depressive disorder, dys-
thymic disorder, generalised anxiety disorder and
insomnia [66].
We considered emergency department, hospital out-
patient departments and inpatient wards/units together
as a single group, when in reality these settings are likely
to be different. However, our secondary analysis
showed no statistically significant predictors of setting
when studies conducted in the emergency department
were compared with those conducted in inpatient
wards/units. Although we performed an extensive
search, checked reference lists of systematic reviews,
searched of a number of electronic databases using
broad and rigorous literature search strategies, it is still
possible that studies were missed, particularly those
reported in languages other than English. Limiting the
language to English could affect precision as analysis
would have been based on fewer studies if any non-
English studies were missed [90]. It would also limit
inference of the results to studies published in English
[91].
Conclusion
In conclusion, differences exist between studies con-
ducted in primary care and those conducted in hospital
settings on number of sessions, exclusion of heavy/
dependent drinkers and gender composition of the
study samples. These differences might partly explain
the difference in the consistency of findings on the
effectiveness of brief interventions on reducing alcohol
consumption between the two settings.
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Supporting information
Additional Supporting Information may be found in
the online version of this article at the publisher’s
web-site:
Table S1 List of included studies.
Appendix 1: search strategy for MEDLINE
(OVID SP)
1946–present
1. exp Alcohol-Related Disorders/
2. exp Drinking Behavior/
3. (alcoholic$ or alcoholism).ti,ab.
4. (alcohol$ adj (abuse$ or misuse$ or use$ or
problem$ or depend$ or addict$ or disorder-
$)).ti,ab.
5. Alcoholics/
6. substance-related disorders/
7. or/1–6
8. exp Hospitals/
9. exp Hospital Units/
10. exp Emergency Service, Hospital/
11. Inpatients/or Outpatients/
12. (hospital$ or inpatient$ or outpatient$ or out-
patient$ or acute care or ward$).ti,ab.
13. (emergency department$ or emergency room$
or (accident adj2 emergency) or trauma center-
$).ti,ab.
14. family pract$/or exp Primary Health Care/
15. general pract$.ti,ab.
16. primary care/
17. community health services/or exp Community
Health Services/
18. Community Care.ti,ab.
19. family medicine/
20. family phys$.ti,ab.
21. or/8–20
BIs: primary care and hospital settings 379
© 2013 Australasian Professional Society on Alcohol and other Drugs
- 134 -
22. ‘Referral and Consultation’/
23. counseling/or directive counseling/
24. (refer$ or counsel$ or talk$).ti,ab.
25. brief intervention$.ti,ab.
26. Patient Education as Topic/
27. (educat$ or advice or advise or advisor$ or
therapy or therapist$ or rehabilitat$).ti,ab.
28. alcohol liaison nurs$.ti,ab.
29. alcohol specialist nurs$.ti,ab.
30. alcohol health worker$.ti,ab.
31. or/22–30
32. randomized controlled trial.pt.
33. controlled clinical trial.pt.
34. (randomized or randomised or rct$).ti,ab.
35. placebo$.ti,ab.
36. (crossover$ or cross over$ or cross-over$ or
(doubl$ adj blind$) or (singl$ adj blind$)).ti,ab.
37. randomly.ti,ab.
38. trial$.ti,ab.
39. clinical trials as topic.sh.
40. or/32–39
41. 7 and 21 and 31 and 40
Appendix 2 Criteria for making judgements on study design characteristics
Study design characteristic Yes No
Exclusion of very heavy/
dependent drinkers
Study had criteria which excluded very
heavy/dependent drinkers from
participating in the study
No criteria excluding very heavy/dependent
drinkers from participating in the study
Adequate sequence
generation
Sequence generation has a random
component that ensured participants were
assigned to different treatment groups in a
study in a truly random manner
Sequence generation procedure not reported/
clearly does not have a random
component
Blinding of outcome
assessor
Outcome assessor reported as blind to
intervention allocation
Outcome assessor reported as ‘not
blinded’/no mention of blinding of
outcome assessor in the study report
Adequate dealing with
incomplete data
Included methods of minimising bias from
incomplete data in the analysis
No measures to minimising bias from
incomplete data
Use of manual during
intervention delivery
Study reported that interventionists were
guided by a manual; logarithm; checklist
or other written material during
intervention delivery
No report of any manual; logarithm;
checklist or other written material being
used during intervention delivery.
Study specifying that no such written material
were used to guide intervention delivery
Training of interventionists Study reported that interventionists were
trained on the study intervention protocol.
No report of training of interventionists on
the study intervention protocol.
Study specifying that interventionists received no
training on the study intervention protocol.
Supervision of
interventionists
Study reported interventionists were
supervised
No report of supervision of interventionists.
Study specifying that there was no supervision
of interventionists
Verification of intervention
fidelity
Study reported including any procedures for
assessing and measuring adherence to
intervention delivery protocol
No procedures for assessing and measuring
adherence to intervention delivery protocol
reported
Accounting for screening/
assessment reactivity in
the study design
Study reporting including any procedure or
design to minimise the impact of
screening/assessment reactivity
No procedure or design to minimise the
impact of screening/assessment reactivity
reported
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Abstract
Rationale, aims and objectives To find consensus, or lack thereof, on the impact of
reducing alcohol consumption on prognosis and the risk of hospital admissions for a
number of alcohol-attributable disorders.
Methods A modified two-round Delphi survey utilizing web-based questionnaires to
collect quantitative and qualitative data was used. Alcohol treatment experts from cardiol-
ogy, emergency medicine, gastroenterology and oncology in the United Kingdom were
invited to participate. The main outcomes were median impact ratings (on a scale of 1–9)
and consensus (unanimous, strong, moderate, weak or no consensus).
Results Of 192 experts invited to participate, 59 completed first questionnaires. The
overall retention rate to the second questionnaires was about 51% (30/59). There was strong
support that reducing alcohol consumption could result in improvement in prognosis for
gastroenterology and emergency medicine patients; but uncertainty on the benefits for
cardiology and oncology patients. Overall, the responses from the expert panel did not
reflect the assumption that reducing alcohol consumption would result in benefits on
hospital admissions for any of the specialties. The specialists viewed the severity of
disorders as important when considering the impact of reducing alcohol consumption.
Conclusions The highest impact of treatment for problem drinking in hospitals is consid-
ered to be for alcohol-related disorders associated with gastroenterology and emergency
medicine. At policy level, if targeted screening for alcohol problems by presenting disease
or condition is the strategy of choice, it would be logical to implement screening and easily
accessible interventions or addiction specialists within these areas where alcohol treatment
is considered as having a high impact.
Introduction
The misuse of alcohol remains a major challenge to population
health, health services costs and society [1]. Most research
studies on interventions for alcohol misuse have involved iden-
tifying eligible patients through universal screening (screening
all patients) [2–4]. However, universal screening may be imprac-
tical, both in routine practice and within research studies, for
various reasons. Time constraints are frequently cited [5–7], as
are concerns that universal screening might not benefit sufficient
numbers of people to warrant the extra workload required and
result in a high rate of disappointment for practitioners [8]. The
widespread scepticism on the treatment benefits of screening
and interventions for alcohol problems also contributes to low
implementation [9,10]. In addition, uncertainty around the
efficiency and acceptability of screening still exists [7,11], par-
ticularly on the universal screening strategy. There are sugges-
tions that targeted screening (screening specific high-risk patient
groups) will be more acceptable to both health care professionals
and patients [2,11,12]. Comparative evidence of the effective-
ness, cost-effectiveness and acceptability of targeted versus uni-
versal screening is however still limited. Targeting can be by age
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[13–15], gender [16], medical condition [6] or new registrations
[17,18], for example.
Although the majority of people with alcohol problems do not
seek treatment specifically for these problems [1,19,20], they may
seek treatment for other conditions which may or may not be
related to alcohol [1]. These contacts with the health care service
are opportunities to engage with them [21]. Qualitative studies
have pointed to awareness of accumulating harms and triggering
occurrences as potential catalysts for change among patients with
unhealthy alcohol use [22,23]. A recent study has also suggested
that having an alcohol-attributable illness at hospital admis-
sion may catalyse intervention benefits among non-dependent
unhealthy alcohol users and those who do not view their drinking
as problematic [24]. A patient’s presenting condition could there-
fore provide a means of targeting those with a high likelihood of
alcohol-related problems who will potentially have the largest
expected health gain from interventions aimed at reducing alcohol
consumption. The Paddington Alcohol Test, for example, targets
10 conditions that are attributable to alcohol for patients attending
emergency departments [6]. However, excessive alcohol consump-
tion also impacts on other acute and chronic diseases besides those
mostly encountered in emergency departments [25]. Evidence on
how to target screening and interventions for alcohol use by pre-
senting disease condition is limited, hence practice may vary
widely. Some researchers suggest that enquiring about medical
conditions associated with alcohol use as a pre-screening pro-
cedure is acceptable to patients and health care professionals [3].
The aim of this study was to find consensus, or lack thereof, on
the impact of reducing alcohol consumption on prognosis and the
risk of hospital admissions for a number of alcohol-attributable
diseases or conditions through a Delphi survey [26]. The study
brings together a wider range of direct knowledge and experience
from medical specialists regarding which patients, based on their
presenting medical problems, would potentially have the largest
expected health gains from interventions aimed at reducing
alcohol consumption [26]. The National Institute of Health and
Clinical Excellence (NICE) in the United Kingdom and other
professional and guideline development bodies in other countries
have used formal consensus development methods in guideline
development to synthesise individual judgements in a structured,
transparent and replicable way, particularly where research
evidence does not exist [26–29].
Methods
The Delphi survey
The Delphi method is a formal, systematic and structured commu-
nication technique for consensus development, priority setting or
collective decision making which relies on a panel of experts
[30,31]. The method is particularly used where research evidence
does not exist, or is impossible to obtain economically within the
time frame it is required [26–29]. The main premise of the method
is that group opinions are more valid and reliable than individual
opinions (i.e. several people are less likely to arrive at a wrong
answer than a single individual) [31,32]. A Delphi survey involves
two or more rounds of questionnaires completed by the experts,
with a facilitator providing anonymized feedback from previous
rounds before the questionnaires for the next round are completed
[26,30,31]. The idea is that with each round the range of answers
will decrease and the group will converge towards the ‘correct’
answer, thus increasing concurrent validity of the findings [26].
The stop criterion is usually predefined. For example, it could be
the number of rounds, achievement of consensus or stability of
results [31].
The participating experts usually remain anonymous even after
the survey is completed in order to prevent them from influencing
each other’s responses [26]. However, to achieve the recom-
mended response rates of above 70% for each round [33], it is
usually necessary for the facilitator or researcher to know the
identity of respondents in order to follow up with non-responders
[32]. In such cases where true anonymity is not possible, ‘quasi-
anonymity’ is pursued where the respondents are known to the
facilitator or researcher [32].
The Delphi survey presented in this article was implemented in
four stages: (1) identification and selection of key issues to focus
on for the survey; (2) panel selection and recruitment; (3) conduct-
ing the two-round survey using web-based questionnaires; and
(4) data analysis. These will be described below.
Identification and selection of key issues
The key focus issues to explore in the Delphi survey were deter-
mined through an iterative process involving scoping of existing
literature, and discussions over four project management team
meetings. Literature scoping was used to identify any existing
theoretical and evidence-based strategies for targeting alcohol
treatment by presenting medical condition. The discussion meet-
ings were then used to set priorities and build consensus on which
key issues to focus on for the Delphi survey. We aimed to capture
the views of clinicians, health care providers (in this case the
United Kingdom’s National Health Service) and researchers.
These meetings were therefore attended by 12 individuals consist-
ing of three clinicians (one emergency medicine consultant, one
addiction psychiatry consultant and one liaison psychiatry consult-
ant), one psychologist, three commissioning managers for alcohol
services, and five researchers specializing on alcohol consumption
and drug use research. The meeting attendees were not part of the
survey panel.
Two key issues that were agreed upon through consensus were:
What would be the impact of reducing alcohol consumption on:
(1) prognosis (or the course of the disease or condition); and
(2) risk of hospital admission?
Panel selection and recruitment
Practitioners within four medical specialties (cardiology, emer-
gency medicine, gastroenterology and oncology), who were also
experts on the treatment of alcohol-related disorders, were identi-
fied from a variety of sources: (i) NICE guideline working groups;
(ii) specialty societies; (iii) hospitals; and (iv) universities. An
email was sent to all those identified in this way inviting them to
participate in the study, and providing them with an explanation of
what the study involved and its aims. The letter also contained a
link to the relevant online survey questionnaire, which was created
using SurveyMonkey (Europe Sarl, Luxembourg). We also asked
these individuals to identify any other experts we could contact for
this study.
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The survey procedure
The survey was predefined as a two-round survey using web-based
questionnaires, with a ‘quasi-anonymity’ strategy where the survey
facilitator or researcher knew the identities of the respondents to
facilitate follow-up of non-responders.
Diseases and conditions attributable to alcohol were identified
from Jones et al. [25]. Jones and colleagues listed 47 alcohol-
attributable conditions, 13 of which are, by definition, wholly
attributable and 34 are partially attributable to alcohol consump-
tion [25]. We utilized this list of alcohol-attributable conditions
because, unlike other studies [34,35], it only reports on conditions
where, at the time the Delphi survey was conducted, there was
sufficient evidence in the available epidemiological literature of a
causal relationship between alcohol consumption and the disease
or condition.
The diseases or conditions attributable to alcohol were grouped
into the following specialties: cardiology, emergency medicine,
gastroenterology and oncology. The clinicians involved in the
project management team meetings recommended that some of the
conditions be omitted (such as pedestrian traffic accidents, water
transport accidents, air/space transport accidents, drowning,
alcohol-induced pseudo-Cushing’s syndrome and alcoholic
polyneuropathy) as they were not common among patients seen by
specialists. This resulted in the list in Appendix 1.
We designed four questionnaires for each of the two rounds
(each specialty had one questionnaire from each round focusing on
diseases or conditions relevant to that specific specialty). The
questionnaires were piloted with a number of health professionals
and necessary changes in the wording and length made. There are
a number of reasons why health care professionals (including
medical specialists) might refuse to participate in surveys. The
most important reason for non-response is lack of time [36]. One
of the most successful strategies to increase response rates is
therefore ensuring the survey questionnaire completion time is as
short as possible, while collecting all the important information
[36]. The feedback from the piloting phase suggested that a com-
pletion time of more than 10 minutes would discourage question-
naire completion. We therefore aimed for a questionnaire
completion time of less than 10 minutes. The questionnaires were
sent out in two rounds as described below.
First round
The first round questionnaire had two main questions asking the
specialists separately to rate, for each of the listed diseases or
conditions, how much reducing alcohol consumption would: (1)
improve prognosis; and (2) reduce the risk of hospital admissions.
A rating scale of 1–9 was adapted [37,38] where: 1 = not at all; 9 =
definitely a significant improvement (for prognosis)/reduction (for
risk of hospital admissions). Respondents were also asked if there
were any other important issues that should be considered in
determining how best to target alcohol treatment by presenting
disease or condition. Data were also collected on respondent’s
gender, age and years of experience in their respective specialty.
Potential respondents in the United Kingdom within the four
specialties (i.e. cardiology, emergency medicine, gastroenterology
and oncology) were emailed their own unique link to the relevant
questionnaire. We sent two reminders to non-responders: the first
one 3 weeks after the initial email; and the second one 3 weeks
after the first reminder with a 3-week deadline.
Second round
The second round began shortly after the analysis of responses
from the first round. Three members of the project management
team consisting of two consultants (one in emergency medicine
and the other in addiction psychiatry) and a researcher in addiction
met to decide items for inclusion in the second questionnaires.
One theme that was common across all four disciplines as
important to consider was how severity of disease or condition
could influence the impact of reduction in alcohol consumption on
prognosis or risk of hospital admission. Thus, for the second
questionnaire, we asked respondents whether, for each disease or
condition, reduction in alcohol consumption would improve prog-
nosis or reduce the risk of hospital admission for mild, moderate or
severe disease or condition (with answer choices yes/no for each
disease or condition severity).
To shorten the questionnaire and encourage a high retention
rate, the second questionnaire only included diseases or conditions
where there was either no consensus, weak consensus or moderate
consensus from the first questionnaire. We assumed that severity of
disease did not matter much for those diseases or conditions where
there had been unanimous (100%) or strong (≥80%) agreement on
the impact rating. The second questionnaire was only sent to those
who had responded to the first questionnaire, and included a
summary of the results from the first questionnaire. Reminders
were scheduled as for the first round.
Data analysis
Quantitative data analysis
The impact levels for the first questionnaire were adapted from
Musila and colleagues [38] as well as the research and develop-
ment approach [37]. We considered median ratings of 1–3 as
indicating no or very low, 4–6 as indicating medium, and 7–9 as
indicating high improvement in prognosis or reduction in risk of
hospital admissions. If the median fell in the middle of the border
(i.e. 3.5 or 6.5), then it was considered in the higher range. For
example, if median was 6.5, then it was considered in the 7–9
range. We established five levels of consensus that are: unanimous
(100% of experts have ratings in one of the three ranges, i.e. 1–3;
4–6; 7–9); strong (<100 and ≥80 of experts); moderate (<80 and
≥70 of experts); weak consensus (<70 and ≥60 of experts); none
(<60 of experts).
For the second questionnaire, we considered at least 80% ‘Yes’
responses as indicating agreement that reducing alcohol consump-
tion would lead to improvement in prognosis or reduction in the
risk of hospital admissions for the disease or condition at that level
of severity. When mapped onto the consensus levels of the first
round, at least 80% ‘Yes’ responses would be within the strong (if
<100 and ≥80% ‘Yes’ responses) or unanimous (if 100% ‘Yes’
responses) consensus levels.
We determined the overall as well as speciality-specific
response rates as the proportion of potential respondents sent
a questionnaire that actually completed it (including partial
completion).
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Analysis of open text responses
Two researchers independently went through the open text
responses extracting and listing the issues to consider in deter-
mining how best to target alcohol treatment that were suggested
by each respondent. The two researchers discussed their findings,
resolving any differences through discussion and referring back
to the open text responses when necessary. This process resulted
in one combined list per specialty. Thematic analysis was then
performed for each of the resulting lists to identify any emerging
themes [39]. These themes, after being agreed upon by the
two researchers through discussion, were used as a coding
framework for each of the issues to consider, with statements
belonging to the same theme being grouped together. The final
stages involved identifying common themes across the four spe-
cialties, as well as those that were unique to each of the four
specialties.
Results
Participant recruitment and response rates
Table 1 summarizes the overall and the specialty-specific
response rates for the first and second round questionnaires, as
well as the participant characteristics. A total of 192 participants
were invited for the Delphi survey (154 identified directly from
the different sources described under ‘Panel selection and
recruitment’ and 38 from the snowballing process). Fifty-nine
out of the 192 invited specialists (31%) completed first-round
questionnaires. Second-round questionnaires were responded to
by 30 of the 59 (51%) who had responded to the first-round
questionnaires.
The Delphi survey results
The results from the Delphi survey are summarized below.
Tables 2 and 3 contain detailed results on the impact of reducing
alcohol consumption on prognosis/course of illness (Table 2) and
the risk of hospital admission (Table 3). The detailed results from
the second-round questionnaires are provided as online-only
Supporting Information material.
Impact of reducing alcohol consumption on
prognosis/course of illness
Overall, the findings from this study reflect strong support among
the experts that reducing alcohol consumption could result in
improvement in prognosis for gastroenterology and emergency
medicine patients. For these two specialties there was a large
proportion of conditions for which consensus was reached with the
median rating suggesting at least medium impact of reducing
alcohol consumption on prognosis/course of illness (i.e. 6 out of
10 for gastroenterology and 8 out of 14 for emergency medicine).
When considering only those conditions where there was at least
moderate consensus for medium or high impact, it was 6 out of
10 conditions for gastroenterology, and 5 out of 14 for emergency
medicine.
On the other hand, there were high levels of uncertainty of the
benefits of reducing alcohol consumption on prognosis/course of
illness for the majority of conditions within the remaining two
specialties: cardiology and oncology. For cardiology, although
some consensus for medium or high impact was reached for four
conditions, it was weak for all except alcoholic cardiomyopathy
where it was unanimous. For oncology, consensus was reached
only for two out of seven conditions, with moderate consensus that
reducing alcohol consumption would result in high levels of
improvement on prognosis for both.
Impact of reducing alcohol consumption on the risk of
hospital admissions
Overall, the responses from the experts who participated in this
study did not reflect the assumption that reducing alcohol con-
sumption would result in benefits on hospital admissions for any
Table 1 Response rates and respondent’s characteristics
First questionnaire
Second
questionnaire
Response
rates (%)
Age in years:
mean (SD)
min-max
Gender: number
(proportion)
of male
respondents (%)
Years of
experience:
mean (SD)
min-max
Retention
rates (%)
All 59/192 (30.7) 46.9 (8.9)
31–68
47 (79.7) 17.7 (8.8)
1–40
30/59 (50.8)
Cardiology 14/48 (29.2) 47.5 (7.4)
37–59
12 (85.7) 18.4 (7.8)
6–30
6/14 (42.9)
Emergency medicine 17/32 (53.1) 41.9 (7.9)
31–62
14 (82.4) 14.9 (8.8)
1–35
8/17 (47.1)
Gastroenterology 17/51 (33.3) 52.3 (10.0)
36–68
14 (82.4) 20.2 (10.5)
3–40
11/17 (64.7)
Oncology 11/61 (18.0) 46.1 (6.7)
37–57
7 (63.6) 17.5 (6.8)
8–28
5/11 (45.5)
SD, standard deviation.
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of the specialties. Although for a number of gastroenterology
(6 out of 10) and emergency medicine conditions (7 out of 14)
there was consensus for medium or high impact, the number
where at least moderate consensus for these impact levels was
reached was very low (three for each of the two specialties). For
cardiology, there was no consensus for all except one condition,
alcoholic cardiomyopathy, where there was strong consensus for
high levels of reduction in risk of hospital admission. For oncol-
ogy, the only condition where consensus was reached (albeit
weak consensus) was malignant neoplasm of oesophagus with
suggestions of high impact.
Other issues to consider
Seven cardiologists, six emergency medicine physicians, nine gas-
troenterologists and seven oncologists gave at least one suggestion
on other issues to consider. Five themes were identified from the
open text responses and these are discussed below.
Table 3 Impact of reducing alcohol consumption on risk of hospital admission
Condition
Number of
respondents
Risk reduction rating
distribution (%)
Median
rating Impact level Consensus1–3 4–6 7–9
Cardiology
Alcoholic cardiomyopathy 13 7.7 0 92.3 8 High Strong
Hypertensive diseases 13 38.5 23.0 38.5 6 Medium None
Ischaemic heart disease 13 46.1 30.8 23.1 4 Medium None
Cardiac arrhythmia 13 23.1 38.5 38.4 5 Medium None
Heart failure 13 23.1 38.5 38.4 6 Medium None
Haemorrhagic stroke 13 30.8 53.8 15.4 5 Medium None
Ischaemic stroke 13 38.5 46.1 15.4 4 Medium None
Emergency medicine
Methanol poisoning 14 64.3 21.4 14.3 2 None/very low Weak
Ethanol poisoning/toxic effects of alcohol 15 13.3 0 86.7 8 High Strong
Road traffic accidents – non-pedestrian 15 6.6 26.7 66.7 7 High Weak
Fall injuries 15 20.0 20.0 60.0 7 High Weak
Work/machine injuries 14 35.7 35.7 28.6 4 Medium None
Firearm injuries 15 40.0 33.3 26.7 4 Medium None
Fire injuries 15 20.0 33.3 46.7 6 Medium None
Accidental excessive cold 15 6.6 26.7 66.7 7 High Weak
Intentional self-harm/event of undetermined intent 15 0 20.0 80.0 8 High Strong
Assault 15 0 20.0 80.0 8 High Strong
Inhalation of gastric contents/inhalation and ingestion
of food causing obstruction of respiratory tract
15 33.3 26.7 40.0 6 Medium None
Epilepsy and status epilepticus 15 40.0 33.3 26.7 4 Medium None
Mental and behavioural disorders due to use of alcohol 15 6.7 33.3 60.0 7 High Weak
Spontaneous abortion 14 64.3 28.6 7.1 2.5 None/very low Weak
Gastroenterology
Alcoholic gastritis 17 17.7 23.5 58.8 7 High None
Alcoholic liver disease 17 0 5.9 94.1 9 High Strong
Oesophageal varices 17 0 11.8 88.2 8 High Strong
Gastro-oesophageal laceration-haemorrhage syndrome 17 11.8 23.5 64.7 7 High Weak
Cholelithiasis 17 82.4 11.8 5.8 1 None/very low Strong
Acute and chronic pancreatitis 17 0 17.6 82.4 8 High Strong
Unspecified liver disease 17 23.5 41.2 35.3 5 Medium None
Diabetes mellitus (type II) 17 64.7 17.6 17.7 3 None/very low Weak
Alcoholic myopathy 17 5.9 29.4 64.7 7 High Weak
Degeneration of nervous system due to alcohol 17 17.7 23.5 58.8 7 High None
Oncology
Malignant neoplasm of colon 10 40.0 40.0 20.0 4.5 Medium None
Malignant neoplasm of rectum 10 40.0 40.0 20.0 4.5 Medium None
Malignant neoplasm of liver and intrahepatic bile ducts 10 10.0 40.0 50.0 6.5 High None
Malignant neoplasm of lip cavity and pharynx 9 0 44.4 55.6 6.5 High None
Malignant neoplasm of larynx 9 11.2 44.4 44.4 6.5 High None
Malignant neoplasm of breast 9 22.2 55.6 22.2 4.5 Medium None
Malignant neoplasm of oesophagus 10 10.0 60.0 30.0 6.5 High Weak
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Severity of disease/condition
As highlighted before, the influence of the severity of disease or
condition on the impact of reduction in alcohol consumption on
prognosis or risk of hospital admission emerged as a common
theme across all four specialties. Severity of disease was suggested
as important by three cardiology respondents, two emergency
medicine respondents, two gastroenterology respondents and one
oncology respondent.
For cardiology, reducing alcohol consumption was viewed as
highly beneficial to the prognosis of mild, moderate and severe
heart failure; moderate and severe hypertensive disease; and severe
cardiac arrhythmias, haemorrhagic stroke and ischaemic stroke.
Reducing alcohol consumption was also viewed as highly benefi-
cial in reducing the risk of hospital admission for moderate and
severe heart failure and cardiac arrhythmias, and severe hyperten-
sive disease.
For emergency medicine, reducing alcohol consumption was
viewed as highly beneficial to the prognosis of mild, moderate and
severe non-pedestrian road traffic accidents and fall injuries; mod-
erate inhalation of gastric contents or inhalation and ingestion of
food causing obstruction of respiratory tract and work or machine
injuries; and moderate and severe fire injuries and accidental exces-
sive cold. Reducing alcohol consumption was also viewed as highly
beneficial in reducing the risk of hospital admission for mild,
moderate and severe pedestrian road traffic accidents, fall injuries
and mental and behavioural disorders due to use of alcohol; mod-
erate epilepsy and status epilepticus; moderate and severe inhala-
tion of gastric contents or inhalation and ingestion of food causing
obstruction of respiratory tract and accidental excessive cold.
The gastroenterologists viewed reducing alcohol consumption
as highly beneficial to the prognosis of mild, moderate and severe
alcoholic gastritis; moderate and severe gastro-oesophageal
laceration-haemorrhage syndrome and alcoholic myopathy; and
severe unspecified liver disease. Reducing alcohol consumption
was also viewed as highly beneficial in reducing the risk of hos-
pital admission for moderate and severe degeneration of nervous
system due to alcohol; and severe alcoholic gastritis, gastro-
oesophageal laceration-haemorrhage syndrome, unspecified liver
disease and alcoholic myopathy.
Oncologists viewed reducing alcohol consumption as highly
beneficial to the prognosis of mild malignant neoplasm of lip
cavity and pharynx, and malignant neoplasm of oesophagus; and
mild, moderate and severe malignant neoplasm of liver and
intrahepatic bile ducts. However, they viewed reducing alcohol
consumption as non-beneficial to the reduction of the risk of hos-
pital admissions of all the conditions included under oncology
regardless of severity. The results are however based on responses
from only three respondents.
Provision of interventions for reducing
alcohol consumption
Provision of interventions for reducing alcohol consumption was
highlighted as important by four emergency medicine physicians,
three gastroenterologists, three cardiologists and one oncologist.
One emergency medicine physicianphysician viewed the emer-
gency department as the best place to intervene as the presenting
condition would potentially be related to alcohol consumption.
The following were also suggested for emergency medicine: a
clear pathway and intervention strategies that are acceptable to
both patients and health care professionals (one respondent); the
time of day that patients with alcohol problems are most likely to
present to the emergency department (one respondent); full cost
analysis, including ambulance time (one respondent).
Three gastroenterology experts perceived use of brief screening
questionnaires, and the availability of easily accessible interven-
tions as well as multidisciplinary teams to support patients with
alcohol problems as important. While two cardiology experts sug-
gested provision of interventions such as counselling and self-help
material within the cardiology setting, another was of the opinion
that alcohol problems among cardiology patients should be dealt
with in community settings and not in the hospital. One oncology
expert suggested the availability of psychological support for
alcohol problems.
Availability of support systems
The availability of appropriate support services after discharge
from hospital, such as easily accessible community or rehabilitation
services, was mentioned by one cardiologist, three gastroenterolo-
gists, one oncologist and one emergency medicine physician. Some
of these experts suggested support should go beyond alcohol ser-
vices to include other aspects such as nutritional support (one
gastroenterologist and one oncologist), and social factors such as
family support, joblessness, homelessness (one gastroenterologist),
and children and young people safeguarding issues (one emergency
medicine physician).
Prioritizing by disease/condition and not by specialty
Some responses suggested prioritizing by disease/condition rather
than by specialty. One cardiology respondent perceived cardiology
patients not as a priority and suggested other conditions such as
liver disease, trauma, acute alcohol excess and patients admitted
with fits as priority.
Five gastroenterology respondents suggested focusing on
patients with particular conditions such as alcohol dependence,
liver cirrhosis or developing cirrhosis, alcoholic liver disease inpa-
tients, head injury and those admitted for detoxification.
For oncology, prioritization of patients with alcohol dependence
or those where alcohol use is known to be problematic was sug-
gested by two respondents. Two specialists highlighted that once a
cancer is diagnosed, oncologists may not be too concerned about
alcohol intake, particularly if the cancer is very advanced. Probing
the patient about alcohol intake would be more likely if the patient
comes to the clinic smelling of alcohol, or is having recurrent
admissions for treatment-related toxicity. Two oncology experts
highlighted that the diagnosis itself can actually alter the drinking
patterns either for better or for worse, and in some instances
making it difficult for patients to stop drinking.
Population level impact
One cardiology respondent suggested considering how the impact
of reducing alcohol consumption on prognosis and risk of hospital
admissions for a particular disease/condition would translate to
an impact at population level. They highlighted that, for some
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conditions such as alcohol-related heart failure or cardiomyopathy,
although reducing alcohol intake could lower the incidence, this
would have a limited impact on the population as a whole.
Discussion
Principal findings
The findings from this study reflect strong support among the
experts that reducing alcohol consumption could result in
improvement in prognosis for gastroenterology and emergency
medicine patients. There were high levels of uncertainty of the
benefits for oncology and cardiology patients, except for alcoholic
cardiomyopathy where there was unanimous consensus for high
benefit. The responses from the experts who participated in this
study did not reflect the assumption that reducing alcohol con-
sumption would result in benefits on the risk of hospital admission
for patients for any of the specialties.
The severity of disease or condition was viewed as an important
consideration when targeting patients for screening and interven-
tions for alcohol problems. For most cardiovascular and gastroen-
terology diseases or conditions included in the second
questionnaire, the proportion of specialists suggesting potential
benefit from reduced alcohol consumption on prognosis and
reduction in the risk of alcohol consumption generally increased
with increasing severity of disease. For oncology, it was the oppo-
site with the proportion suggesting potential benefit generally
decreasing with increasing severity of disease. For emergency
medicine, while in some cases the proportion suggesting potential
benefit increased with increasing severity of disease, for some it
was highest for moderate disease or condition (e.g. for work or
machine injuries). The availability of easily accessible intervention
for reducing alcohol consumption was suggested as important
particularly for emergency and gastroenterology patients. Another
issue viewed as important was the availability of aftercare and
social support services within the community.
Study strengths and weaknesses
Although respondents were anonymous to each other, the
researchers could link their responses to their email addresses. It is
therefore possible that participants gave responses that they per-
ceived to be aligned with current scientific and professional opin-
ions. Linking the email addresses to the responses was however
necessary to facilitate follow-up of non-responders for higher
response rates. Even with such a procedure, however, the overall
response rate from all those invited for the Delphi survey was
about 31%, with approximately 51% retention rate for the second
questionnaire. The number of respondents for each specialty for
the first round of the Delphi was sufficient for consensus when
considering recommendations by Fitch and colleagues of a
minimum of seven [37]; while in the second round this was
achieved for two specialties. For oncology, only three specialists
responded to questions on the impact of reducing alcohol con-
sumption on the risk of hospital admissions in the second ques-
tionnaire, making the interpretation of data from this section
particularly difficult. It is also possible that participants gave
responses that they perceived to be aligned to current discussions
and literature on the topic because of the increased attention on
alcohol problems and increased expectation for health care pro-
fessionals to proactively detect and provide interventions for
patients with alcohol problems.
We specifically asked the respondents not to consider the cost
implications as this was not within the scope of the research
described here. Moreover, although cost is important in the selec-
tion of treatment options, a recent study suggests outcomes of
consensus development are affected by availability of resources
only to a very limited extent [27]. In order for the research to be
relevant to a number of stakeholders, we involved clinicians, a
psychologist, commissioning managers for alcohol services and a
team of researchers in the research process. The research process
could however also have benefited from involving a representative
from each of the other specialty areas of focus, namely cardiology,
gastroenterology and oncology; for example, in the framing of the
questions. However, the framing of the questions was only high-
lighted as problematic by one oncologist.
Comparison with other studies
There are suggestions that providing treatment for problem drink-
ers can reduce health care utilization, including hospital admis-
sions, and cost [40–42]. However, our study suggests that benefits
on reducing hospital admissions are not clear to health care pro-
fessionals. In addition, a recent systematic review by Bray and
colleagues concluded that screening and brief interventions for
alcohol problems have little or no effect on inpatient or outpatient
health care utilization, but may have a small, negative effect on
emergency department utilization [43].
Implications of the study
The fact that availability of easily accessible intervention for
reducing alcohol consumption was suggested for emergency and
gastroenterology patients in particular is potentially related to the
fact that, overall, reducing alcohol consumption was viewed to be
more beneficial within these two settings when compared with
cardiology and oncology patients. These findings could imply that
health care professionals might be more willing to implement
screening and interventions for alcohol problems among patients
with gastroenterology and emergency medicine conditions than
among patients with oncology and cardiology conditions. This
opens up a useful discussion about the targeting of resources for
hospital-based alcohol treatment. For example, where targeted
screening and intervention by presenting condition is the strategy
of choice, a focus on gastroenterology and emergency medicine
could be an acceptable starting point.
Even though interventions for alcohol problems might be
viewed as important for emergency medicine and gastroenterology
patients, attempts to get health care professionals working with
these patients, as well as in other general hospital settings, to
screen for alcohol problems and deliver appropriate interventions
have repeatedly failed [44,45]. Literature suggests that implemen-
tation can be facilitated by education and training of health care
professionals to: (i) increase the awareness and understanding of
alcohol problems; (ii) increase their knowledge on the benefits of,
and skills in, detecting alcohol problems and providing interven-
tions; and (iii) perceive screening and interventions for alcohol
problems as their responsibility [44,46].
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Where it is difficult for health care professionals to detect and
deliver appropriate interventions, easy access to specialists on
interventions for alcohol problems would encourage better identi-
fication and referral of patients, particularly where alcohol treat-
ment could have a high impact [44]. Thus, at policy and practice
levels, hospital settings such as emergency medicine and gastro-
enterology where high proportions of patients could greatly benefit
from alcohol interventions can, as a minimum, implement an inter-
disciplinary collaborative team model where addiction specialists
work alongside other health care professionals [44,45].
Unanswered questions and future research
Williams et al. conducted a secondary analysis of data to evaluate
the associations between poor physical health and drinking after
hospitalization and whether associations varied by alcohol
dependence status and readiness to change [24]. Their results
suggest that having an alcohol-attributable illness may catalyse
reduction in drinking among medical inpatients with non-
dependent unhealthy alcohol use and those who do not view their
drinking as problematic. Our results suggest that even among the
alcohol-attributable diseases or conditions, some are perceived by
health care professionals as benefiting more from reduction in
alcohol consumption in terms of prognosis and risk of hospital
admissions than others. There is however still a need for robust
empirical evidence on whether patients with diseases or condi-
tions, which are perceived as potentially having the largest
expected health gains from interventions aimed at reducing
alcohol consumption, actually benefit more than those with other
diseases or conditions. There is also a need for comparative evi-
dence on the effectiveness, cost-effectiveness and acceptability of
targeted screening by disease or condition versus universal screen-
ing. Research exploring effective and cost-effective ways of max-
imizing response rates of health care professional questionnaires is
also needed [47].
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Appendix 1: List of diseases or
conditions included in the Delphi
survey by specialty
Cardiology
Alcoholic cardiomyopathy
Hypertensive diseases
Ischaemic heart disease
Cardiac arrhythmia
Heart failure
Haemorrhagic stroke
Ischaemic stroke
Emergency medicine
Methanol poisoning
Ethanol poisoning/toxic effects of alcohol
Road traffic accidents – non-pedestrian
Fall injuries
Work/machine injuries
Firearm injuries
Fire injuries
Accidental excessive cold
Intentional self-harm/event of undetermined intent
Assault
Inhalation of gastric contents/inhalation and ingestion of food
causing obstruction of respiratory tract
Epilepsy and status epilepticus
Mental and behavioural disorders due to use of alcohol
Spontaneous abortion
Gastroenterology
Alcoholic gastritis
Alcoholic liver disease
Oesophageal varices
Gastro-oesophageal laceration-haemorrhage syndrome
Cholelithiasis
Acute and chronic pancreatitis
Unspecified liver disease
Diabetes mellitus (type II)
Alcoholic myopathy
Degeneration of nervous system due to alcohol
Oncology
Malignant neoplasm of colon
Malignant neoplasm of rectum
Malignant neoplasm of liver and intrahepatic bile ducts
Malignant neoplasm of lip cavity and pharynx
Malignant neoplasm of larynx
Malignant neoplasm of breast
Malignant neoplasm of oesophagus
Supporting information
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Table S1. Impact on prognosis by severity of disease/condition.
Table S2. Impact on risk of hospital admissions by disease
condition.
Impact of reducing alcohol consumption: a Delphi survey N.D. Mdege et al.
© 2013 John Wiley & Sons, Ltd.110
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Definitions 
 
Assessment The use of procedures designed to explore fully the 
nature and extent of a person’s problems with alcohol 
or illicit drugs, and to gain an understanding of exactly 
how they might be helped. 
Comprehensive 
assessment package 
Questionnaire(s) that are used as a package to 
explore fully the nature and extent of a person’s 
problems with alcohol or illicit drugs, and to gain an 
understanding of exactly how they might be helped. 
Dependence When the level and pattern of alcohol or illicit drug use 
has resulted in a dependence syndrome which is a 
cluster of cognitive, behavioural and physiological 
symptoms. 
General hospital 
setting 
Inpatient medical units, hospital outpatients and 
accident and emergency departments (including 
trauma centres) based at hospitals not specializing in 
the treatment of psychiatric disorders or addiction. 
Harmful use When alcohol or illicit drug use is already causing 
damage to the user’s physical or mental health. 
Hazardous use A level and pattern of unhealthy alcohol use or illicit 
drug use that puts the user at risk of harmful 
consequences (which maybe negative physical 
health, mental health or social consequences). 
Illicit drug use The use of drugs which are under international control 
(and which may or may not have licit medical 
purposes) but which are produced, trafficked and 
consumed illicitly. 
Intervention An act performed to prevent harm to a patient or to 
improve the mental, emotional, or physical function of 
a patient. 
Novel psychoactive 
substance 
A new narcotic or psychotropic drug, in pure form or in 
preparation, that is not controlled by the 1961 United 
Nations Single Convention on Narcotic Drugs or the 
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1971 United Nations Convention on Psychotropic 
Substances, but which may pose a public health 
threat comparable to that posed by substances listed 
in these conventions.  
Problem drug use Regular illicit drug use with or without drug use 
disorders or dependence. 
Screening The use of procedures to identify individuals with 
alcohol or illicit drug use related problems or 
consequences, or those who are at risk for such 
problems. 
Screening instruments Questionnaires that are used to identify individuals 
with alcohol or illicit drug use related problems or 
consequences, or those who are at risk for such 
problems. 
Unhealthy alcohol use Any level of drinking that causes problems or puts the 
drinker at risk of developing problems  
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Glossary 
 
ADAPTA Addressing Drinking Among Patients: comparing Two 
Approaches 
AHW Alcohol health worker 
ARiAS Addiction Research in Acute Settings 
BI Brief intervention 
HSCIC Health and Social Care Information Centre 
GGT Serum gamma-glutamyltransferase 
MCV Mean corpuscular volume 
NHS National Health Service 
NICE National Institute for Health and Clinical Excellence 
NPS Novel psychoactive substance 
RCT Randomised controlled trial 
UNODC United Nations Office on Drugs and Crime 
WHO World Health Organization 
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